7+(/$:$1'32/,&<2)23,2,'6)253$,10$1$*(0(17$'',&7,21
75($70(17$1'29(5'26(5(9(56$/
&RUH\6'DYLV'HUHN+&DUU
7$%/(2)&217(176
, ,1752'8&7,21
,, 23,2,'6$1'3$,1
A. The burden of untreated pain.
% The importance of opioid therapy
& Potential pitfalls of opioid therapy
,,,23,2,'6$1''58*55($70(17
$ The burden of untreated opioid addiction
% Medication assisted treatment
& Federal Regulation of MAT: Historical Context
' Federal Regulation of Methadone
( Federal Regulation of Buprenorphine
) Insurance Coverage of MAT
,9$&&(66721$/2;21(
$ Access to emergency overdose treatment
% Addressing legal and policy barriers to naloxone access
1. Immunity
2. Prescribing outside of the traditional prescriber relationship
3. Overdose Good Samaritan laws
4. Over-the-counter access
9 &21&/86,21««««««««««««««««««««««««
, ,1752'8&7,21
3HUKDSV IHZ GUXJV DUH PRUH HPEOHPDWLF RI WKH KXPDQ FRQGLWLRQ WKDQ WKRVH GHULYHG IURP
RSLRLGV3UHSDUDWLRQVRIWKHRSLRLGSRSS\KDYHEHHQXVHGIRUWKRXVDQGVRI\HDUVIRUERWKWKHLU
HXSKRULFDQGDQDOJHVLFHIIHFWV7KHVHQDWXUDOSUHSDUDWLRQVKDYHEHHQMRLQHGE\V\QWKHWLFDQGVHPL
&RUH\6'DYLV'HSXW\'LUHFWRU1HWZRUNIRU3XEOLF+HDOWK/DZ6RXWKHDVWHUQ
5HJLRQ
'HUHN+&DUU/HJDO)HOORZ1HWZRUNIRU3XEOLF+HDOWK/DZ6RXWKHDVWHUQ5HJLRQ
,1',$1$+($/7+/$:5(9,(:
9RO
V\QWKHWLFSURGXFWVWKDWFDQEHKXQGUHGVDQGVRPHWLPHVWKRXVDQGVRIWLPHVVWURQJHUEXWWKH
PDLQ UHDVRQV IRU WKHLU SRSXODULW\²UHOLHI RI SK\VLRORJLFDO DQG SV\FKRORJLFDO SDLQ²UHPDLQ
XQFKDQJHG,QWKH8QLWHG6WDWHVSDLQLVVRSUHYDOHQWDQGRSLRLGPHGLFDWLRQVVRZLGHO\DYDLODEOH
WKDWRYHUGRVHVRISUHVFULSWLRQRSLRLGVDQGKHURLQKDYHEHFRPHDSXEOLFKHDOWKFULVLVUHVSRQVLEOH
IRUWHQVRIWKRXVDQGVRIGHDWKVSHU\HDU$WWKHVDPHWLPHDQGGHVSLWHWKHHIIRUWVRIGHGLFDWHG
UHIRUPHUVPLOOLRQVRISHRSOHLQGHYHORSLQJFRXQWULHVVXIIHUDJRQL]LQJSDLQWKDWFRXOGEHUHOLHYHG
ZLWKDIHZGROODUV¶ZRUWKRIPRUSKLQH
,Q DQ LURQLF WZLVW RSLRLGV KDYH SURYHQ H[WUHPHO\ HIIHFWLYH LQ UHGXFLQJ PDQ\ RI WKH KDUPV
DVVRFLDWHGZLWKRSLRLGPLVXVHEXWODFNRIHYLGHQFHEDVHGODZDQGSROLF\FRQVSLUHZLWKVWLJPDWR
PDNH LW GLIILFXOWIRUPDQ\SHRSOHWRDFFHVVWKHVH OLIHVDYLQJWUHDWPHQWV7KHFKLHIPHGLFDWLRQV
XVHG IRU WKH WUHDWPHQW RI DGGLFWLRQ PHWKDGRQH DQG EXSUHQRUSKLQH DUH FRQVLGHUHG ³(VVHQWLDO
0HGLFDWLRQV´E\WKH:RUOG+HDOWK2UJDQL]DWLRQ³:+2´EXWDUHRIWHQQRWDYDLODEOHHYHQLQWKH
H[WUHPHO\ZHOOUHVRXUFHG8QLWHG6WDWHV7KHVDPHLVRIWHQWUXHUHJDUGLQJWKHPHGLFDWLRQQDOR[RQH
LWVHOIGHULYHGIURPWKHRSLRLGWKHEDLQHZKLFKTXLFNO\DQGHIIHFWLYHO\UHYHUVHVRSLRLGRYHUGRVHEXW
LVRIWHQQRWUHDGLO\DYDLODEOHZKHQDQGZKHUHLWLVQHHGHG
,QWKLVSDSHUZHDGGUHVVWKHVHLVVXHVLQWXUQDQGFRQFOXGHZLWKDEULHIGLVFXVVLRQRISURPLVLQJ
OHJDODQGSROLF\DSSURDFKHVWRUHGXFHWKHWHUULEOHEXUGHQVRIXQWUHDWHGSDLQRSLRLGDGGLFWLRQDQG
RYHUGRVHPRUELGLW\DQGPRUWDOLW\:HEHJLQLQ3DUW,,E\GLVFXVVLQJWKHLPSRUWDQFHRIRSLRLGVLQ
WKHWUHDWPHQWRIVRPHW\SHVRISDLQDVZHOODVLQHTXLWLHVLQDFFHVVWRRSLRLGV²DQGVHWWKHVWDJH
IRU WKH UHVW RI WKH SDSHU ZKLFK IRFXVHV RQ DWWHPSWV WR DGGUHVV WKH SUREOHPV FDXVHG E\ D
PLVDSSOLFDWLRQRIRSLRLGWKHUDS\WRFRQGLWLRQVIRUZKLFKLWLVQRWLQGLFDWHG,Q3DUW,,,ZHKLJKOLJKW
WKHLPSRUWDQFHRIRSLRLGVIRUWKHWUHDWPHQWRIRSLRLGXVHGLVRUGHUDQGWKHVRFLDOOHJDODQGSROLF\
EDUULHUVWRDFFHVVRIWKLVHYLGHQFHEDVHGWUHDWPHQW,Q3DUW,9ZHQRWHLQQRYDWLRQVLQDFFHVVWRWKH
PHGLFDWLRQQDOR[RQHLQFOXGLQJXQSUHFHGHQWHGDFWLRQVDWWKHVWDWHOHYHOWREUHDNWKURXJKEDUULHUV
FDXVHGE\WKHGUXJ¶VVWDWXVDVDSUHVFULSWLRQPHGLFDWLRQXQGHUIHGHUDOODZ:HFRQFOXGHLQ3DUW9
ZLWKVRPHEULHIWKRXJKWVUHJDUGLQJSURPLVLQJDSSURDFKHVWRUHGXFHWKHWZLQSXEOLFKHDOWKFULVHV
RIXQWUHDWHGSDLQDQGWKHQHJDWLYHHIIHFWVRIRSLRLGDEXVHDGGLFWLRQDQGRYHUGRVH
,, 23,2,'6$1'3$,1
A. The Burden of Untreated Pain
8QWUHDWHGRULQDGHTXDWHO\WUHDWHGSDLQLVDVHULRXVPHGLFDOVRFLHWDODQGHFRQRPLFFRQFHUQ
³3DLQDIIHFWVPLOOLRQVRI$PHULFDQVFRQWULEXWHVJUHDWO\WRQDWLRQDOUDWHVRIPRUELGLW\PRUWDOLW\
DQG GLVDELOLW\ DQG LV ULVLQJ LQ SUHYDOHQFH´ &KURQLF SDLQ LV H[WUHPHO\ FRPPRQ LQ WKH 8QLWHG
6WDWHVDQGWKURXJKRXWWKHZRUOGZLWKDQHVWLPDWHGPLOOLRQ$PHULFDQVVXIIHULQJIURPSDLQ
,1672)0('86&20021$'9$1&,1*3$,15(6($5&+&$5($1'('8&5(/,(9,1*
3$,1,1$0(5,&$$%/8(35,17)2575$16)250,1*35(9(17,21&$5(('8&$7,21$1'
5(6($5&+KHUHLQDIWHU³,205HSRUW´
3HWHU)09HUKDDNHWDOPrevalence of Chronic Benign Pain Disorder Among Adults: A
Review of the Literature3$,1$GOH\7VDQJHWDOCommon Chronic Pain
Conditions in Developed and Developing Countries: Gender and Age Differences and
Comorbidity with Depression-Anxiety Disorders - 3$,1 5HSRUWLQJ WKDW WKH
DJHVWDQGDUGL]HGSUHYDOHQFHRIFKURQLFSDLQLQWKHSUHYLRXVPRQWKVZDVLQGHYHORSHG
FRXQWULHVDQGLQGHYHORSLQJFRXQWULHV
7+(/$:$1'32/,&<2)23,2,'6
WKDWSHUVLVWVIRUPRQWKVRUORQJHU,W³DIIHFWVPRUH$PHULFDQVWKDQGLDEHWHVKHDUWGLVHDVHDQG
FDQFHUFRPELQHG´,QDUHFHQWV\VWHPDWLFVXUYH\PRUHWKDQRQHTXDUWHURI$PHULFDQVUHSRUWHG
WKDWWKH\KDGORZEDFNSDLQWKDWODVWHGDWOHDVWRQHGD\LQWKHSDVWWKUHHPRQWKVWKHQXPEHUVZHUH
IRUPLJUDLQHRUVHYHUHKHDGDFKHDQGDOPRVWIRUQHFNSDLQ,QDVHSDUDWHUHSRUWNQHH
SDLQZDVUHSRUWHGE\QHDUO\RI$PHULFDQVDQGVKRXOGHUSDLQE\5DWHVRIFKURQLFSDLQ
DSSHDUWREHULVLQJDWUHQGWKDWLVH[SHFWHGWRFRQWLQXHIRUDYDULHW\RIUHDVRQVLQFOXGLQJWKHDJLQJ
RIWKH$PHULFDQSRSXODWLRQ$FXWHSDLQZKLFKFDQDQGRIWHQGRHVEHFRPHFKURQLFLVDOVRKLJKO\
SUHYDOHQWDPRQJ$PHULFDQV
,QDGGLWLRQWRWKHPRUELGLW\FDXVHGE\SDLQLWVHOIFKURQLFSDLQLVDVVRFLDWHGZLWKDQXPEHURI
RWKHUQHJDWLYHFRQGLWLRQVLQFOXGLQJDQJHUGHSUHVVLRQDQGDQ[LHW\:KLOHWKHHFRQRPLFFRVWRI
SDLQLVGLIILFXOWWRPHDVXUHLWLVFOHDUWKDWERWKGLUHFWFRVWVLQWKHIRUPRIPHGLFDOH[SHQGLWXUHVDV
ZHOODVLQGLUHFWFRVWVLQWKHIRUPRIORVWSURGXFWLYLW\DQGORZHUTXDOLW\RIOLIHDUHKLJKDQGULVLQJ
2QHUHFHQWUHYLHZHVWLPDWHGWKHFRVWRISHUVLVWHQWSDLQLQWKH8QLWHG6WDWHVDWDSSUR[LPDWHO\
WRELOOLRQDQQXDOO\7KHLQGLUHFWDQGGLUHFWFRVWRIORZHUEDFNSDLQDORQHKDVEHHQHVWLPDWHG
DWDPLQLPXPRIEHWZHHQDSSUR[LPDWHO\DQGELOOLRQSHU\HDULQWKH8QLWHG6WDWHVZLWK
RQHHVWLPDWHRIRYHUELOOLRQSHU\HDU2QHVWXG\IRXQGELHQQLDOH[SHQGLWXUHVRQRXWSDWLHQW
FDUHIRUFKURQLFEDFNWRKDYHLQFUHDVHGIURPELOOLRQLQWRELOOLRQLQ
,205HSRUW supraQRWHDW
$PHULFDQ$FDGRI3DLQ0HGAAPM Facts and Figures on PainKWWSZZZSDLQPHGRUJ
>KWWSVSHUPDFF0<)/)<@ODVWYLVLWHG1RY
5LFKDUG$'H\RHWDOBack Pain Prevalence and Visit Rates: Estimates from U.S. National
Surveys, 200263,1(
,205HSRUWsupra QRWHDW
,205HSRUWsupra QRWHDW³>&@KURQLFSDLQUDWHVDUHOLNHO\WRFRQWLQXHWRULVHIRU
DWOHDVWILYHUHDVRQV´-&KLXHWDOAccess to Therapeutic Opioids: A Plan of Action for Donors,
NGOs, and Governments7(03/( ,17
/ &203 / - QRWLQJWKDWUDWHVRI
FDQFHUDQG+,9FDVHVDUHOLNHO\WRLQFUHDVHSDUWLFXODUO\LQWKHGHYHORSLQJZRUOG
+ .HKOHWHW DO Persistent Postsurgical Pain: Risk Factors and Prevention /$1&(7
HVWLPDWLQJWKDWRIEUHDVWVXUJHU\SDWLHQWVRIFRURQDU\E\SDVV
SDWLHQWVGHELOLWDWLQJDQGRIFDHVDUHDQSDWLHQWVVXIIHUSRVWVXUJHU\FKURQLFSDLQ
GHELOLWDWLQJ
/DFKODQ $ 0F:LOOLDPV HW DO Depression and Anxiety Associated with Three Pain
Conditions: Results from a Nationally Representative Sample3$,1ILQGLQJ
WKDWSV\FKLDWULFGLVRUGHUVZHUHPXFKPRUHSURQRXQFHGLQLQGLYLGXDOVZLWKDUWKULWLVPLJUDLQHDQG
EDFN SDLQ WKDQ LQ LQGLYLGXDOV ZLWKRXW WKRVH FRQGLWLRQV & 5 *UHHQ HW DO Cancer-Related
Chronic Pain: Examining Quality of Life in Diverse Cancer Survivors&$1&(5 SDLQDVVRFLDWHGZLWKGHSUHVVLRQ
'DUUHOO-*DVNLQ3DWUFLN5LFKDUGThe economic costs of pain in the United States-
3$,1FDOFXODWLQJWKHFRVWRISDLQUHODWHGKHDOWKFDUHDWELOOLRQDQG
ORVWSURGXFWLYLW\DWELOOLRQ
6LPRQ'DJHQDLVHWDOA Systematic Review of Low Back Pain Cost of Illness Studies in the
United States and Internationally63,1(-
0RQLFD 6PLWK HW DO Aging Baby Boomers and the Rising Cost of Chronic Back Pain:
Ssecular Trend Analysis of Longitudinal Medical Expenditures Panel Survey Data for Years 2000
,1',$1$+($/7+/$:5(9,(:
9RO
,Q OLJKW RI WKH KXPDQ VXIIHULQJ DQG HFRQRPLF EXUGHQV DVVRFLDWHG ZLWK SDLQ WUHDWLQJ DQG
SUHYHQWLQJLWLVERWKDNH\FKDOOHQJHDQGDPRUDOLPSHUDWLYH7KH,QVWLWXWHRI0HGLFLQHGHYRWHG
D QHDUO\ SDJH UHSRUW WR XQWUHDWHG SDLQ LQ GHFODULQJ LW ³D VLJQLILFDQW SXEOLF KHDOWK
SUREOHP´IRUZKLFKD³SRSXODWLRQKHDOWKOHYHOVWUDWHJ\LVQHHGHG´7KH:+2([SHUW&RPPLWWHH
RQ&DQFHU3DLQ5HOLHIKDVGHFODUHGWKDW³>I@UHHGRPIURPSDLQVKRXOGEHVHHQDVDULJKWDQG
DFFHVVWRSDLQWKHUDS\DVDPHDVXUHRIUHVSHFWIRUWKLVULJKW´
B. The Importance of Opioid Therapy
2SLRLGVKDYHEHHQNQRZQWRKXPDQVIRUDWOHDVW\HDUVZLWKWKHLUXVHIRUWUHDWPHQWRI
SDLQUHFRUGHGDVHDUO\DVDSSUR[LPDWHO\%&2SLRLGVDFWLYDWHDQXPEHURIUHFHSWRUVPRVW
QRWDEO\WKHPXUHFHSWRU7KHVHUHFHSWRUVDIIHFWDQXPEHURIPHQWDODQGSK\VLFDOVWDWHVLQFOXGLQJ
HXSKRULDVHGDWLRQVXSUDVSLQDODQDOJHVLDDQGUHVSLUDWRU\GHSUHVVLRQ7KH\DUHSULPDULO\ORFDWHG
LQWKHEUDLQEXWDUHDOVRIRXQGLQWKHKHDUWLPPXQHV\VWHPDQGJDVWURLQWHVWLQDOWUDFWDPRQJRWKHU
SODFHV
2SLRLGV FDQ EH EURDGO\ FDWHJRUL]HG LQWR WZR FODVVLILFDWLRQV DJRQLVWV ZKLFK VWLPXODWH WKH
RSLRLGUHFHSWRUVDQGDQWDJRQLVWVZKLFKELQGWRWKHRSLRLGUHFHSWRUEXWGRQRWVWLPXODWHWKHP
to 2007- 0$1,38/$7,9($1' 3+<6,2/2*,&$/ 7+(5$387,&67KHVDPHVWXG\
IRXQGDLQFUHDVHLQWKHSUHYDOHQFHRIEDFNSDLQGXULQJWKHVWXG\SHULRGId. $W7KHVHFRVWV
DUHDOPRVWFHUWDLQO\KLJKHUWRGD\
-DQH&%DOODQW\QH-LDQUHQ0DROpioid Therapy for Chronic Pain1(:(1*-0('
>2@SLRLG WKHUDS\ FDQ UHOLHYH SDLQ DQG LPSURYH PRRG DQG IXQFWLRQLQJ LQ PDQ\
SDWLHQWVZLWKFKURQLFSDLQ-HIIUH\/$SIHOEDXPHWDOPostoperative Pain Experience: Results
from a National Survey Suggest Postoperative Pain Continues to be Undermanaged $1(67+(6,$$1$/(6,$3UHYHQWLRQDQGHIIHFWLYHUHOLHIRIDFXWHSDLQPD\LPSURYH
FOLQLFDORXWFRPHVDYRLGFOLQLFDOFRPSOLFDWLRQVVDYHKHDOWKFDUHUHVRXUFHVDQGLPSURYHTXDOLW\RI
OLIH
,205HSRUWsupraQRWHDW
:25/' +($/7+ 25* &$1&(5 3$,1 5(/,() $1' 3$//,$7,9( &$5( KWWSZKTOLEGRFZKRLQW>KWWSVSHUPDFF.:$=43@
See $1,/ $**5$:$/ 1$5&27,& '58*6 GRFXPHQWLQJ UHIHUHQFHV WR RSLRLGV LQ
6XPHULDQ $VV\ULDQ DQG (J\SWLDQ WH[WV SULRU WR %& $QGUHD0 7UHVFRWHW DO Opioid
Pharmacology 3$,1 3+<6,&,$1 6 6 ³$QFLHQW (J\SWLDQ SDS\UXV UHFRUGV
UHSRUWHGWKHXVHRIRSLXPIRUSDLQUHOLHI´
7UHVFRW HW DO supra QRWH DW 6 +DVDQ 3DWKDQ -RKQ :LOOLDPV Basic Opioid
Pharmacology: An Update%5,7,6+-3$,1³$OORSLRLGVXVHGLQFOLQLFDO
SUDFWLFHWRGD\H[HUWWKHLUDFWLRQDWOHDVWLQSDUWDWWKH023UHFHSWRU´7KHPXUHFHSWRUZDVQDPHG
IRUWKHILUVWOHWWHURIWKHILUVWFRPSRXQGVKRZQWRELQGWRLWPRUSKLQH
7UHVFRWHWDOsupra QRWHDW6
3DWKDQ:LOOLDPVsupraQRWHDW
6RPH RSLRLGV KDYH HOHPHQWV RI ERWK FDWHJRULHV DQG DUH FODVVLILHG DV SDUWLDO DJRQLVWV RU
DJRQLVWDQWDJRQLVWV7UHVFRWHWDOsupra QRWHDW63DWKDQ:LOOLDPVsupra QRWH
DW
7+(/$:$1'32/,&<2)23,2,'6
0RUSKLQHWKHSURWRW\SLFDORSLRLGDJRQLVWZDVLVRODWHGLQ6LQFHWKDWWLPHDODUJHQXPEHU
RI VHPLV\QWKHWLF DQG IXOO\ V\QWKHWLF RSLRLGV KDYH EHHQ FUHDWHG DQG SURGXFHG ,Q WKH 8QLWHG
6WDWHV DQG PRVW RWKHU KLJKUHVRXUFH FRXQWULHV WKHUDS\ ZLWK WKHVH PHGLFDWLRQV KDV EHFRPH WKH
PDLQVWD\RIWUHDWPHQWRIDFXWHSRVWRSHUDWLYHSDLQDQGPD\EHLQGLFDWHGIRUVRPHSDWLHQWVZKR
VXIIHU VXUJHU\UHODWHG FKURQLF SDLQ DQG VHYHUH FDQFHU SDLQ 7KH\ DUH DOVR LPSRUWDQW IRU WKH
WUHDWPHQWRISDLQLQLQGLYLGXDOVZLWK+,9RU$,'6IRUZKRPSDLQLVQRWZHOOFRQWUROOHGZLWKRWKHU
PHGLFDWLRQV$VZLOOEHGHVFULEHGLQWKHQH[W6HFWLRQVRPHRSLRLGVDUHDOVRH[WUHPHO\HIIHFWLYH
LQ WKH WUHDWPHQWRIRSLRLGDGGLFWLRQ,QUHFRJQLWLRQRIWKHYLWDOQDWXUHRIDFFHVVWRRSLRLGV WKH
:RUOG+HDOWK2UJDQL]DWLRQOLVWVWKUHHRSLRLGV±FRGHLQHPRUSKLQHDQGPHWKDGRQH±DV³HVVHQWLDO
PHGLFLQHV´WKDW³VKRXOGEHDYDLODEOHDWDOOWLPHVLQDGHTXDWHDPRXQWVDQGLQWKHDSSURSULDWHGRVDJH
IRUPV´
8QIRUWXQDWHO\WKLVLVQRWDOZD\VWKHFDVH,QDODUJHQXPEHURIFRXQWULHVSDWLHQWVZLWKVHYHUH
+,9FDQFHUDQGSRVWRSHUDWLYHSDLQKDYHOLWWOHRUQRDFFHVVWRRSLRLGWUHDWPHQW'HVSLWHKDYLQJ
7UHVFRWHWDOsupra QRWHDW3DWKDQ:LOOLDPVsupraQRWHDW3DWKDQDQG
:LOOLDPVSODFHWKHGDWHRILVRODWLRQRIPRUSKLQHDW
$OO RI WKH FXUUHQWO\ SUHVFULEHG RSLRLG DQDOJHVLFV VXFK DV R[\FRGRQH K\GURFRGRQH DQG
IHQWDQ\ODUHV\QWKHWLFRUVHPLV\QWKHWLFFRPSRXQGVWKDWPLPLFWKHJHQHUDODFWLRQRIWKHRSLXP
SRSS\EXWDUHQRWQHFHVVDULO\GHULYHGIURPLW3DWKDQ:LOOLDPVsupraQRWHDW
9HHUDEKDGUDP *DULPHOOD &KULVWLQD &HOOLQL Postoperative Pain Control &/,1,&6
&2/21 5(&7$/ 685*(5<5RVHPDU\&3RORPDQRHWDOPerspective on Pain
Management in the 21st Century,3$,10*071856,1*66³2SLRLGVXVHGLQ
FOLQLFDOSUDFWLFHUHPDLQWKHFRUQHUVWRQHRIPRGHUDWHDQGVHYHUHDFXWHSDLQWUHDWPHQW´
$XJXVWR &DUDFHQL HW DO Use of Opioid Analgesics in the Treatment of Cancer Pain:
Evidence-Based Recommendations from the EAPC7+( /$1&(7 21&2/2*< H GHVFULELQJ
RSLRLGDQDOJHVLFVDV³FUXFLDOWRWKHUHOLHIRIFDQFHUSDLQ´0+-YDQGHQ%HXNHQYDQ(YHUGLQJHQ
HWDOPrevalence of Pain in Patients with Cancer: A Systematic Review of the Past 40 Years
$11$/621&2/2*<ILQGLQJWKDWPRUHWKDQRIFDQFHUSDWLHQWVUHSRUWSDLQ
ZLWKPRUHWKDQRQHWKLUGRIWKHVHSDWLHQWVUDWLQJWKHLUSDLQDVPRGHUDWHRUVHYHUH
* 1HZVKDQ -$ 6WDDWV Evidence-Based Pain Guidelines in HIV Care - $662&
1856(6$,'6&$5(66:,//,$0%5(,7%$57$&/,1,&$/*8,'(726833257,9(
3$//,$7,9( &$5()25 +,9$,'6-RVHSK)2¶1HLOOHWDOHGVGHVFULELQJ
RSLRLGPHGLFDWLRQVDVD³PDLQVWD\´LQWKHWUHDWPHQWRIPRGHUDWHWRVHYHUHSDLQLQSDWLHQWVZLWK
FDQFHUDQG+,9
:25/'+($/7+25*:+202'(//,672)(66(17,$/0(',&,1(6OLVWLQJ
FRGHLQHPRUSKLQHDQGPHWKDGRQHDVHVVHQWLDOPHGLFLQHV:25/' +($/7+ 25*7+( 86(2)
(66(17,$/'58*6(,*+7+5(32572)7+(:+2(;3(57&200,77((
See ,17¶/1$5&27,&6&21752/%'1$5&27,&'58*6(67,0$7(':25/'5(48,5(0(176
)25 VKRZLQJ ZLGH GLVSDULWLHV LQ FRQVXPSWLRQ RI GUXJV EHWZHHQ PHPEHU
VWDWHV
See generally ( $QGHUVRQ &6 'DYLV Breaking the Cycle of Preventable Suffering:
Fulfilling the Principle of Balance7(03,17¶/&203/-QRWLQJWKDW³IHZ
EXUGHQV DUH DV IXQGDPHQWDOO\ FULSSOLQJ DQG VR HOHJDQWO\ UHIOHFW JOREDO KHDOWK GLVSDULWLHV DV
XQWUHDWHGSDLQ´'/RKPDQHWDOAccess to Pain Treatment as a Human Right%0&0('
QRWLQJWKDWODFNRISDLQWUHDWPHQWPHGLFLQHLQVRPHFRXQWULHVLV³ERWKSHUSOH[LQJDQG
,1',$1$+($/7+/$:5(9,(:
9RO
OHVVWKDQRIWKHZRUOG¶VSRSXODWLRQWKH8QLWHG6WDWHVFRQVXPHVPRUHWKDQRIWKHZRUOG¶V
RSLRLGV ,Q WKH DYHUDJH SHUFDSLWD FRQVXPSWLRQ RI WKH RSLRLG R[\FRGRQH LQ WKH 8QLWHG
6WDWHVZDVMXVWXQGHUPJZKLOHWKHYDVWPDMRULW\RIFRXQWULHVUHSRUWHGOHVVWKDQPJDQG
UHSRUWHGOHVVWKDQPJ7KHWRSPRUSKLQHFRQVXPLQJFRXQWULHV$XVWULD&DQDGD'HQPDUN
86$1HZ=HDODQGDQG6ZLW]HUODQGFRQVXPHGPRUHRIWKHGUXJWKDQWKHERWWRPFRPELQHG
7KH DYHUDJH FRQVXPSWLRQ RI WKHVH VL[ FRXQWULHV ZDV DSSUR[LPDWHO\ PJ SHU SHUVRQ
&RQYHUVHO\HLJKW\VL[FRXQWULHVUHSRUWHGFRQVXPLQJOHVVWKDQPJSHUFDSLWDZKLOHVL[W\VHYHQ
UHSRUWHG OHVV WKDQ PJ SHU FDSLWD %HFDXVH RI WKLV GLVSDULW\ LQ DFFHVV WR FOLQLFDOO\ LQGLFDWHG
RSLRLGV LW KDV EHHQ HVWLPDWHG WKDW PLOOLRQ SHRSOH ZLWK PRGHUDWH WR VHYHUH FDQFHU SDLQ JR
XQWUHDWHGHYHU\\HDUPRVWLQWKHGHYHORSLQJZRUOG
:KLOHOHVVSURQRXQFHGWKHVHGLVSDULWLHVH[LVWLQWKH8QLWHG6WDWHVDVZHOO1XPHURXVVWXGLHV
KDYH GRFXPHQWHG KLJKHU UDWHV RI SDLQ DPRQJ ZRPHQ FRPSDUHGWR PHQ DQG V\VWHPDWLF XQGHU
WUHDWPHQWRISDLQDSSHDUVWREHSUHYDOHQWDPRQJDWOHDVWVRPHUDFLDODQGHWKQLFPLQRULWLHV$
UHFHQW PHWDDQDO\VLV IRXQG WKDW +LVSDQLF DQG /DWLQR $PHULFDQV ZHUH OHVV OLNHO\ WR EH
SUHVFULEHG RSLRLG DQDOJHVLFV WKDQ WKHLU &DXFDVLDQ FRXQWHUSDUWV ZKLOH $IULFDQ $PHULFDQV ZHUH
OHVVOLNHO\WKDQVLPLODUO\VLWXDWHG&DXFDVLDQWREHSUHVFULEHGRSLRLGV
C. Potential Pitfalls of Opioid Therapy
$W WKH SRSXODWLRQ OHYHO KRZHYHU WKH SUREOHP LQ WKH 8QLWHG 6WDWHV LV PRUH RIWHQ RYHU
SUHVFULSWLRQ:KLOHSDWLHQWVZLWKVHYHUHFDQFHUSDLQLQPDQ\FRXQWULHVILQGLWLPSRVVLEOHWRDFFHVV
DQ\RSLRLGVDWDOOLQ$PHULFDHQRXJKRSLRLGVZHUHSUHVFULEHGLQWRPHGLFDWHHYHU\DGXOW
LQH[FXVDEOH´ )UDQN %UHQQDQ HW DO Pain Management: A Fundamental Human Right $1(67+(6,$ $1$/*(6,$ GHVFULELQJ ³D PDMRU JDS EHWZHHQ DQG LQFUHDVLQJO\
VRSKLVWLFDWHG XQGHUVWDQGLQJ RI WKH SDWKRSV\FKRORJ\ RI SDLQ DQG ZLGHVSUHDG LQDGHTXDF\ RI LWV
WUHDWPHQW´
'56RODQNLHWDOMonitoring Opioid Adherence in Chronic Pain Patients: Assessment of
Risk of Substance Misuse3$,13+<6,&,$1
3DLQ DQG 3ROLF\ 6WXGLHV *URXS 2014 Global Consumption of Oxycodone (mg/capita)
KWWSZZZSDLQSROLF\ZLVFHGX >KWWSVSHUPDFF*;*5<:3@ ODVW YLVLWHG 1RY 2QO\VHYHQW\VL[FRXQWULHVUHSRUWHGR[\FRGRQHXVHLQ
Id.
Id.
:LOOHP6FKROWHQHWDOThe World Health Organization Paves the Way for Action to Free
People From the Shackles of Pain$1(67+(6,$$1$/*(6,$
5 %HUQDEHL HW DO Management of Pain in Elderly Patients with Cancer. SAGE Study
Group. Systematic Assessment of Geriatric Drug Use via Epidemiology>-@$0$
EODFNQXUVLQJKRPHUHVLGHQWVOHVVOLNHO\WKDQVLPLODUO\VLWXDWHGZKLWHVWRUHFHLYHRSLRLGVIRU
FDQFHU SDLQ ,167 2) 0(' 81(48$/ 75($70(17 &21)5217,1* 5$&,$/ $1' (7+1,&
',63$5,7,(6,1+($/7+&$5(%'6PHGOH\HWDOHGVFLWLQJQXPHURXVH[DPSOHV
7KHSDSHUUHSRUWHGWKDWWKHVHGLIIHUHQFHVDUH³VXIILFHQWO\ODUJHWRLPSDFWFOLQLFDORXWFRPH´
6+0HJKDQLHWDOTime to Take Stock: A Meta-Analysis and Systematic Review of Analgesic
Treatment Disparities for Pain in the United States3$,10(',&,1(
7+(/$:$1'32/,&<2)23,2,'6
DURXQGWKHFORFN IRU D PRQWK 1HDUO\ SHUFHQW RI RIILFHEDVHG SK\VLFLDQ YLVLWV ZKHUH QRQ
FDQFHU SDLQ ZDV HLWKHU D SULPDU\ V\PSWRP RU GLDJQRVLV UHVXOW LQ D SUHVFULSWLRQ IRU RSLRLG
SDLQNLOOHUVDQGRIDOOHPHUJHQF\GHSDUWPHQWYLVLWV±HYHQWKRVHWKDWZHUHQRWSDLQUHODWHG±
UHVXOWLQDWOHDVWRQHRSLRLGEHLQJSUHVFULEHG
8QIRUWXQDWHO\PDQ\RIWKHVHSUHVFULSWLRQVZLOOOLNHO\GROLWWOHWRKHOSWKHSDWLHQWDQGVRPH
ZLOO FDXVH LUUHYHUVLEOH KDUP :KLOH RSLRLGV DUH RIWHQ SUHVFULEHG IRU DFXWH SRVWVXUJLFDO SDLQ
HYLGHQFHRIWKHLUHIILFDF\LQWUHDWLQJWKLVDQGRWKHUVKRUWWHUPSDLQLVZHDNDQGRIJHQHUDOO\ORZ
TXDOLW\SDUWLFXODUO\FRPSDUHGZLWKRWKHUWKHUDSLHV)RUH[DPSOHD&RFKUDQHUHYLHZRIWKH
VKRUWWHUPXVHRIRSLRLGVIRUORZEDFNSDLQFRQFOXGHGWKDW³WKHFXUUHQWOLWHUDWXUHGRHVQRWVXSSRUW
WKDW RSLRLGV DUH PRUH HIIHFWLYH WKDQ RWKHU JURXSV RI DQDOJHVLFV´ 6LPLODU ILQGLQJV KDYH EHHQ
UHSRUWHGIRUUKHXPDWRLGDUWKULWLVDQGRVWHRDUWKULWLVRIWKHNQHHDQGKLS(YHQIRUSRVWVXUJLFDO
SDLQWKH&RFKUDQHUHYLHZVIRXQGWKDWWKHPRVWHIIHFWLYHWKHUDS\ZDVQRWDQRSLRLGRURSLRLGLQ
FRPELQDWLRQZLWKDQRWKHUPHGLFDWLRQEXWUDWKHUDFRPELQDWLRQRILEXSURIHQDQGDFHWDPLQRSKHQ
$ V\VWHPDWLF UHYLHZ RI SDLQ UHOLHI IROORZLQJ WKLUG PRODU H[WUDFWLRQV VLPLODUO\ IRXQG WKDW D
FRPELQDWLRQRIDFHWDPLQRSKHQDQGLEXSURIHQ³DSSHDUHGWRSURYLGHDQDOJHVLDDWOHDVWHTXLYDOHQWWR
WKRVHRIFRPPRQO\SUHVFULEHGRSLRLGFRPELQDWLRQIRUPXODWLRQV´
&HQWHUVIRU'LVHDVH&RQWURODQG3UHYHQWLRQVital Signs: Overdoses of Prescription Opioid
Pain Relievers–United States, 1999-2008 025%,',7< $1' 0257$/,/7< :./< 5(3 1RY
0 'DXEUHVVH HW DO Ambulatory Diagnosis and Treatment of Nonmalignant Pain in the
United States, 2000-20100('&$5(
00D]HU$PLUVKDKLHWDORising Opioid Prescribing in Adult U.S. Emergency Department
Visits: 2001-2010$&$'(0(5*0('
/(&KDSDUURHWDOOpioids Compared to Placebo or Other Treatments for Chronic LowBack Pain7+(&2&+5$1('$7$%$6(6<65(9$XJKWWSRQOLQHOLEUDU\ZLOH\FRP
>KWWSVSHUPDFF34*$&@ 2SLRLGV ZHUH IRXQG WR EH QRW HIIHFWLYH DW DOO DW WUHDWLQJ SDLQ
UHODWHG WR VFLDWLFD 5 $ /HZLV HW DO Comparative Clinical Effectiveness of Management
Strategies for Sciatica: Systematic Review and Network Meta-Analyses63,1(-
6/:KLWWOHHWDOOpioid Therapy for Treating Rheumatoid Arthritis Pain&2&+5$1(
'$7$%$6(
6<6
5(9
1RY
KWWSRQOLQHOLEUDU\ZLOH\FRPGRL&'SXEDEVWUDFW
>KWWSVSHUPDFF.(;17:@
%5GD&RVWDHWDOOral or Transdermal Opioids for Osteoarthritis o f the Knee or Hip
&2&+5$1( '$7$%$6( 6<6 5(9 6HSW KWWSRQOLQHOLEUDU\ZLOH\FRP
>KWWSVSHUPDFF<'4&8&8@ILQGLQJWKDW³WKHVPDOOPHDQEHQHILWRIQRQWUDPDGRORSLRLGVDUH
FRQWUDVWHGE\VLJQLILFDQWLQFUHDVHVLQWKHULVNRIDGYHUVHHYHQWV´DQGWKDWWKHHIIHFWVRIRSLRLGVRQ
SDLQ³ZHUHRITXHVWLRQDEOHFOLQLFDOUHOHYDQFH´
'RQDOG 7HDWHU 1$7¶/ 6$)(7< &281&,/ (9,'(1&( )25 7+( ()),&$&< 2) 3$,1
0(',&$7,216 KWWSZZZQVFRUJ >KWWSVSHUPDFF=00(0@ ODVW YLVLWHG 1RY UHYLHZLQJ&RFKUDQHUHSRUWV
3 $ 0RRUH ( 9 +HUVK Combining Ibuprofen and Acetaminophen for Acute Pain
Management After Third-Molar Extractions: Translating Clinical Research to Dental Practice
-$0'(17$/$662&
,1',$1$+($/7+/$:5(9,(:
9RO
$OWKRXJKRSLRLGVDUHRIWHQSUHVFULEHGIRUFKURQLFQRQFDQFHUSDLQWKHUHLVVXUSULVLQJO\OLWWOH
HYLGHQFH VXSSRUWLQJ WKLV SUDFWLFH $ &RFKUDQH UHYLHZ RI WKH XVH RI FKURQLF RSLRLGV IRU
FKURQLFQRQFDQFHUSDLQIRXQGWKDWPDQ\SHRSOHGLVFRQWLQXHRSLRLGWKHUDS\GXHWRQHJDWLYHVLGH
HIIHFWVRUODFNRIDGHTXDWHSDLQUHOLHIDQGWKHUHLVRQO\³ZHDNHYLGHQFH´WKDWWKRVHZKRFRQWLQXH
ZLWKRSLRLGVH[SHULHQFH³FOLQLFDOO\VLJQLILFDQWSDLQUHOLHI´$V\VWHPDWLFUHYLHZIRXQGQR
VWXGLHVHYDOXDWLQJRSLRLGYVQRQRSLRLGWKHUDS\RYHUSHULRGVRIPRUHWKDQRQH\HDUWKHVWXGLHV
WKDWGRH[LVWVXJJHVWHGWKDWFKURQLFRSLRLGWKHUDS\³LVDVVRFLDWHGZLWKLQFUHDVHGULVNRIRYHUGRVH
RSLRLG DEXVH DQG GHSHQGHQFH IUDFWXUHV P\RFDUGLDO LQIDUFWLRQ DQG XVH RI PHGLFDWLRQV WR WUHDW
VH[XDOG\VIXQFWLRQ´7KH$PHULFDQ$FDGHP\RI1HXURORJ\UHFHQWO\FRQFOXGHGWKDW³>W@KHULVNV
IRU FKURQLF RSLRLG WKHUDS\ IRU VRPH FKURQLF FRQGLWLRQV VXFK DV KHDGDFKH ILEURP\DOJLD DQG
FKURQLFORZEDFNSDLQOLNHO\RXWZHLJKWKHEHQHILWV´
(YHQZKHQXVHGDVGLUHFWHGIRUFRQGLWLRQVIRUZKLFKWKH\DUHLQGLFDWHGRSLRLGVRIWHQFDXVH
QHJDWLYH VLGH HIIHFWV LQFOXGLQJ FRQVWLSDWLRQ QDXVHD YRPLWLQJ DQG KRUPRQDO FKDQJHV
3HUYHUVHO\ LW DSSHDUV WKDW IRU VRPH QXPEHU RI SHRSOH UHFHLYLQJ RSLRLGV DFWXDOO\ FDXVHV DQ
LQFUHDVHLQSDLQVHQVLWLYLW\:KHQRSLRLGVDUHGLVFRQWLQXHGDIWHUPRUHWKDQILYHWRVHYHQGD\V
PRVWSDWLHQWVZLOOVXIIHUZLWKGUDZDOV\PSWRPVZKLFKFDQUDQJHIURPPLOGGLVFRPIRUWWRSDLQIXO
PXVFOHSDLQVGLDUUKHDDQGQDXVHD3HUKDSVPRVWDODUPLQJO\VRPHQXPEHURISHRSOHZKRUHFHLYH
FKURQLFRSLRLGV±EHWZHHQDQGDFFRUGLQJWRDUHFHQWV\VWHPDWLFUHYLHZRIWKHOLWHUDWXUH±
,.LVVLQLong-Term Opioid Treatment of Chronic Nonmalignant Pain: Unproven Efficacy
and Neglected Safety?- 3$,1 5(6FRQFOXGLQJWKDWWKHUHLVQRVWURQJHYLGHQFH
EDVHGIRXQGDWLRQIRUWKHFRQFOXVLRQWKDWORQJWHUPRSLRLGWUHDWPHQWRIFKURQLFQRQPDOLJQDQWSDLQ
LVHIIHFWLYH&5&KDSPDQHWDOOpioid Pharmacotherapy for Chronic Non-Cancer Pain in
the United States: A Research Guideline for Developing an Evidence-Base7+( -2) 3$,1
2)),&,$/-2)7+($03$,162&¶<GLVFXVVLQJODFNRIHIIHFWLYHQHVVRIORQJWHUPXVH
RIRSLRLGVIRUFKURQLFQRQFDQFHUSDLQ
0 1REOH HW DO Long-Term Opioid Management for Chronic Noncancer Pain 7+(
&2&+5$1( '$7$%$6( 2) 6<6 5(9 -DQ KWWSRQOLQHOLEUDU\ZLOH\FRP
>KWWSVSHUPDFF)'%107@
5&KRXHWDOThe Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain:
A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop
$11$/62),17(510('LQWHUQDOFLWDWLRQVRPLWWHG
*0)UDQNOLQOpioids for Chronic Noncancer Pain: A Position Paper of the American
Academy Of Neurology1(852/2*<
3DWKDQ:LOOLDPVsupraQRWHFLWLQJFRQVWLSDWLRQQDXVHDDQGYRPLWLQJDVVLGHHIIHFWV
RIRSLRLGWKHUDS\5%HQ\DPLQHWDOOpioid Complications and Side Effects3$,13+<6,&,$1
6
0 /HH (7 $/ A Comprehensive Review of Opioid-Induced Hyperalgesia 3$,1
3+<6,&,$1UHYLHZLQJOLWHUDWXUH
7+(/$:$1'32/,&<2)23,2,'6
ZLOOGHYHORSDGGLFWLRQZLWKHQRUPRXVFRVWVLQWHUPVRIORVWSURGXFWLYLW\LQFUHDVHGPHGLFDOFDUH
DVZHOODVHPRWLRQDOORVVHV
,Q IDFW LW QRZ VHHPV FOHDU WKDW RYHUSUHVFULSWLRQ RI RSLRLGV KDV UHVXOWHG LQ KXQGUHGV RI
WKRXVDQGV RI SUHYHQWDEOH GHDWKV LQ WKH 8QLWHG 6WDWHV ZKLFK LV LQ WKH JULSV RI DQ RYHUGRVH
HSLGHPLFWKDWKDVEHHQEXLOGLQJIRUQHDUO\WZRGHFDGHV,QFUHDVHGSUHVFULELQJRIRSLRLGVLVDNH\
IDFWRU LQ WKH ULVH LQ SUHYHQWDEOH GHDWKV 2SLRLG SUHVFULSWLRQV QHDUO\ TXDGUXSOHG IURP WR
DFFRPSDQLHGE\DQHDUO\LGHQWLFDOULVHLQWKHUDWHRISUHVFULSWLRQRSLRLGUHODWHGGHDWKV,Q
QHDUO\$PHULFDQVGLHGRISUHVFULSWLRQRSLRLGRYHUGRVHVDUDWHRIPRUHWKDQSHU
GD\:KLOHWKHH[DFWUHODWLRQVKLSLVGHEDWHGLWLVFOHDUWKDWWKLVLQFUHDVHLQRSLRLGSUHVFULSWLRQV
DQG UHODWHG DGGLFWLRQ KDV DOVR KHOSHG IXHO WKH UHFHQW LQFUHDVHLQ KHURLQ RYHUGRVH LQ WKH 8QLWHG
6WDWHVZKLFKPRUHWKDQWULSOHGEHWZHHQDQG'HVSLWHWKHQRZZHOONQRZQULVNVRI
RSLRLG WKHUDS\ DQG WKH JURZLQJ DFNQRZOHGJHPHQW WKDW LWV XVH LV QRW HIIHFWLYH IRU PDQ\ RI WKH
FRQGLWLRQVWKDWLWLVSUHVFULEHGWRWUHDWRUDWEHVWWKDWLWLVQRPRUHHIIHFWLYHWKDQRWKHUWKHUDSLHV
GHVSLWH FDUU\LQJ KLJKHU ULVNV ORQJWHUP XVH RI RSLRLGV KDV EHHQ LQFUHDVLQJ DQG PLOOLRQV RI
$PHULFDQVDUHRQFKURQLFRSLRLGWUHDWPHQWIRUQRQFDQFHUSDLQ7KHUHDUHDQXPEHURIUHDVRQV
IRUWKLVGLVFRQQHFWLQFOXGLQJZHOOLQWHQWLRQHGHIIRUWVWRDGGUHVVXQWUHDWHGSDLQ+RZHYHUWKH
8QLWHG 6WDWHV DOVR VXIIHUHG DQ RQVODXJKW RI PDUNHWLQJ IURP PDNHUV RI RSLRLG PHGLFDWLRQV WKDW
. ( 9RZOHV HW DO Rates of Opioid Misuse, Abuse, and Addiction in Chronic Pain: A
Systematic Review and Data Synthesis3$,1
+ * %LUQEDXP HW DO Societal Costs of Prescription Opioid Abuse, Dependence, and
Misuse in the United States3$,10('HVWLPDWLQJFRVWVGXHWRSUHVFULSWLRQ
RSLRLGDEXVHDWDSSUR[LPDWHO\ELOOLRQLQ
5$5XGGHWDOIncreases in Drug and Opioid Overdose Deaths — United States, 2000–
2014025%,',7<$1'0257$/,7<:./<5(3UHSRUWLQJWKDW³)URP
WR QHDUO\ KDOI D PLOOLRQ SHUVRQV LQ WKH 8QLWHG 6WDWHV KDYH GLHG IURP GUXJ RYHUGRVHV 2SLRLGV SULPDULO\ SUHVFULSWLRQ SDLQ UHOLHYHUV DQG KHURLQ DUH WKH PDLQ GUXJV DVVRFLDWHG ZLWK
RYHUGRVHGHDWKV´
Id.
$ 6 %RKQHUW HW DO Association Between Opioid Prescribing Patterns and Opioid
Overdose-Related Deaths >-@$0$ ) 0RGDUDL HW DO Relationship of
Opioid Prescription Sales and Overdoses, North Carolina'58*$/&2+2/'(3(1'(1&(
&HQWHUVIRU'LVHDVH&RQWURODQG3UHYHQWLRQsupra QRWH
&HQWHUV IRU 'LVHDVH &RQWURO DQG 3UHYHQWLRQ Number and Age-Adjusted Rates of DrugPoisoning Deaths Involving Opioid Analgesics and Heroin: United States, 2000–2014
KWWSZZZFGFJRY>KWWSVSHUPDFF(=.9.@ ODVWYLVLWLHG1RY
5$5XGGHWDOsupraQRWH:0&RPSWRQHWDORelationship Between Nonmedical
Prescription-Opioid Use and Heroin Use1 (1* - 0('GLVFXVVLQJWUDQVLWLRQ
WRKHURLQXVH
'%RXGUHDXHWDOTrends in Long-term Opioid Therapy for Chronic Non-Cancer Pain
3+$50$&2(3,'(0,2/'58*6$)
See, e.g.'(-RUDQVRQHWDOPain Management, Controlled Substances, and State Medical
Board Policy: A Decade of Change-3$,16<037200$1$*(
,1',$1$+($/7+/$:5(9,(:
9RO
WDUJHWHGGRFWRUVZLWKVRPHWLPHVPLVOHDGLQJLQIRUPDWLRQUHJDUGLQJWKHHIIHFWLYHQHVVDQGGDQJHUV
RIRSLRLGPHGLFDWLRQV
,Q VRPH LQVWDQFHV WKLV PDUNHWLQJ FURVVHG WKH OLQH LQWR LOOHJDOLW\ ,Q WKUHH 3XUGXH
H[HFXWLYHV DQG WKH FRUSRUDWH HQWLW\ SOHG JXLOW\ WR VHYHUDO IHGHUDO FKDUJHV UHODWHG WR LOOHJDO
PDUNHWLQJRI2[\FRQWLQ7KHFRPSDQ\FRQWLQXHVWRIDFHFULPLQDOVFUXWLQ\LQLWUHDFKHGD
PLOOLRQ VHWWOHPHQW ZLWK WKH .HQWXFN\ $WWRUQH\ *HQHUDO UHJDUGLQJ FODLPV WKDW LW LOOHJDOO\
PDUNHWHG 2[\&RQWLQ DV QRQDGGLFWLYH DQG D VHSDUDWH VHWWOHPHQW ZLWK WKH 1HZ <RUN $WWRUQH\
*HQHUDOWRUHVROYHFODLPVWKDWLWKDGLOOHJDOO\PDUNHWHG2[\&RQWLQLQWKHVWDWH6LPLODUFODLPV
KDYH EHHQ PDGH DJDLQVW QXPHURXV RWKHU RSLRLG PDQXIDFWXUHUV ,QV\V ZKLFK PDNHV WKH SRWHQW
IHQWDQ\O VSUD\ 6XEV\V UHFHQWO\ UHDFKHG D PLOOLRQ VHWWOHPHQW ZLWK WKH 2UHJRQ $WWRUQH\
*HQHUDOWRUHVROYHFODLPVWKDWWKHFRPSDQ\LPSURSHUO\PDUNHWHGWKHPHGLFDWLRQLQWKHVWDWHDQG
LVFXUUHQWO\XQGHULQYHVWLJDWLRQE\DWOHDVWWKUHHRWKHUVWDWHVDVZHOODVWKHIHGHUDOJRYHUQPHQW
,QWKH1HZ<RUN$WWRUQH\*HQHUDOILQHG(QGR3KDUPDFHXWLFDOVDIWHUILQGLQJ
WKDW WKH FRPSDQ\ LPSURSHUO\ PDUNHWHG 2SDQD (5 D SRZHUIXO RSLRLG DQG LQVWUXFWHG LWV VDOHV
UHSUHVHQWDWLYHV WR ³GLPLQLVK DQG GLVWRUW´ ULVNV DVVRFLDWHG ZLWK WKH PHGLFDWLRQ 1XPHURXV
PXQLFLSDOLWLHVKDYHDFWLYHVXLWVDJDLQVWDYDULHW\RIRSLRLGPDQXIDFWXUHUVDOOHJLQJDQXPEHURI
FODLPVUHODWHGWRLOOHJDOPDUNHWLQJDQGUHODWHGFODLPV'RFWRUVPD\EHSDUWLFXODUO\VXVFHSWLEOHWR
$.RORGQ\HWDOThe Prescription Opioid and Heroin Crisis: A Public Health Approach
to an Epidemic of Addiction $11 5(9 38% +($/7+ GRFXPHQWLQJ
QXPHURXVHIIRUWVE\3XUGXH3KDUPDPDNHUVRI2[\FRQWLQWRHQFRXUDJHSUHVFULELQJRIRSLRLGVIRU
SDLQsee $9DQ=HHThe Promotion and Marketing of Oxycontin: Commercial Triumph, Public
Health Tragedy $0 - 38% +($/7+ GHVFULELQJ WKH DJJUHVVLYH SURPRWLRQ RI
2[\FRQWLQIRUWKHQRQPDOLJQDQWSDLQPDUNHWDQGHQVXLQJLQUHDVHLQSUHVFULELQJ
:KLOHQRQHVHUYHGMDLOWLPHRYHUPLOOLRQLQILQHVZHUHOHYLHG%DUU\0HLHUIn Guilty
Plea, OxyContin Maker to Pay $600 Million1<7,0(60D\
3UHVV 5HOHDVH 1HZ <RUN 6WDWH 2IILFH RI WKH $WWRUQH\ *HQHUDO $* 6FKQHLGHUPDQ
$QQRXQFHV6HWWOHPHQW:LWK3XUGXH3KDUPDWKDW(QVXUHV5HVSRQVLEOHDQG7UDQVSDUHQW0DUNHWLQJ
2I 3UHVFULSWLRQ2SLRLG'UXJV%\7KH0DQXIDFWXUHU$XJ 3UHVV 5HOHDVH.HQWXFN\
2IILFHRIWKH$WWRUQH\*HQHUDO$*&RQZD\$QQRXQFHV7ZR3KDUPDFHXWLFDO6HWWOHPHQWV7RWDOLQJ
0LOOLRQ'HF
25 '(3
72) -867,&( $* 526(1%/80 6(77/(6:,7+ 3+$50$&(87,&$/ &203$1< ,16<6
29(5 81/$:)8/ 352027,21 2) 7+( 32:(5)8/ 23,2,' 68%6<6 $XJ KWWSZZZGRMVWDWHRUXV>KWWSVSHUPDFF8%1/:*/@Form 10-Q Insys Therapeutics, Inc.
675((7 ,16,'(5$XJ30KWWSZZZVWUHHWLQVLGHUFRP>KWWSVSHUPDFF6-7
:'&+@
3UHVV 5HOHDVH $WWRUQH\ *HQHUDO (ULF 7 6FKQHLGHUPDQ $* 6FKQHLGHUPDQ $QQRXQFHV
6HWWOHPHQW :LWK (QGR +HDOWK 6ROXWLRQV ,QF (QGR 3KDUPDFHXWLFDOV ,QF 2YHU 0DUNHWLQJ 2I
3UHVFULSWLRQ2SLRLG'UXJV0DURQILOHZLWK1HZ<RUN&LW\3UHVV2IILFH
/LVD*LULRQJudge Halts Counties' Lawsuit Against 5 Narcotic Drug Manufacturers/$
7,0(6$XJKWWSZZZODWLPHVFRP>KWWSVSHUPDFF*9*4;=$@'RFWRUVPD\EH
SDUWLFXODUO\ VXVFHSWLEOH WR VXFK PDUNHWLQJ EHFDXVH WKH\ UHFHLYH OLWWOH LQIRUPDWLRQ UHJDUGLQJ
HYLGHQFHEDVHGRSLRLGSUHVFULELQJGXULQJPHGLFDOVFKRRODQGUHVLGHQF\WUDLQLQJsee&6'DYLV
'&DUUPhysician Continuing Education to Reduce Opioid Misuse, Abuse, and Overdose: Many
Opportunities, Few Requirements'58*$/&2+2/'(3(1'
7+(/$:$1'32/,&<2)23,2,'6
VXFK PDUNHWLQJ EHFDXVH WKH\ UHFHLYH OLWWOH LQIRUPDWLRQ UHJDUGLQJ HYLGHQFHEDVHG RSLRLG
SUHVFULELQJGXULQJPHGLFDOVFKRRODQGUHVLGHQF\WUDLQLQJ
,,,23,2,'6$1''58*75($70(17
A. The Burden of Untreated Opioid Addiction
,Q QHDUO\ PLOOLRQ $PHULFDQV KDG D VXEVWDQFH XVH GLVRUGHU LQYROYLQJ RSLRLGV PLOOLRQRIWKHVHFDVHVLQYROYHGRSLRLGSDLQUHOLHYHUV³235V´DQGLQYROYHGKHURLQ7KH
SUHYDOHQFHRIRSLRLGDGGLFWLRQDQGRSLRLGXVHGLVRUGHU³28'´FRPHVDWJUHDWFRVWV3UHVFULSWLRQ
RSLRLGDEXVHDFFRXQWHGIRUPRUHWKDQELOOLRQLQVRFLHWDODQGHFRQRPLFFRVWVLQLQFOXGLQJ
ORVWSURGXFWLYLW\DQGFULPLQDOMXVWLFHFRVWV1XPHURXVVWXGLHVGHPRQVWUDWHWKDWLQGLYLGXDOVZLWK
28'KDYHVLJQLILFDQWO\KLJKHUKHDOWKFDUHFRVWV0RUHRYHUWKHIHGHUDO2IILFHRI1DWLRQDO'UXJ
&RQWURO3ROLF\³21'&3´VSHQGVPRUHWKDQELOOLRQDQQXDOO\RQGUXJFRQWUROOHVVWKDQKDOI
RI ZKLFK LV DOORFDWHG IRU SUHYHQWLRQ DQG WUHDWPHQW 6WDWHV DQG ORFDO JRYHUQPHQWV VSHQG DQ
DGGLWLRQDOELOOLRQDQQXDOO\2SLRLGDGGLFWLRQDQG28'DOVRFRPHVDWJUHDWSHUVRQDOFRVW
,Q WKH ODVW GHFDGH +HSDWLWLV & LQIHFWLRQ UDWHV KDYH ULVHQ GUDPDWLFDOO\ GXH LQ ODUJH SDUW WR
LQFUHDVLQJSUHVFULSWLRQRSLRLGDQGKHURLQLQMHFWLRQDQGWKHODFNRIV\ULQJHH[FKDQJHDQGVWHULOH
&6'DYLV'&DUUPhysician Continuing Education to Reduce Opioid Misuse, Abuse,
and Overdose: Many Opportunities, Few Requirements'58*$/&2+2/'(3(1'
86'(3¶72)+($/7+$1'+80$16(59,&(6%(+$9,25$/+($/7+75(1'6,17+(81,7('
67$7(6 5(68/76)5207+( 1$7,21$/ 6859(<21 '58* 86($1' +($/7+ KWWSZZZVDPKVDJRY>KWWSVSHUPDFF;0=//@
+RZDUG*%LUQEDXPHWDOSocietal Costs of Prescription Opioid Abuse, Dependence, and
Misuse in the United States3$,1 0('7KLVLQFOXGHVELOOLRQLQORVW
ZRUNSODFHSURGXFWLYLW\ELOOLRQLQKHDOWKFDUHFRVWVDQGELOOLRQLQFULPLQDOMXVWLFHFRVWV
Id.
See, e.g., $ODQ*:KLWHHWDOEconomic Impact of Opioid Abuse, Dependence, and Misuse
$0-2)3+$50$&<%(1(),76HH0HDQH[FHVVDQQXDOFRVWVSHUSULYDWHO\LQVXUHG
SDWLHQWZHUHDQGPHDQH[FHVVFRVWVSHUSULYDWHO\LQVXUHGFDUHJLYHUZHUH0HDQ
H[FHVVFRVWVSHU)ORULGD0HGLFDLGSDWLHQWZHUH-%UDGIRUG5LFHHWDOThe Economic
Burden of Diagnosed Opioid Abuse Among Commercially Insured Individuals3267*5$'
0(' WRWDO KHDOWK FDUH FRVWV PRUH WKDQ WZLFH DV KLJK IRU RSLRLG DEXVHUV
,QGLYLGXDOVZLWKXQGLDJQRVHG28'KDYHORZHUKHDOWKFDUHFRVWVWKDQLQGLYLGXDOVGLDJQRVHGZLWK
28'EXWWKHLUFRVWVVWLOOH[FHHGLQGLYLGXDOVZLWKRXW28'See 1RDP<.LUVRQHWDOThe Burden
of Undiagnosed Opioid Abuse Among Commercially Insured Individuals 3$,1 0(' (;(& 2)),&( 2) 7+( 35(6,'(17 2) 7+( 81,7(' 67$7(6 1$7,21$/ '58* &21752/
675$7(*< )< %8'*(7 $1' 3(5)250$1&( 6800$5< WEO KWWSVZZZZKLWHKRXVHJRY>KWWSVSHUPDFF%561.@
-())5(< $ 0,521 .$7+(5,1( :$/'2&. 7+( %8'*(7$5< ,03$&7 2) (1',1* '58*
352+,%,7,21KWWSREMHFWFDWRRUJ>KWWSVSHUPDFF-3(74$@
,1',$1$+($/7+/$:5(9,(:
9RO
V\ULQJHDFFHVV,QRIILFLDOVOLQNHGDODUJH+,9RXWEUHDNLQ,QGLDQDWRWKHVKDULQJRIQHHGOHV
XVHGWRLQMHFWSUHVFULSWLRQRSLRLGVSDUWLFXODUO\WKHPHGLFDWLRQ2SDQD0RUHRYHUDVGLVFXVVHG
HOVHZKHUHRSLRLGRYHUGRVHQRZUHVXOWVLQWHQVRIWKRXVDQGVRIGHDWKVSHU\HDU
(YLGHQFHEDVHG WUHDWPHQW SDUWLFXODUO\ WUHDWPHQW ZLWK RSLRLG DJRQLVWV KDV EHHQ VKRZQ WR
VLJQLILFDQWO\UHGXFHERWKWKHKDUPIXOHIIHFWVDQGFRVWVRI28'+RZHYHUDUHSRUWIURPWKH
IHGHUDO6XEVWDQFH$EXVHDQG0HQWDO+HDOWK6HUYLFHV$GPLQLVWUDWLRQ³6$0+6$´IRXQGWKDWOHVV
WKDQRIDOOLQGLYLGXDOVZLWKRSLRLGXVHGLVRUGHU³28'´LQFOXGLQJOHVVWKDQRIWKRVH
XQGHUDJHWZHQW\ILYHUHFHLYHGWUHDWPHQW0RUHRYHUGHVSLWHWKHVWLOOJURZLQJRSLRLGHSLGHPLF
WKH SHUFHQWDJH RI LQGLYLGXDOV ZLWK 28' UHFHLYLQJ VXEVWDQFH DEXVH WUHDWPHQW KDV UHPDLQHG
UHODWLYHO\VWDJQDQW
7KHVH ORZ WUHDWPHQW SDUWLFLSDWLRQ QXPEHUV DV ZHOO DV WKH SHUVRQDO DQG ILQDQFLDO FRVWV
DVVRFLDWHG ZLWK XQWUHDWHG RSLRLG DGGLFWLRQ UHIOHFW WKH ODFN RI HYLGHQFHEDVHG UHVSRQVHV WR WKH
RSLRLGHSLGHPLF7KRVHVXIIHULQJIURP28'RIWHQIDFHWKHKDUVKUHDOLW\WKDWHYHQZKHQWKH\ZLVK
WRDGGUHVVWKHLUDGGLFWLRQWKHKHOSDQGWUHDWPHQWQHHGHGLVWRRRIWHQXQDYDLODEOH7KHLUIULHQGVDQG
IDPLO\ PHPEHUV DUH IRUFHG WR VLW LGO\ E\ DQG ZLWQHVV WKH HIIHFWV RI 28' RQ WKHLU ORYHG RQHV
EHFDXVHGHVSLWHWKHLUEHVWHIIRUWVWKH\WRRFDQQRWILQGWKHLQGLYLGXDOWKHKHOSRUWUHDWPHQWQHHGHG
WR DGGUHVV WKH LQGLYLGXDO¶V 28' 3HUKDSV WKH PRVW FUXHO DQG WUDJLF IDFW LV WKDW ZH NQRZ WKDW
HIIHFWLYHHYLGHQFHEDVHGWUHDWPHQWH[LVWVEXWLWLVQRWDFFHVVLEOHWRWKRVHZKRQHHGLWPRVW
B. Medication Assisted Treatment (“MAT”)
$VGHVFULEHGLQ6HFWLRQ,RSLRLGXVHLVDVVRFLDWHGZLWKVHYHUHDGYHUVHHIIHFWVLQFOXGLQJLQ
VRPHFDVHVDGGLFWLRQDQGGHDWK6RPHZKDWFRXQWHULQWXLWLYHO\RSLRLGVFDQDOVREHXVHGWRWUHDW
RSLRLGPLVXVHDQGDGGLFWLRQ,QGHHGPHGLFDWLRQDVVLVWHGWUHDWPHQW³0$7´ZKLFKFRPELQHV
FRXQVHOLQJ ZLWK PHGLFDWLRQ WKHUDS\ LV ZLGHO\ UHFRJQL]HG DV WKH PRVW HIIHFWLYH WUHDWPHQW IRU
28'
$QLO*6XU\DSUDVDGHWDOEmerging Epidemic of Hepatitis C Virus Infections Among Young
Nonurban Persons Who Inject Drugs in the United States2006–2012&/,1,&$/ ,1)(&7,286
',6($6(6
,1' 67$7( '(3
7 2) +($/7+ +,9 287%5($. ,1 6287+($67(51 ,1',$1$ KWWSZZZLQJRY>KWWSVSHUPDFF411+50@
5XGGHWDOsupra QRWHDW
86'(3¶72)+($/7+$1'+80$16(59,&(6%(+$9,25$/+($/7+%$520(7(581,7('
67$7(6KWWSZZZVDPKVDJRY>KWWSVSHUPDFF$+-4<@
%UHQGDQ 6DORQHU 6KDQNDU .DUWKLNH\DQ Changes in Substance Abuse Treatment Use
Among Individuals with Opioid Use Disorders in the United States, 2004-2013>-@$0$
'XULQJWKHGHFDGHIURPWRXVHRIWUHDWPHQWUHPDLQHGORZIRULQGLYLGXDOVZLWK
28'VDQGGLGQRWLQFUHDVHDIWHUDFFRXQWLQJIRUFKDQJLQJSRSXODWLRQFKDUDFWHULVWLFVXQGHUVFRULQJ
VXEVWDQWLDOURRPIRULPSURYHPHQW,PSRUWDQWO\WKLVVWXG\GLGQRWPHDVXUH0$7XVHId.
See, e.g., :25/' +($/7+ 25* *8,'(/,1(6 )25 7+( 36<&+262&,$//< $66,67('
3+$50$&2/2*,&$/ 75($70(17 2) 23,2,' '(3(1'(1&( KWWSDSSVZKRLQW
>KWWSVSHUPDFF97/:4*@
See generally 86'(3¶7+($/7++806(59638%12 60$0(',&$7,21
$66,67(' 75($70(17 )25 23,2,' $'',&7,21 ,1 23,2,' 75($70(17 352*5$06 7+(/$:$1'32/,&<2)23,2,'6
7KHIHGHUDO)RRGDQG'UXJ$GPLQLVWUDWLRQ³)'$´KDVDSSURYHGWKUHHPHGLFDWLRQVIRUWKH
WUHDWPHQW RI 28' PHWKDGRQH EXSUHQRUSKLQH DQG QDOWUH[RQH +RZHYHU HIIHFWLYH 0$7 IRU
28'JHQHUDOO\LQYROYHVPHWKDGRQHRUEXSUHQRUSKLQHDQGDVVXFKWKLVDUWLFOHGRHVQRWGLVFXVV
QDOWUH[RQHLQGHSWK0HWKDGRQHDSSURYHGE\WKH)'$LQIRUWUHDWLQJRSLRLGDGGLFWLRQLV
D ORQJDFWLQJ IXOO PX RSLRLG DJRQLVW ZLWK D KDOIOLIH EHWZHHQ WZHQW\IRXU WR WKLUW\VL[ KRXUV
WKHUHE\DOORZLQJIRURQFHDGD\WUHDWPHQW7KHGUXJKDVDUHODWLYHO\VDIHSURILOHZKHQXVHGIRU
WUHDWLQJ RSLRLG DGGLFWLRQ %XSUHQRUSKLQH UHFHLYHG )'$ DSSURYDO IRU XVH LQ WUHDWLQJ RSLRLG
DGGLFWLRQLQ7KHGUXJFDQUHPDLQHIIHFWLYHIRUXSWRVHYHQW\WZRKRXUVZLWKSURSHUGRVLQJ
DQG EHFDXVH LWLV RQO\D SDUWLDO PX RSLRLG DJRQLVWLQFUHDVHG GRVDJHV JHQHUDOO\ RQO\ SURGXFH D
KWWSVWRUHVDPKVDJRY >KWWSVSHUPDFF94(-*@ see also :25/' +($/7+ 25*
68%67,787,21 0$,17(1$1&( 7+(5$3< ,1 7+( 0$1$*(0(17 2) 23,2,' '(3(1'(1&( $1'
+,9$,'635(9(17,21³6XEVWLWXWLRQPDLQWHQDQFHWKHUDS\LVRQHRIWKHPRVWHIIHFWLYH
W\SHV RI SKDUPDFRORJLFDO WKHUDS\ RI RSLRLG GHSHQGHQFH see also 5ROOH\ ( -RKQVRQ HW DO A
Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
1(:(1*-0('see also$1'<*5$<6<67(0$7,&5(9,(:2)7+(
6$)(7< 2) %835(1253+,1( 0(7+$'21( $1' 1$/75(;21( KWWSZZZZKRLQW
>KWWSVSHUPDFF41*-93@ %DFNJURXQG GRFXPHQW SUHSDUHG IRU 7HFKQLFDO 'HYHORSPHQW
*URXS IRU WKH :+2 *XLGHOLQHV IRU 3V\FKRVRFLDOO\ $VVLVWHG 3KDUPDFRWKHUDS\ RI 2SLRLG
'HSHQGHQFH*HQHYD
68=$11( *(/%(5 5,1$/'2 '$9,' : 5,1$/'2 $'9$1&,1* $&&(66 72 $'',&7,21
0(',&$7,216 ,03/,&$7,216 )25 23,2,' $'',&7,21 75($70(17 KWWSZZZDVDPRUJ>KWWSVSHUPDFF'..5-@
1DOWUH[RQHLVDSXUHRSLRLGDQWDJRQLVWWKDWEORFNVWKHHIIHFWVRIRWKHURSLRLGVEXWGRHVQRW
UHGXFH FUDYLQJV DQG KDV VKRZQ OLWWOH HIILFDF\ LQ WUHDWLQJ RSLRLG DGGLFWLRQ See +LODU\ 6PLWK
&RQQHU\ Medication-Assisted Treatment of Opioid Use Disorder: Review of the Evidence and
Future Directions +DUYDUG 5HY 3V\FKLDWU\ QRWLQJ VWXGLHV GHPRQVWUDWLQJ
QDOWUH[RQH¶VSRRUHIILFDF\LQWUHDWLQJ28'
,1672)0(')('(5$/5(*8/$7,212)0(7+$'21(75($70(175LFKDUG$5HWWLJ
$GDP<DUPROLQVN\HGVPHWKDGRQHZDVILUVWDSSURYHGLQIRUXVHDVDQDQDOJHVLFDQG
DQWLWXVVLYH
KWWSZZZQDSHGXFDWDORJIHGHUDOUHJXODWLRQRIPHWKDGRQHWUHDWPHQW
>KWWSVSHUPDFF&(::3=@
0(',&$7,21$66,67(' 75($70(17 )25 23,2,' $'',&7,21 ,1 23,2,' 75($70(17
352*5$06supraQRWHDW
See -DPHV 5 5REHUWV Deaths During Methadone Maintenance (0(5*(1&< 0('
1(:60D\DW³>0HWKDGRQH0DLQWHQDQFH7KHUDS\@GRHVQRWLPSDLUFRJQLWLYHIXQFWLRQ
KDVQRDGYHUVHHIIHFWVRQPHQWDOFDSDELOLW\RULQWHOOLJHQFHDQGGRHVQ¶WNHHS\RXIURPZRUNLQJ
2QFHDVWHDG\VWDWHLVREWDLQHGPHWKDGRQHLVQRWRYHUO\VHGDWLQJRULQWR[LFDWLQJDQGLWGRHVQ¶W
NHHS \RX IURP GULYLQJ D FDU´ -DPHV 5 5REHUWV Methadone Maintenance: The Basics (0(5*(1&< 0(' 1(:6)HEDW³$OWKRXJKPHWKDGRQHLVDSRWHQWQDUFRWLFPRUH
GHDWKV DUH UHSRUWHG IURP PHWKDGRQH SUHVFULEHG IRU SDLQ WKDQ PHWKDGRQH REWDLQHG IURP
PDLQWHQDQFHSURJUDPV7KHVDIHW\RI007LVZHOOHVWDEOLVKHG7KHGUXJKDVQRORQJWHUP
KDUPIXOHIIHFWVWRWKHKHDUWNLGQH\OXQJVDQGOLYHU´
-DPHV55REHUWVBuprenorphine: A Drug You Need to Know About(0(5*(1&<0('
1(:6'HFDW
,1',$1$+($/7+/$:5(9,(:
9RO
ORQJHU GXUDWLRQ RI DFWLRQ UDWKHU WKDQ JUHDWHU DJRQLVW HIIHFWV 7KLV ³FHLOLQJ HIIHFW´ UHQGHUV
EXSUHQRUSKLQHJHQHUDOO\VDIHUWKDQPHWKDGRQH%HWZHHQDQGWKHQXPEHURIRSLDWH
GHSHQGHQW LQGLYLGXDOV UHFHLYLQJ PHWKDGRQH DQG EXSUHQRUSKLQH LQFUHDVHG E\ DQG UHVSHFWLYHO\
1XPHURXV VWXGLHV KDYH GHPRQVWUDWHG 0$7¶V HIILFDF\ )RU H[DPSOH RQH VWXG\ IRXQG WKDW
LQGLYLGXDOVUHFHLYLQJ0$7DUHOHVVOLNHO\WRUHODSVHWKDQWKRVHUHFHLYLQJQRQPHGLFDWLRQ
DVVLVWHG WKHUDS\ 2WKHUV QRWH WKH VLJQLILFDQWO\ ORZHU PRUWDOLW\ UDWHV DVVRFLDWHG ZLWK WKH
DYDLODELOLW\DQGXVHRI0$7,QDPHWDDQDO\VLVRIVWXGLHVRQ0$7LQSULVRQVHWWLQJVUHVHDUFKHUV
IRXQGLQFUHDVHGSDUWLFLSDWLRQLQWUHDWPHQWSRVWUHOHDVHDVZHOODVVXEVWDQWLDOO\UHGXFHGKHURLQXVH
DQGV\ULQJHVKDULQJ0RUHJHQHUDOO\0$7LV³DVVRFLDWHGZLWKGHFUHDVHGLQMHFWL>RQ@GUXJXVH
Id. 0(',&$7,21$66,67(' 75($70(17 )25 23,2,' $'',&7,21 ,1 23,2,' 75($70(17
352*5$06supraQRWHDW
0(',&$7,21$66,67(' 75($70(17 )25 23,2,' $'',&7,21 ,1 23,2,' 75($70(17
352*5$06supraQRWHDW³$VDUHVXOW>RIEXSUHQRUSKLQH¶VFHLOLQJHIIHFW@WKHUHLVDJUHDWHU
PDUJLQRIVDIHW\IURPGHDWKE\UHVSLUDWRU\GHSUHVVLRQZKHQLQFUHDVHGGRVHVRIEXSUHQRUSKLQHDUH
XVHG FRPSDUHG ZLWK LQFUHDVHG GRVHV RI IXOO RSLRLG DJRQLVWV %XSUHQRUSKLQH RYHUGRVH LV
XQFRPPRQ DOWKRXJK LW KDV EHHQ UHSRUWHG LQ )UDQFH DQG LW LV DVVRFLDWHG DOPRVW DOZD\V ZLWK
LQMHFWLRQRIEXSUHQRUSKLQHFRXSOHGZLWKLQJHVWLRQRIKLJKGRVHVRIEHQ]RGLD]HSLQHVDOFRKRORU
RWKHUVHGDWLYHW\SHVXEVWDQFHVFLWDWLRQRPLWWHG´
%(+$9,25$/+($/7+%$520(7(581,7('67$7(6 supra QRWHDW
6($100853+<(7$/6+2:0(7+(021(<(&2120,&(9$/8$7,2162)23,2,'86(
',625'(5 ,17(59(17,216 KWWSOGLXSHQQHGX >KWWSVSHUPDFF*19-;@ ³$
VWXG\RI0HGLFDLGSDWLHQWVIRXQGWKDWWKRVHUHFHLYLQJHLWKHU%07RU007ZHUHOHVVOLNHO\
WRUHODSVHWKDQWKRVHUHFHLYLQJEHKDYLRUDOWUHDWPHQWVRQO\´
Methadone Maintenance: The BasicssupraQRWHDW³7KHRQH\HDUPRUWDOLW\UDWHIRU
D SDWLHQW LQ 007 LV DERXW RQH SHUFHQW FRPSDUHG ZLWK HLJKW SHUFHQW DPRQJ WKRVH ZKR XVH
DOWHUQDWLYHPHWKRGVRUVWD\ZLWKKHURLQ´1RUD'9RONRZHWDOMedication-Assisted Therapies
— Tackling the Opioid-Overdose Epidemic 1(: (1* - 0(' FLWLQJ
5REHUW36FKZDUW]HWDOOpioid Agonist Treatments and Heroin Overdose Deaths in Baltimore,
Maryland, 1995-2009$0-38%+($/7+³$VWXG\RIKHURLQRYHUGRVHGHDWKV
LQ%DOWLPRUHEHWZHHQDQGIRXQGDQDVVRFLDWLRQEHWZHHQWKHLQFUHDVLQJDYDLODELOLW\RI
PHWKDGRQH DQG EXSUHQRUSKLQH DQG DQ DSSUR[LPDWHO\ GHFUHDVH LQ WKH QXPEHU RI IDWDO
RYHUGRVHV´KWWSZZZQHMPRUJ>KWWSVSHUPDFF'54.8'@-RKQ50&DSOHKRUQHWDO
Methadone Maintenance and Addicts’ Risk of Fatal Heroin Overdose 68%67$1&( 86( 0,686( PHWKDGRQH UHGXFHV WKH ULVN RI GHDWK DPRQJ RSLRLG GHSHQGHQW
LQGLYLGXDOVE\
'DJPDU +HGULFK HW DO The Effectiveness of Opioid Maintenance Treatment in Prison
Settings:
A
Systematic
Review
$'',&7,21
KWWSRQOLQHOLEUDU\ZLOH\FRPGRLM[HSGI
>KWWSVSHUPDFF+:6%$@
7+(/$:$1'32/,&<2)23,2,'6
GHFUHDVHGFULPLQDODFWLYLW\LQFUHDVHGUHWHQWLRQLQWUHDWPHQWIRUFKHPLFDOGHSHQGHQFHLQFUHDVHG
DGKHUHQFHWR+,9PHGLFDWLRQLPSURYHGIDPLO\UHODWLRQVDQGVXFFHVVIXOUHWXUQWRHPSOR\PHQW´
'HVSLWHLWVSURYHQHIILFDF\0$7KDVEHHQLPSOHPHQWHGLQOHVVWKDQRISULYDWHVHFWRU
DGGLFWLRQWUHDWPHQWSURJUDPVDQGRQO\RIRSLDWHGHSHQGHQWLQGLYLGXDOVLQVXFKSURJUDPV
UHFHLYH 0$7 1XPHURXV IDFWRUV FRQWULEXWH WR WKLV ORZ XWLOL]DWLRQ RI 0$7 LQFOXGLQJ
PLVFRQFHSWLRQVVWLJPDDQGWKHODFNRIDYDLODEOHSUHVFULEHUV7KHOHJDOUHJLPHFRQWUROOLQJDFFHVV
WRPHWKDGRQHDQGEXSUHQRUSKLQHIRURSLRLGDGGLFWLRQWUHDWPHQWSUHVHQWVDQRWKHUVLJQLILFDQWEDUULHU
WRLQFUHDVLQJWKHXVHRI0$77KHIROORZLQJVHFWLRQVGHVFULEHWKLVOHJDODFFHVVUHJLPHLQFOXGLQJ
WKHLUKLVWRU\DQGSURSRVHGFKDQJHV
C. Federal Legal Regulation of MAT: Historical Context
$WWKHWXUQRIWKHWZHQWLHWKFHQWXU\PHGLFDOSURIHVVLRQDOVFRPPRQO\SURYLGHGRSLRLGVDQG
RWKHUGUXJVZLWKRXWOHJDOUHVWULFWLRQVLQFOXGLQJIRUWKHWUHDWPHQWRIDGGLFWLRQ%HWZHHQDQG
IHGHUDO VWDWH DQG ORFDO DJHQFLHV SURPRWHG PDLQWHQDQFH FOLQLFV IRU GUXJGHSHQGHQW
LQGLYLGXDOV+RZHYHULQ&RQJUHVVSDVVHGWKH+DUULVRQ1DUFRWLFV7D[$FWZKLFKLPSRVHG
OLFHQVLQJ WD[ SUHVFULSWLRQ DQG UHFRUG UHTXLUHPHQWV RQ SK\VLFLDQV SURYLGLQJ RSLDWH DQG FRFRD
SURGXFWVDVZHOODVUHVWULFWHGSK\VLFLDQVIURPGLVSHQVLQJDQGGLVWULEXWLQJVXFKSURGXFWVH[FHSW
³LQWKHFRXUVHRIKLVSURIHVVLRQDOSUDFWLFH´,PSRUWDQWO\IHGHUDORIILFLDOVLQWHUSUHWHGWKHODZDV
SURKLELWLQJ SK\VLFLDQV IURP SUHVFULELQJ RSLDWH DQG FRFRD SURGXFWV WR GUXJGHSHQGHQW
LQGLYLGXDOV$VDUHVXOWHQIRUFHPHQWRIWKH+DUULVRQ1DUFRWLFV$FWHIIHFWLYHO\HQGHGDGGLFWLRQ
PDLQWHQDQFHWUHDWPHQWIRUQHDUO\DKDOIFHQWXU\
23(1 62&¶< ,167 %$55,(56 72 $&&(66 0(',&$7,21$66,67(' 75($70(17 $1'
,1-(&7,21'5,9(1 +,9 (3,'(0,&6 KWWSVZZZRSHQVRFLHW\IRXQGDWLRQVRUJ
>KWWSVSHUPDFF<)$3@LQWHUQDOFLWDWLRQRPLWWHG
+DQQDK . .QXGVHQ HW DO Adoption and Implementation of Medications in Addiction
Treatment Programs - 2) $'',&7 0(' KWWSVZZZQFELQOPQLKJRY
>KWWSVSHUPDFF/6$6&@
9RONRZHWDOsupraQRWHDW
(OOHQ 0 :HEHU Failure of Physicians to Prescribe Pharmacotherapies for Addiction:
Regulatory Restrictions and Physician Resistance-+($/7+&$5(/32/¶<
Id.
+DUULVRQ1DUFRWLFV$FWRI3XE/1R6WDW
:HEHUsupraQRWHDWQRWLQJWKDWZKLOHWKLVSURYLVLRQZDVLQLWLDOO\UHMHFWHGE\WKH
6XSUHPH &RXUW VXEVHTXHQW DPHQGPHQWVWR WKH ODZ DQG RWKHU 6XSUHPH &RXUW FDVHV XSKHOG WKH
SURKLELWLRQRQ³SK\VLFLDQV>@IURPSUHVFULELQJKHURLQDQGFRFDLQHWRSDWLHQWVZLWKDGGLFWLRQV´
Id. DW³$OOPDLQWHQDQFHFOLQLFVZHUHVKXWWHUHGE\´,167,787(2)0(',&,1(86
)('(5$/ 5(*8/$7,21 2) 0(7+$'21( 75($70(17 HGV 5LFKDUG 5HWWLJ $GDP
<DUPRQOLQVNLQRWLQJWKHFORVXUHRIFOLQLFVXVLQJPRUSKLQHWRWUHDWRSLDWHDGGLFWLRQDQG
WKH )HGHUDO%XUHDX RI 1DUFRWLFV¶ \HDU ³DQWLPDLQWHQDQFH SRVLWLRQ´ 7KH $PHULFDQ 0HGLFDO
$VVRFLDWLRQDOVRRSSRVHGRSLRLGPDLQWHQDQFHWKHUDS\See -HURPH -DIIH&KDUOHV2¶.HHIHFrom
Morphine Clinics to Buprenorphine: Regulating Opioid Agonist Treatment of Addiction in the
United States'58*$/&2+2/'(3(1'(1&(6
,1',$1$+($/7+/$:5(9,(:
9RO
,QWZRGRFWRUV9LQFHQW'ROHDQG0DULH1\VZDQGHUSXEOLVKHGDODQGPDUNVWXG\LQWKH
Journal of the American Medical AssociationKLJKOLJKWLQJWKHHIIHFWLYHQHVVRIPHWKDGRQHWRWUHDW
KHURLQDGGLFWLRQ7KLVDQGVLPLODUUHVHDUFKOHDGWRWKHUDSLGLQFUHDVHLQXVLQJPHWKDGRQHWRWUHDW
RSLRLGDGGLFWLRQXQGHU,QYHVWLJDWLRQDO1HZ'UXJ³,1'´DSSOLFDWLRQVLVVXHGE\WKH)'$
DQGWKHQXPEHURIPHWKDGRQHPDLQWHQDQFHSDWLHQWVURVHIURPOHVVWKDQLQWRLQ
$W WKH VDPH WLPH WKH OHJDO ODQGVFDSH IRU RSLRLG DGGLFWLRQ WUHDWPHQW ZDV DOVR HYROYLQJ ,Q
UHVSRQGLQJWRFRQFHUQVRYHUPHWKDGRQHGLYHUVLRQDQGDGGLFWLRQWKH)'$SURSRVHGDQHZ
UXOHHVWDEOLVKLQJSURWRFROVIRUPHWKDGRQHWUHDWPHQWXQGHU,1'VWKHUXOHZDVILQDOL]HGLQ$SULO
,Q 2FWREHU &RQJUHVV SDVVHG WKH &RPSUHKHQVLYH 'UXJ $EXVH 3UHYHQWLRQ DQG
&RQWURO$FW³&'$3&$´DGGUHVVLQJ³UHVHDUFKWUHDWPHQWDQGSUHYHQWLRQRIGUXJDEXVHDQGGUXJ
GHSHQGHQFHDQGZLWKGUXJDEXVHODZHQIRUFHPHQWDXWKRULW\´,Q$SULOWKH)'$SURSRVHG
QHZ UHJXODWLRQV RQ PHWKDGRQH WUHDWPHQW 7KHVH UHJXODWLRQV ILQDOL]HG LQ 'HFHPEHU 9LFWRU 'ROH 0DULH 1\VZDQGHU A Medical Treatment for Diacetylmorphine (Heroin)
Addiction A Clinical Trial with Methadone Hydrochloride>-@$0$
See 0(%ODLU+ROEHLQUnderstanding FDA Regulatory Requirements for Investigational
New Drug Applications for Sponsor-Investigators-,19(67,*$7,9(0('
KWWSVZZZXFGPFXFGDYLVHGX >KWWSVSHUPDFF6=87@ *HQHUDOO\ IHGHUDO ODZ UHTXLUHV
DQDSSURYHGPDUNHWLQJDSSOLFDWLRQEHIRUHDGUXJPD\EHVKLSSHGDFURVVVWDWHOLQHV+RZHYHUDQ
H[HPSWLRQ SURFHGXUH NQRZQ DV DQ ,QYHVWLJDWLRQDO 1HZ 'UXJ ³,1'´ DSSOLFDWLRQ DOORZV
UHVHDUFKHUV WR REWDLQ )'$ DSSURYDO WR VKLS D GUXJ DFURVV VWDWH OLQHV IRU H[SHULPHQWDO DQG
LQYHVWLJDWLRQDO XVHV ,Q RWKHU ZRUGV ³>W@KH ,1' LV WKH PHFKDQLVP E\ ZKLFK WKH >GUXJ¶V@
LQYHVWLJDWRU RU VSRQVRU SURYLGHV WKH UHTXLVLWH LQIRUPDWLRQ >WR WKH )'$ DERXW WKH VDIHW\ RI WKH
LQWHQGHGUHVHDUFKVWXG\@WRREWDLQDXWKRUL]DWLRQWRDGPLQLVWHUDQLQYHVWLJDWLRQDODJHQWWRKXPDQ
VXEMHFWVRUDQDSSURYHGGUXJXVHGIRUDQHZLQGLFDWLRQRUDQHZSRSXODWLRQRISDWLHQWV´
-DIIH2¶.HHIHsupra QRWHDW6
)('(5$/5(*8/$7,212)0(7+$'21(75($70(17supraQRWH
Id.DW-DIIH2¶.HHIHsupraQRWHDW66
&RPSUHKHQVLYH'UXJ$EXVH3UHYHQWLRQDQG&RQWURO$FWRI3XE/1R
6WDW)('(5$/5(*8/$7,212)0(7+$'21(75($70(17supraQRWHDW7LWOH
,, RI WKH &'$3&$ WKH &RQWUROOHG 6XEVWDQFHV $FW ³&6$´ HVWDEOLVKHG ILYH VFKHGXOHV IRU
FRQWUROOHG VXEVWDQFHV 86& † DQG UHTXLUHG UHJLVWUDWLRQ ZLWK WKH IHGHUDO 'UXJ
(QIRUFHPHQW $GPLQLVWUDWLRQ ³'($´ EHIRUH PDQXIDFWXULQJ GLVWULEXWLQJ RU GLVSHQVLQJ D
FRQWUROOHG VXEVWDQFH 86& † 7KH &'$3&$ LQWHQGHG ³WR FODULI\ IRU WKH PHGLFDO
SURIHVVLRQWKHH[WHQWWRZKLFKWKH\PD\VDIHO\JRLQWUHDWLQJQDUFRWLFDGGLFWVDVSDWLHQWV´DQG
LQ D VKLIW LQ IHGHUDO SROLF\ GHFODUHG WKDW ³WKH KHDOWK HVWDEOLVKPHQW not WKH ODZ HQIRUFHPHQW
FRPPXQLW\ZRXOGGHWHUPLQHWKHVFRSHRISUDFWLFHRIPHGLFLQHLQ>WUHDWLQJQDUFRWLFDGGLFWLRQ@´
)('(5$/ 5(*8/$7,21 2) 0(7+$'21( 75($70(17 supra QRWH DW 7KH &'$3&$
³FKDUJHGWKH6HFUHWDU\RI+HDOWK(GXFDWLRQDQG:HOIDUHWRµGHWHUPLQHWKHDSSURSULDWHPHWKRGV
RISURIHVVLRQDOSUDFWLFHLQWKHPHGLFDOWUHDWPHQWRIWKHQDUFRWLFDGGLFWLRQRIYDULRXVFODVVHVRI
QDUFRWLF DGGLFWV¶´ Id. 7KH 6HFUHWDU\ RI +HDOWK (GXFDWLRQ DQG :HOIDUH LV QRZ NQRZQ DV WKH
6HFUHWDU\RI+HDOWKDQG+XPDQ6HUYLFHV
)('(5$/5(*8/$7,212)0(7+$'21(75($70(17supraQRWHDW
7+(/$:$1'32/,&<2)23,2,'6
HVWDEOLVKHGWKHPRGHUQUHJXODWRU\IUDPHZRUNIRUPHWKDGRQHWUHDWPHQW7KHUHJXODWLRQVOLPLWHG
PHWKDGRQHGLVSHQVLQJWRIHGHUDOO\OLFHQVHGSURJUDPVDQGDSSURYHGKRVSLWDOSKDUPDFLHVUHVWULFWHG
SDWLHQWHOLJLELOLW\IRUSDUWLFLSDWLRQUHTXLUHGSK\VLFLDQMXVWLILFDWLRQIRUKLJKGRVDJHVDQGVSHFLILHG
FULWHULDIRUJUDQWLQJDQGUHVFLQGLQJWDNHKRPHGRVHV
&RQJUHVVFRPSOHPHQWHGWKHVHQHZ)'$UHJXODWLRQVZLWKWKHSDVVLQJRIWKH1DUFRWLF$GGLFW
7UHDWPHQW $FW RI ³1$7$´ 1$7$ ZKLFK DPHQGHG WKH &6$ UHTXLUHG PHGLFDO
SURIHVVLRQDOV WUHDWLQJ RSLRLG DGGLFWLRQ ZLWK RSLRLGV WR REWDLQ D VHSDUDWH '($ UHJLVWUDWLRQ
HVWDEOLVKHGWKH1DWLRQDO,QVWLWXWHRQ'UXJ$EXVHDQGUHWDLQHGWKH6HFUHWDU\RI+HDOWK(GXFDWLRQ
DQG :HOIDUH¶V UROH LQ VHWWLQJ PHGLFDO SUDFWLFH VWDQGDUGV IRU DGGLFWLRQ WUHDWPHQW 7KH ODZ
UHSUHVHQWHG&RQJUHVV¶IRUPDOUHFRJQLWLRQRIWKHSUDFWLFHRIXVLQJRSLRLGVWRWUHDWRSLRLGDGGLFWLRQ
DQGZDVWKHILUVWWLPHWKDWIHGHUDOVWDWXWHVGHILQHG³GHWR[LILFDWLRQ´DQG³PDLQWHQDQFH´WUHDWPHQW
0LQRUUHYLVLRQVWRWKHPHWKDGRQHWUHDWPHQWUHJXODWLRQVLQDQGUHSUHVHQWHGWKHRQO\
FKDQJHVWRWKLVIHGHUDOOHJDOODQGVFDSHEHWZHHQDQG
D. Federal Regulation of Methadone
$WWKHIHGHUDOOHYHOWKHOHJDOUHTXLUHPHQWVIRUSUHVFULELQJDQGGLVSHQVLQJPHWKDGRQHGHSHQG
RQLWVLQWHQGHGSXUSRVH:KHQXVHGWRWUHDWSDLQPHWKDGRQHLVVXEMHFWWRWKHVDPHUHTXLUHPHQWV
DQGUHVWULFWLRQVDSSOLFDEOHWRDOORWKHU6FKHGXOH,,FRQWUROOHGVXEVWDQFHVVXFKDV2[\&RQWLQ
+RZHYHUIHGHUDOUHJXODWLRQVVSHFLI\PRUHULJRURXVUHTXLUHPHQWVDQGOLPLWDWLRQVIRUPHWKDGRQH
GHWR[LILFDWLRQ DQG PDLQWHQDQFH WKHUDS\ ³PHWKDGRQH WKHUDS\´ IRU WUHDWLQJ RSLRLG DGGLFWLRQ
)('(5$/5(*8/$7,212)0(7+$'21(75($70(17supraQRWHDW
Id DW.
1DUFRWLF$GGLFW7UHDWPHQW$FWRI3XE/1R6WDW
0(',&$7,21$66,67(' 75($70(17 )25 23,2,' $'',&7,21 ,1 23,2,' 75($70(17
352*5$06supraQRWHDW)('(5$/5(*8/$7,212)0(7+$'21(75($70(17supraQRWH
DW-DIIH2¶.HHIHsupraQRWHDW6
0(',&$7,21$66,67(' 75($70(17 )25 23,2,' $'',&7,21 ,1 23,2,' 75($70(17
352*5$06supraQRWHDW7KH)'$UHJXODWLRQVUHSUHVHQWHGWKHILUVWWLPHIHGHUDOODZ
GHILQHG GHWR[LILFDWLRQ DQG PDLQWHQDQFH WUHDWPHQW see also )('(5$/ 5(*8/$7,21 2)
0(7+$'21(75($70(17supraQRWHDW
)('(5$/ 5(*8/$7,21 2) 0(7+$'21( 75($70(17 supra QRWH DW -DIIH 2¶.HHIHsupraQRWHDW6QRWLQJWKDWWKH)'$UHYLVLRQV³ZHUHUHODWLYHO\PLQRUPRVWO\KDYLQJ
WRGRZLWKXULQHWHVWLQJRQVLWHVHUYLFHVDQGHDVLQJFRQVWUDLQWVRQDGPLVVLRQV´
Prescriptions '58* (1)25&(0(17 $'0,1 KWWSZZZGHDGLYHUVLRQXVGRMJRY
>KWWSVSHUPDFF6''+0/@ ³)HGHUDO ODZ DQG UHJXODWLRQV GR QRW UHVWULFW WKH SUHVFULELQJ
GLVSHQVLQJ RU DGPLQLVWHULQJ RI DQ\ VFKHGXOH ,, ,,, ,9 RU 9 QDUFRWLF PHGLFDWLRQ LQFOXGLQJ
PHWKDGRQH IRU WKH WUHDWPHQW RI SDLQ LI VXFK WUHDWPHQW LV GHHPHG PHGLFDOO\ QHFHVVDU\ E\ D
UHJLVWHUHGSUDFWLWLRQHUDFWLQJLQWKHXVXDOFRXUVHRISURIHVVLRQDOSUDFWLFH´ODVWYLVLWHG2FWREHU
See 86& J DSSO\LQJ DGGLWLRQDO UHTXLUHPHQWV WR GLVSHQVLQJ ³QDUFRWLF
GUXJV WR LQGLYLGXDOV IRU PDLQWHQDQFH WUHDWPHQW RU GHWR[LILFDWLRQ WUHDWPHQW´; &)5
D )HGHUDO ODZ GHILQHV WZR W\SHV RI PHWKDGRQH WKHUDS\ GHWR[LILFDWLRQ DQG
PDLQWHQDQFHWUHDWPHQW'HWR[LILFDWLRQWKHUDS\LVGHILQHGDV³WKHGLVSHQVLQJRIDQRSLRLGDJRQLVW
,1',$1$+($/7+/$:5(9,(:
9RO
7KHVHLQFOXGHUHTXLUHPHQWVRQZKRFDQSURYLGHDQGUHFHLYHPHWKDGRQHWKHUDS\DVZHOODVZKHUH
DQGKRZPHWKDGRQHWKHUDS\FDQEHSURYLGHG6WDWHVDQGORFDOJRYHUQPHQWVPD\DOVRLPSRVH
DGGLWLRQDOUHTXLUHPHQWVRQPHWKDGRQHWKHUDS\
WUHDWPHQW PHGLFDWLRQ LQ GHFUHDVLQJ GRVHV WR DQ LQGLYLGXDO WR DOOHYLDWH DGYHUVH SK\VLFDO RU
SV\FKRORJLFDOHIIHFWVLQFLGHQWWRZLWKGUDZDOIURPWKHFRQWLQXRXVRUVXVWDLQHGXVHRIDQRSLRLG
GUXJDQGDVDPHWKRGRIEULQJLQJWKHLQGLYLGXDOWRDGUXJIUHHVWDWHZLWKLQVXFKSHULRG´&)5
† 'HWR[LILFDWLRQ WUHDWPHQW LQFOXGHV ERWK VKRUWWHUP DQG ORQJWHUP GHWR[LILFDWLRQ
6KRUWWHUP GHWR[LILFDWLRQ WUHDWPHQW LV GHILQHG DV ³GHWR[LILFDWLRQ WUHDWPHQW IRU D SHULRG QRW LQ
H[FHVVRIGD\V´Id. /RQJWHUPGHWR[LILFDWLRQWUHDWPHQWLVGHILQHGDV³GHWR[LILFDWLRQWUHDWPHQW
IRUDSHULRGPRUHWKDQGD\VEXWQRWLQH[FHVVRIGD\V´0DLQWHQDQFHWUHDWPHQWLVGHILQHG
DV³WKHGLVSHQVLQJRIDQRSLRLGDJRQLVWWUHDWPHQWPHGLFDWLRQDWVWDEOHGRVDJHOHYHOVIRUDSHULRGLQ
H[FHVVRIGD\VLQWKHWUHDWPHQWRIDQLQGLYLGXDOIRURSLRLGDGGLFWLRQ´Id. 0DLQWHQDQFHWUHDWPHQW
LQFOXGHVERWKLQWHULPDQGFRPSUHKHQVLYHPDLQWHQDQFHWUHDWPHQW,QWHULPPDLQWHQDQFHWUHDWPHQW
LVGHILQHGDV³PDLQWHQDQFHWUHDWPHQWSURYLGHGLQFRQMXQFWLRQZLWKDSSURSULDWHPHGLFDOVHUYLFHV
ZKLOH D SDWLHQW LV DZDLWLQJ WUDQVIHU WR D SURJUDP WKDW SURYLGHV FRPSUHKHQVLYH PDLQWHQDQFH
WUHDWPHQW´ Id. &RPSUHKHQVLYH PDLQWHQDQFH WUHDWPHQW LV GHILQHG DV ³PDLQWHQDQFH WUHDWPHQW
SURYLGHG LQ FRQMXQFWLRQ ZLWK D FRPSUHKHQVLYH UDQJH RI DSSURSULDWH PHGLFDO DQG UHKDELOLWDWLYH
VHUYLFHV´Id.
See &)5†7KHVHUHJXODWLRQVXQGHUZHQWPDMRUUHYLVLRQLQSee 2SLRLG
'UXJVLQ0DLQWHQDQFHDQG'HWR[LILFDWLRQ7UHDWPHQWRI2SLDWH$GGLFWLRQ)LQDO5XOH)HG5HJ
-DQFRGLILHGDW&)5†&)5†,QEXSUHQRUSKLQHZDVDGGHG
WR WKH OLVW RI DSSURYHG RSLRLG WUHDWPHQW PHGLFDWLRQV WKDW 273V PD\ XVH 2SLRLG 'UXJV LQ
0DLQWHQDQFHDQG'HWR[LILFDWLRQ7UHDWPHQWRI2SLDWH$GGLFWLRQ$GGLWLRQRI%XSUHQRUSKLQHDQG
%XSUHQRUSKLQH &RPELQDWLRQ WR /LVW RI $SSURYHG 2SLRLG 7UHDWPHQW0HGLFDWLRQV )HG 5HJ
0D\FRGLILHGDW&)5†
&)5 † I ³273V VKDOO FRPSO\ ZLWK DOO SHUWLQHQW 6WDWH ODZV DQG
UHJXODWLRQV1RWKLQJLQWKLVSDUWLVLQWHQGHGWROLPLWWKHDXWKRULW\RI6WDWHDQGDVDSSURSULDWHORFDO
JRYHUQPHQWDOHQWLWLHVWRUHJXODWHWKHXVHRIRSLRLGGUXJVLQWKHWUHDWPHQWRIRSLRLGDGGLFWLRQ´
7KHGLIIHULQJUHTXLUHPHQWVLPSRVHGE\VWDWHODZDUHEH\RQGWKHVFRSHRIWKLVDUWLFOH
7+(/$:$1'32/,&<2)23,2,'6
6XEMHFW WR OLPLWHG H[FHSWLRQ IHGHUDO ODZ OLPLWV PHWKDGRQH WKHUDS\ WR DFFUHGLWHG DQG
FHUWLILHGRSLRLGWUHDWPHQWSURJUDPV³273´$VDFRQGLWLRQWRWKLVFHUWLILFDWLRQ273VPXVW
SURYLGH WKH PHWKDGRQH WKHUDS\ LQ DFFRUGDQFH ZLWK IHGHUDO WUHDWPHQW VWDQGDUGV DOWKRXJK WKH
SURJUDPVPD\DSSO\IRUH[HPSWLRQVIURPWKHVHUHTXLUHPHQWV0RUHRYHUSUDFWLWLRQHUVSURYLGLQJ
PHWKDGRQHWKHUDS\PXVWREWDLQDVHSDUDWHDQQXDOUHJLVWUDWLRQIURPWKH'($
)HGHUDO ODZ DOVR UHTXLUHV LQGLYLGXDOV VHHNLQJ PHWKDGRQH WKHUDS\ WR PHHW VSHFLILHG FULWHULD
EDVHGRQWKHLUDJHDQGWKHW\SHRIWUHDWPHQWVRXJKW)RUPDLQWHQDQFHWUHDWPHQWDQLQGLYLGXDO
PXVWPHHWWKH'60,9FULWHULDIRUDGGLFWLRQWRDQRSLRLGGUXJDQGPXVWKDYHEHFRPH³DGGLFWHG
DWOHDVW\HDUEHIRUHDGPLVVLRQIRUWUHDWPHQW´7KHRQH\HDUUHTXLUHPHQWPD\EHZDLYHGIRU
LQGLYLGXDOV UHFHQWO\ UHOHDVHG IURP LQFDUFHUDWLRQ SUHJQDQW ZRPHQ DQG SUHYLRXVO\ WUHDWHG
SDWLHQWV3HUVRQVXQGHUDJHHLJKWHHQPXVWDOVR³KDYHWZRGRFXPHQWHGXQVXFFHVVIXODWWHPSWVDW
VKRUWWHUP GHWR[LILFDWLRQ RU GUXJIUHH WUHDWPHQW ZLWKLQ D PRQWK SHULRG´ $OWKRXJK
7KHUHDUHWZRUHOHYDQWH[HPSWLRQVWRWKHUHTXLUHPHQWWKDWPHWKDGRQHRQO\EHGLVSHQVHGE\
273VZKHQXVHGIRUGHWR[LILFDWLRQRUPDLQWHQDQFHWUHDWPHQW)LUVW
>$@SK\VLFLDQZKRLVQRWVSHFLILFDOO\UHJLVWHUHGWRFRQGXFWDQDUFRWLF
WUHDWPHQWSURJUDP>PD\@DGPLQLVWHU>@EXWQRWSUHVFULE>H@QDUFRWLF
GUXJV WR D SHUVRQ IRU WKH SXUSRVH RI UHOLHYLQJ DFXWH ZLWKGUDZDO
V\PSWRPVZKHQQHFHVVDU\ZKLOHDUUDQJHPHQWVDUHEHLQJPDGHIRU
UHIHUUDOIRUWUHDWPHQW1RWPRUHWKDQRQHGD\
VPHGLFDWLRQPD\EH
DGPLQLVWHUHGWRWKHSHUVRQRUIRUWKHSHUVRQ
VXVHDWRQHWLPH6XFK
HPHUJHQF\WUHDWPHQWPD\EHFDUULHGRXWIRUQRWPRUHWKDQWKUHHGD\V
DQGPD\QRWEHUHQHZHGRUH[WHQGHG
&)5 † E 6HFRQG ³D SK\VLFLDQ RU DXWKRUL]HG KRVSLWDO VWDII >PD\@
DGPLQLVWHURUGLVSHQVHQDUFRWLFGUXJVLQDKRVSLWDOWRPDLQWDLQRUGHWR[LI\DSHUVRQDVDQLQFLGHQWDO
DGMXQFWWRPHGLFDORUVXUJLFDOWUHDWPHQWRIFRQGLWLRQVRWKHUWKDQDGGLFWLRQ´Id.†F
See &)5 † D ³$Q 273 PXVW EH WKH VXEMHFW RI D FXUUHQW YDOLG
FHUWLILFDWLRQIURP6$0+6$WREHFRQVLGHUHGTXDOLILHGE\WKH6HFUHWDU\XQGHUVHFWLRQJ
RIWKH&RQWUROOHG6XEVWDQFHV$FW86&JWRGLVSHQVHRSLRLGGUXJVLQWKHWUHDWPHQW
RIRSLRLGXVHGLVRUGHU´1RWHWKDW273UHIHUVWRERWKWKHSURJUDPDQGSUDFWLWLRQHUsee id.†
GHILQLQJ273DV³Dprogram or practitionerHQJDJHGLQRSLRLGWUHDWPHQWRILQGLYLGXDOVZLWKDQ
RSLRLGDJRQLVWWUHDWPHQWPHGLFDWLRQ´HPSKDVLVDGGHG
See &)5†I
See id.†K³$QH[DPSOHRIDFDVHLQZKLFKDQH[HPSWLRQPLJKWEHJUDQWHGZRXOGEH
IRUDSULYDWHSUDFWLWLRQHUZKRZLVKHVWRWUHDWDOLPLWHGQXPEHURISDWLHQWVLQDQRQPHWURSROLWDQ
DUHD ZLWK IHZ SK\VLFLDQV DQG QR UHKDELOLWDWLYH VHUYLFHV JHRJUDSKLFDOO\ DFFHVVLEOH DQG UHTXHVWV
H[HPSWLRQIURPVRPHRIWKHVWDIILQJDQGVHUYLFHVWDQGDUGV´
See 86&†J
See &)5†H
See id.†H
Seeid.†H7KLVH[FHSWLRQLVOLPLWHGWRVL[PRQWKVDIWHUUHOHDVHIRUSDWLHQWV
UHOHDVHGIURPSHQDOLQVWLWXWLRQVDQGWZR\HDUVDIWHUGLVFKDUJHIRUSUHYLRXVO\WUHDWHGSDWLHQWV
Id.†H
,1',$1$+($/7+/$:5(9,(:
9RO
GHWR[LILFDWLRQWUHDWPHQWLVDYDLODEOHIRUDQ\SHUVRQPHHWLQJWKHGLDJQRVWLFFULWHULDHVWDEOLVKHGE\
WKH273LQGLYLGXDOVDUHOLPLWHGWRWZRGHWR[LILFDWLRQWUHDWPHQWHSLVRGHVSHU\HDU
,Q DGGLWLRQ WR WKHVH SURYLGHU DQG SDWLHQW TXDOLILFDWLRQV IHGHUDO UHJXODWLRQV DOVR VSHFLI\ WKH
VHUYLFHV 273V PXVW SURYLGH DQG KRZ273V PD\GLVSHQVHWKH PHWKDGRQH$WWKHPRVWJHQHUDO
OHYHO 273V PXVW SURYLGH ³DGHTXDWH PHGLFDO FRXQVHOLQJ YRFDWLRQDO HGXFDWLRQDO RWKHU
DVVHVVPHQWDQGWUHDWPHQWVHUYLFHV´7KLVLQFOXGHVDQLQLWLDOIXOOPHGLFDOH[DPLQDWLRQDVZHOO
DVLQLWLDODQGSHULRGLFDVVHVVPHQWVHUYLFHVWRFUHDWHDQGUHYLVHWUHDWPHQWSODQV&RXQVHOLQJPXVW
FRYHUQRWRQO\VXEVWDQFHDEXVHEXWDOVRSUHYHQWLRQRIH[SRVXUHWRDQGWUDQVPLVVLRQRI+,9
FRPPXQLW\UHVRXUFHVYRFDWLRQDOUHKDELOLWDWLRQHGXFDWLRQDQGHPSOR\PHQWVHUYLFHV
7KH SURYLVLRQ RI WKH PHWKDGRQH LWVHOI LV DOVR VWULFWO\ UHJXODWHG 273V PD\ RQO\ SURYLGH
PHWKDGRQHLQRUDOIRUP7KHLQLWLDOGRVHPXVWQRWH[FHHGPLOOLJUDPVDQGWKHHQWLUHGRVH
SURYLGHGRQWKHILUVWGD\RIWUHDWPHQWPXVWQRWH[FHHGPLOOLJUDPV%\GHIDXOWSDWLHQWVPXVW
WDNH WKH PHWKDGRQH XQGHU VXSHUYLVLRQ KRZHYHU SDWLHQWV LQ FRPSUHKHQVLYH PDLQWHQDQFH
WUHDWPHQWPD\UHFHLYHXQVXSHUYLVHG³WDNHKRPH´GRVDJHVXQGHUOLPLWHGFLUFXPVWDQFHVVXFKDV
ZKHQWKHFOLQLFLVFORVHG,IDQ273PHGLFDOGLUHFWRUGHWHUPLQHVEDVHGRQVSHFLILHGIDFWRUVWKDW
³D SDWLHQW LV UHVSRQVLEOH LQ KDQGOLQJ RSLRLG GUXJV IRU XQVXSHUYLVHG XVH´ DQ LQGLYLGXDO PD\
Id.†H
&)5†I
Id.†I
Id.†I
Id.†IL
Id.†ILL
&)5†ILLL
Id.†KL
Id.†KLL7KHWRWDOGRVHIRUWKHILUVWGD\PD\H[FHHGPLOOLJUDPVLI³WKHSURJUDP
SK\VLFLDQGRFXPHQWVLQWKHSDWLHQW
VUHFRUGWKDWPLOOLJUDPVGLGQRWVXSSUHVVRSLDWHDEVWLQHQFH
V\PSWRPV´
Id. † L 8QVXSHUYLVHG RU WDNHKRPH GRVHV DUH SURKLELWHG IRU VKRUWWHUP
GHWR[LILFDWLRQDQGLQWHULPPDLQWHQDQFHWUHDWPHQW
Id.†L
&)5†L³$Q\SDWLHQWLQFRPSUHKHQVLYHPDLQWHQDQFHWUHDWPHQWPD\
UHFHLYHDVLQJOHWDNHKRPHGRVHIRUDGD\WKDWWKHFOLQLFLVFORVHGIRUEXVLQHVVLQFOXGLQJ6XQGD\V
DQG6WDWHDQG)HGHUDOKROLGD\V´
Id.†L7KHVHIDFWRUVLQFOXGHWKH
L >D@EVHQFH RI UHFHQW DEXVH RI GUXJV RSLRLG RU QRQQDUFRWLF
LQFOXGLQJ DOFRKRO LL >U@HJXODULW\ RI FOLQLF DWWHQGDQFH LLL
>D@EVHQFHRIVHULRXVEHKDYLRUDOSUREOHPVDWWKHFOLQLFLY>D@EVHQFH
RINQRZQUHFHQWFULPLQDODFWLYLW\HJGUXJGHDOLQJY>V@WDELOLW\
RI WKH SDWLHQW
V KRPH HQYLURQPHQW DQG VRFLDO UHODWLRQVKLSV YL
>O@HQJWK RI WLPH LQ FRPSUHKHQVLYH PDLQWHQDQFH WUHDWPHQW YLL
>D@VVXUDQFHWKDWWDNHKRPHPHGLFDWLRQFDQEHVDIHO\VWRUHGZLWKLQ
WKHSDWLHQW
VKRPHDQGYLLL>Z@KHWKHUWKHUHKDELOLWDWLYHEHQHILWWKH
SDWLHQWGHULYHGIURPGHFUHDVLQJWKHIUHTXHQF\RIFOLQLFDWWHQGDQFH
RXWZHLJKVWKHSRWHQWLDOULVNVRIGLYHUVLRQ
7+(/$:$1'32/,&<2)23,2,'6
UHFHLYH D VSHFLILHG QXPEHU RI WDNHKRPH GRVHV EDVHG RQ KRZ ORQJ WKH LQGLYLGXDO KDV EHHQ LQ
WUHDWPHQW7KLVLQFOXGHVDVLQJOHGRVHHDFKZHHNGXULQJWKHILUVWQLQHW\GD\VRIWUHDWPHQWWZR
GRVHVSHUZHHNLQWKHVHFRQGQLQHW\GD\VRIWUHDWPHQWWKUHHGRVHVSHUZHHNLQWKHWKLUGQLQHW\
GD\VRIWUHDWPHQWDVL[GD\VXSSO\³LQWKHUHPDLQLQJPRQWKVRIWKHILUVW\HDU´DWZRZHHNVXSSO\
DIWHU RQH \HDU RI FRQWLQXRXV WUHDWPHQW DQG D RQH PRQWK VXSSO\ DIWHU WZR \HDUV RI FRQWLQXRXV
WUHDWPHQW
E. Federal Regulation of Buprenorphine
,QWKH)'$DSSURYHGEXSUHQRUSKLQHIRUWUHDWLQJRSLRLGGHSHQGHQFHDQGWKH'($
UHVFKHGXOHG WKH GUXJ IURP D 6FKHGXOH 9 WR D 6FKHGXOH ,,, FRQWUROOHG VXEVWDQFH 7ZR \HDUV
HDUOLHULQ2FWREHU&RQJUHVVSDVVHGWKH'UXJ$GGLFWLRQ7UHDWPHQW$FWRI³'$7$
´7KHODZDPHQGHGWKH&6$WRDOORZSUDFWLWLRQHUVPHHWLQJFHUWDLQTXDOLI\LQJFULWHULDWR
SUHVFULEHDQGGLVSHQVH6FKHGXOH,,,,9DQG9FRQWUROOHGVXEVWDQFHVDSSURYHGE\WKH)'$IRU
DGGLFWLRQWUHDWPHQWRXWVLGH273VDQGZLWKRXWUHFHLYLQJDVHSDUDWH'($UHJLVWUDWLRQ7KHVHWZR
HYHQWVFUHDWHGWKHFXUUHQWUHJXODWRU\VFKHPHIRUEXSUHQRUSKLQHEDVHG0$7
'$7$UHTXLUHVSK\VLFLDQVWRREWDLQDZDLYHUE\VXEPLWWLQJDQRWLILFDWLRQWRWKH6HFUHWDU\
RI+HDOWKDQG+XPDQ6HUYLFHVRIWKHSK\VLFLDQ¶VLQWHQWWRSUHVFULEHDQGGLVSHQVHEXSUHQRUSKLQH
RURWKHU6FKHGXOH,,,9FRQWUROOHGVXEVWDQFHVIRUWKHWUHDWPHQWRIRSLRLGGHSHQGHQFH7KLV
ZDLYHUPXVWFRQWDLQDFHUWLILFDWLRQWKDWWKHSK\VLFLDQLVTXDOLILHGWRSUHVFULEHWKHPHGLFDWLRQVIRU
WUHDWLQJ RSLRLG GHSHQGHQFH ³KDV WKH FDSDFLW\ WR UHIHU > @ >WKHLU@ SDWLHQWV IRU DSSURSULDWH
FRXQVHOLQJDQGRWKHUDSSURSULDWHDQFLOODU\VHUYLFHV´DQGZLOOFRPSO\ZLWKOLPLWDWLRQVRQWKH
WRWDO QXPEHU RI SDWLHQWV WKH SK\VLFLDQ PD\ WUHDW DW DQ\ RQH WLPH 3K\VLFLDQV DUH FRQVLGHUHG
TXDOLILHGWRGLVSHQVHEXSUHQRUSKLQHWRWUHDWRSLRLGGHSHQGHQFHLIWKH\DUHOLFHQVHGXQGHUVWDWHODZ
&)5†L
Id.†LLYL
Buprenorphine: A Drug You Need to Know AboutsupraQRWHDW
6FKHGXOHVRI&RQWUROOHG6XEVWDQFHV5HVFKHGXOLQJRI%XSUHQRUSKLQH)URP6FKHGXOH9WR
6FKHGXOH,,,)HG5HJ2FWWREHFRGLILHGDW&)5SW7KH'($
VSHFLILFDOO\FLWHG '$7$ ¶V DOORZLQJ RIILFHEDVHG 0$7 ZLWK EXSUHQRUSKLQH DV D IDFWRU LQ
UHVFKHGXOLQJ WKH GUXJ See id. DW ³+LJKGRVH VXEOLQJXDO WDEOHWV LQWHQGHG IRU QDUFRWLF
WUHDWPHQWDQGXWLOL]HGRXWVLGHWKHFRQVWUDLQWVRIWUDGLWLRQDOQDUFRWLFWUHDWPHQWSURJUDPVLQFUHDVHV
WKHULVNWKDWWKHVHSURGXFWVZLOOEHGLYHUWHGWUDIILFNHGDQGDEXVHG6LPSO\VWDWHGSURYLGLQJDQ
DEXVDEOHVXEVWDQFHWRNQRZQGUXJDEXVHUVLPSDUWVHQKDQFHGULVNV´+RZHYHUWKH'($GHQLHG
UHVFKHGXOLQJ RQ WKLV EDVLV DORQH Id. DW ³7KH SURSRVHG SODFHPHQW RI EXSUHQRUSKLQH LQ
6FKHGXOH,,,ZDVQRWPDGHRQWKHEDVLVRIPDNLQJEXSUHQRUSKLQHSURGXFWVDYDLODEOHIRURIILFH
EDVHGQDUFRWLFWUHDWPHQW>D@VSDUWRIRXUVFKHGXOLQJUHYLHZ'($GLGFRQVLGHUWKHLPSDFWRI
EXSUHQRUSKLQHWUHDWPHQWSURGXFWVXVHGZLWKLQWKHFRQWH[WRIRIILFHEDVHGSUDFWLFH´Id
&KLOGUHQ¶V+HDOWK$FWRI3XE/1R6WDW†
86&†J
Id.†J%&)5†DE
&)5†ELLLL
86&†J%LLLL&)5†ELLLL
,1',$1$+($/7+/$:5(9,(:
9RO
DQGPHHWVDWOHDVWRQHVSHFLILHGHGXFDWLRQDORUH[SHULHQFHUHTXLUHPHQWV$SK\VLFLDQPD\WUHDW
RQO\XSWRWKLUW\SDWLHQWVDWDQ\RQHWLPHGXULQJWKHILUVW\HDUWKHSK\VLFLDQWUHDWVRSLDWHGHSHQGHQW
SDWLHQWVXQGHUD'$7$ZDLYHU,QVXEVHTXHQW\HDUVDQGXSRQQRWLI\LQJWKH6HFUHWDU\RI
+HDOWKDQG+XPDQ6HUYLFHVDSK\VLFLDQPD\WUHDWXSWRSDWLHQWVDWDQ\RQHWLPH
2Q -XO\ 6$0+6$ D GLYLVLRQ RI WKH 'HSDUWPHQW RI +HDOWK DQG +XPDQ 6HUYLFHV
ILQDOL]HG UHYLVLRQV WR WKH 273 UHJXODWLRQV UHODWLQJ WR EXSUHQRUSKLQHEDVHG 0$7 (IIHFWLYH
$XJXVWWKHVHQHZUHJXODWLRQVLQFUHDVHWKHSDWLHQWOLPLWWRIRUTXDOLILHGSUDFWLWLRQHUV
SURYLGLQJ EXSUHQRUSKLQHEDVHG 0$7 7R TXDOLI\ IRU WKHVH LQFUHDVHG SDWLHQW OLPLWV WKH
SUDFWLWLRQHUPXVWERWKSRVVHVVD'$7$ZDLYHUDOORZLQJWKHPWRWUHDWXSWRSDWLHQWV
IRUDWOHDVWRQH\HDUDQGSRVVHVVDVXEVSHFLDOW\ERDUGFHUWLILFDWLRQLQDGGLFWLRQPHGLFLQHRU
DGGLFWLRQ SV\FKLDWU\ RU SUDFWLFH LQ D ³TXDOLILHG SUDFWLFH VHWWLQJ´ 7KHVH TXDOLILHG SUDFWLFH
VHWWLQJVPXVWHQVXUHSDWLHQWVFDQDFFHVVHPHUJHQF\FDUHZKHQWKHSUDFWLFHLVFORVHGSURYLGHDFFHVV
WRFDVHPDQDJHPHQWVHUYLFHVXVHKHDOWKLQIRUPDWLRQWHFKQRORJ\V\VWHPVVXFKDVHOHFWURQLFKHDOWK
86&†J*LL7KHVHHGXFDWLRQDODQGH[SHULHQFHUHTXLUHPHQWVDUH
+ROGLQJ D FHUWLILFDWLRQ LQ DGGLFWLRQ IURP WKH $PHULFDQ %RDUG RI 0HGLFDO
6SHFLDOWLHV WKH $PHULFDQ 6RFLHW\ RI $GGLFWLRQ 0HGLFLQH RU WKH $PHULFDQ 2VWHRSDWKLF
$VVRFLDWLRQ
&RPSOHWLQJDWOHDVWKRXUVRIWUDLQLQJLQ³WKHWUHDWPHQWDQGPDQDJHPHQWRIRSLDWH
GHSHQGHQW SDWLHQWV´ IURP ³WKH $PHULFDQ 6RFLHW\ RI $GGLFWLRQ 0HGLFLQH WKH $PHULFDQ
$FDGHP\ RI $GGLFWLRQ 3V\FKLDWU\ WKH $PHULFDQ 0HGLFDO $VVRFLDWLRQ WKH $PHULFDQ
2VWHRSDWKLF$VVRFLDWLRQWKH$PHULFDQ3V\FKLDWULF$VVRFLDWLRQRUDQ\RWKHURUJDQL]DWLRQ
WKDWWKH6HFUHWDU\>RI+HDOWKDQG+XPDQ6HUYLFHV@GHWHUPLQHVLVDSSURSULDWHIRU>WKHVH@
SXUSRVHV´
3DUWLFLSDWLQJ³DVDQLQYHVWLJDWRULQRQHRUPRUHFOLQLFDOWULDOVOHDGLQJWRWKHDSSURYDO
RIDQDUFRWLFGUXJLQVFKHGXOH,,,,9RU9IRUPDLQWHQDQFHRUGHWR[LILFDWLRQWUHDWPHQWDV
GHPRQVWUDWHGE\DVWDWHPHQWVXEPLWWHGWRWKH6HFUHWDU\E\WKHVSRQVRURIVXFKDSSURYHG
GUXJ´
+DYLQJ³VXFKRWKHUWUDLQLQJRUH[SHULHQFHDVWKH6WDWHPHGLFDOOLFHQVLQJERDUGRI
WKH 6WDWH LQ ZKLFK WKH SK\VLFLDQ ZLOO SURYLGH PDLQWHQDQFH RU GHWR[LILFDWLRQ WUHDWPHQW
FRQVLGHUVWRGHPRQVWUDWHWKHDELOLW\RIWKHSK\VLFLDQWRWUHDWDQGPDQDJHRSLDWHGHSHQGHQW
SDWLHQWV´RU
+DYLQJ³VXFKRWKHUWUDLQLQJRUH[SHULHQFHDVWKH6HFUHWDU\FRQVLGHUVWRGHPRQVWUDWH
WKHDELOLW\RIWKHSK\VLFLDQWRWUHDWDQGPDQDJHRSLDWHGHSHQGHQWSDWLHQWV´DVVSHFLILHGE\
UHJXODWLRQ
86&†J%LLL&)5†ELLL
Id.
0HGLFDWLRQ $VVLVWHG 7UHDWPHQW IRU 2SLRLG 8VH 'LVRUGHUV )HG 5HJ -XO\ WREHFRGLILHGDW&)5SW
Id.DWWREHFRGLILHGDW&)5†
Id. DW7KHSUDFWLWLRQHUPXVWDOVRQRWKDYH³KDGKLVRUKHUHQUROOPHQWDQGELOOLQJ
SULYLOHJHVLQWKH0HGLFDUHSURJUDPUHYRNHGXQGHU†RIWKLVWLWOH´DQGKDYH³EHHQIRXQG
WRKDYHYLRODWHGWKH&RQWUROOHG6XEVWDQFHV$FWSXUVXDQWWR86&D´
7+(/$:$1'32/,&<2)23,2,'6
UHFRUGVXWLOL]HWKHLUVWDWHSUHVFULSWLRQGUXJPRQLWRULQJSURJUDP³3'03´DQGDFFHSWWKLUGSDUW\
SD\PHQW
6LPLODUO\WKH&RPSUHKHQVLYH$GGLFWLRQDQG5HFRYHU\$FWRI³&$5$´VLJQHGLQWR
ODZ RQ -XO\ PDNHV DGGLWLRQDO FKDQJHV WR IHGHUDO ODZ DLPHG DW LQFUHDVLQJ DFFHVV WR
0$7 0RVW SURPLQHQWO\ &$5$ DPHQGV WKH &6$ WR DOORZ FHUWDLQ QXUVH SUDFWLWLRQHUV DQG
SK\VLFLDQDVVLVWDQWVWRSURYLGH0$7ZLWK6FKHGXOH,,,9RU9FRQWUROOHGVXEVWDQFHVLQFOXGLQJ
EXSUHQRUSKLQH7RTXDOLI\WKHQXUVHSUDFWLWLRQHURUSK\VLFLDQDVVLVWDQWPXVWEH³OLFHQVHGXQGHU
6WDWH ODZ WR SUHVFULEH VFKHGXOH ,, ,9 RU 9 PHGLFDWLRQV IRU WKH WUHDWPHQW RI SDLQ´ DQG KDYH
VXIILFLHQW WUDLQLQJ &$5$ DOVR LQFOXGHV PRUH VSHFLILF FRQWHQW UHTXLUHPHQWV IRU SK\VLFLDQ
HGXFDWLRQZKHQXVHGE\WKHSK\VLFLDQWRTXDOLI\IRUD'$7$ZDLYHU
F. Insurance Coverage of MAT
+LVWRULFDOO\ PDQ\ LQVXUDQFH SODQV SDUWLFXODUO\ WKRVH DYDLODEOH WR ORZHU LQFRPH SHRSOH
SURYLGHGSRRURUQRFRYHUDJHIRU28'WUHDWPHQW0RUHRYHUKHDOWKLQVXUDQFHSURYLGHUVOHJDOO\
Id.WREHFRGLILHGDW&)5†
&RPSUHKHQVLYH$GGLFWLRQDQG5HFRYHU\$FWRI3XE/1R6WDW
Id. † D&YLY, WR EH FRGLILHG DW 86& †† J*LY, &$5$
LQFOXGHVDVXQVHWSURYLVLRQSURYLGLQJWKDWLWVDXWKRUL]DWLRQIRUQXUVHSUDFWLWLRQHUVDQGSK\VLFLDQ
DVVLVWDQWV WR SURYLGH 0$7 H[SLUHV RQ 2FWREHU Id. WR EH FRGLILHG DW 86& †
J*LLL,,
Id. † D&YLY,,,,, WR EH FRGLILHG DW 86& † J*LY,,,,,
1XUVH SUDFWLWLRQHUV DQG SK\VLFLDQ DVVLVWDQWV FDQ PHHW WKH WUDLQLQJ UHTXLUHPHQW HLWKHU E\ FRPSOHWLQJDWOHDVWWZHQW\IRXUKRXUVRILQLWLDOWUDLQLQJDGGUHVVLQJWKHVDPHWRSLFVUHTXLUHGIRU
SK\VLFLDQVsee infra QRWHRU³KD>YLQJ@VXFKRWKHUWUDLQLQJRUH[SHULHQFHDVWKH6HFUHWDU\
GHWHUPLQHVZLOOGHPRQVWUDWHWKHDELOLW\RIWKHQXUVHSUDFWLWLRQHURUSK\VLFLDQDVVLVWDQWWRWUHDWDQG
PDQDJH RSLDWHGHSHQGHQW SDWLHQWV´ Id. 1XUVH SUDFWLWLRQHUV DQG SK\VLFLDQ DVVLVWDQWV PXVW EH
³VXSHUYLVHGE\RUZRUNLQFROODERUDWLRQZLWKDTXDOLI\LQJSK\VLFLDQLIWKHQXUVHSUDFWLWLRQHURU
SK\VLFLDQDVVLVWDQWLVUHTXLUHGE\6WDWHODZWRSUHVFULEHPHGLFDWLRQVIRUWKHWUHDWPHQWRIRSLRLG
XVHGLVRUGHULQFROODERUDWLRQZLWKRUXQGHUWKHVXSHUYLVLRQRIDSK\VLFLDQ´Id.
Id.†D&LY,9WREHFRGLILHGDW86&†J*LL,97KHVHWRSLFV
DUH
RSLRLGPDLQWHQDQFHDQG GHWR[LILFDWLRQ DSSURSULDWH FOLQLFDOXVHRI
DOO GUXJV DSSURYHG E\ WKH )RRG DQG 'UXJ $GPLQLVWUDWLRQ IRU WKH
WUHDWPHQW RI RSLRLG XVH GLVRUGHU LQLWLDO DQG SHULRGLF SDWLHQW
DVVHVVPHQWV LQFOXGLQJ VXEVWDQFH XVH PRQLWRULQJ LQGLYLGXDOL]HG
WUHDWPHQW SODQQLQJ RYHUGRVH UHYHUVDO DQG UHODSVH SUHYHQWLRQ
FRXQVHOLQJ DQG UHFRYHU\ VXSSRUW VHUYLFHV VWDIILQJ UROHV DQG
FRQVLGHUDWLRQV GLYHUVLRQ FRQWURO DQG RWKHU EHVW SUDFWLFHV DV
LGHQWLILHGE\WKH6HFUHWDU\
0$5< *,/,%(57, (7 $/ &29(5$*( )25 $// ,1&/86,21 2) 0(17$/ ,//1(66 $1'
68%67$1&(86(',625'(56,167$7(+($/7+&$5(5()250,1,7,$7,9(61DWLRQDO$OOLDQFHRQ
0HQWDO,OOQHVVDQG1DWLRQDO&RXQFLOIRU&RPPXQLW\%HKDYLRUDO+HDOWKFDUH-XQHILQGLQJ
,1',$1$+($/7+/$:5(9,(:
9RO
FRXOG DQG JHQHUDOO\ GLG LPSRVH PRUH VWULQJHQW UHTXLUHPHQWV DQG OLPLWDWLRQV RQ FRYHUDJH IRU
PHQWDO KHDOWK VHUYLFHV LQFOXGLQJWUHDWPHQW IRU 28' WKDQ IRU RWKHU PHGLFDO VHUYLFHV 7KHVH
UHTXLUHPHQWVDQGOLPLWDWLRQVPDGHLWH[WUDRUGLQDULO\GLIILFXOWDQGFRVWO\IRULQGLYLGXDOVZLWK28'±
HYHQWKRVHZLWKKHDOWKLQVXUDQFH±WRREWDLQQHHGHGFDUH%HJLQQLQJLQ&RQJUHVVWRRNVHYHUDO
VWHSVWRLQFUHDVHDFFHVVWRPHQWDOKHDOWKFDUHEXWWKHLPSDFWRQDFFHVVWRVXEVWDQFHXVHGLVRUGHU
³68'´WUHDWPHQWDQGPRUHVSHFLILFDOO\0$7UHPDLQVXQFOHDU
,Q&RQJUHVVHQDFWHGWKH0HQWDO+HDOWK3DULW\$FW³03+$´SURKLELWLQJODUJHJURXS
LQVXUHUVIURPLPSRVLQJPRUHUHVWULFWLYHDQQXDODQGOLIHWLPHILQDQFLDOOLPLWDWLRQVRQPHQWDOKHDOWK
VHUYLFHVWKDQWKRVHDSSOLFDEOHWRRWKHUPHGLFDOFDUH+RZHYHUWKHODZGLGQRWDGGUHVV68'GLG
QRWUHTXLUHLQVXUHUVWRRIIHUPHQWDOKHDOWKFRYHUDJHDWDOODQGH[SOLFLWO\SHUPLWWHGFRVWVKDULQJDQG
XWLOL]DWLRQOLPLWDWLRQV,QWKH3DXO:HOOVWRQHDQG3HWH'RPHQLFL0HQWDO+HDOWK3DULW\DQG
$GGLFWLRQ(TXLW\$FWRI³0+3$($´VWUHQJWKHQHGWKH03+$E\DGGLQJ68'EHQHILWVDQG
SURKLELWLQJLQVXUHUVIURPLPSRVLQJPRUHUHVWULFWLYHILQDQFLDODQGWUHDWPHQWOLPLWDWLRQVRQPHQWDO
KHDOWKDQG68'EHQHILWV0RUHRYHUUHJXODWLRQVSURPXOJDWHGXQGHUWKH0+3$($UHTXLUHGWKDW
KHDOWK SODQV WKDW RIIHUHG EHQHILWV IRU D VSHFLILF VXEVWDQFH XVH FRQGLWLRQ LQ DQ\ RQH RI VL[
FODVVLILFDWLRQVLQSDWLHQWLQQHWZRUNLQSDWLHQWRXWRIQHWZRUNRXWSDWLHQWLQQHWZRUNRXWSDWLHQW
RXWRIQHWZRUNHPHUJHQF\FDUHDQGSUHVFULSWLRQGUXJVDOVRSURYLGHEHQHILWVIRUWKDWFRQGLWLRQ
LQHYHU\RWKHUFODVVLILFDWLRQLQZKLFKPHGLFDORUVXUJLFDOEHQHILWVZHUHRIIHUHG+RZHYHUWKH
ODZ¶V H[HPSWLRQ IRU VPDOO HPSOR\HUV OHIW D ODUJH VHJPHQW RI WKH SRSXODWLRQ ZLWKRXW LWV
SURWHFWLRQV
7KH3DWLHQW3URWHFWLRQDQG$IIRUGDEOH&DUH$FW³$&$´VLJQHGLQWRODZRQ0DUFK
UHTXLUHV DOO LQGLYLGXDO DQGVPDOOJURXSKHDOWKLQVXUDQFHSROLFLHVWRSURYLGHFRYHUDJHIRU
WKDWRQO\RIVXUYH\HGVWDWHVKDYHDWOHDVWRQHSURJUDPIRUWKHXQLQVXUHGWKDWSURYLGHV68'
VHUYLFHVDWSDULW\
See (OOHQ :HEHU Equality Standards for Health Insurance Coverage: Will the Mental
Health Parity and Addiction Equity Act End The Discrimination?*2/'(1 *$7( 8 / 5(9
$SULO
See 0LFKDHO&%DUQHV6WDFH\/:RUWK\Achieving Real Parity: Increasing Access to
Treatment for Substance Use Disorders Under the Patient Protection and Affordable Care Act
and the Mental Health and Addiction Equity Act8 $5. /,77/( 52&. / 5(9
6WDWHVKDYHDOVRWDNHQDFWLRQWRLQFUHDVHPHQWDOKHDOWKDQGVXEVWDQFHXVHGLVRUGHUWUHDWPHQW
SDULW\Id. DW
'HSDUWPHQWVRI9HWHUDQV$IIDLUVDQG+RXVLQJDQG8UEDQ'HYHORSPHQWDQG,QGHSHQGHQW
$JHQFLHV$SSURSULDWLRQV$FWRI3XE/1R6WDW
Id.
(PHUJHQF\(FRQRPLF6WDELOL]DWLRQ$FWRI3XE/1R6WDW
)LQDQFLDO UHTXLUHPHQWV LQFOXGHG ³GHGXFWLEOHV FRSD\PHQWV FRLQVXUDQFH DQG RXWRISRFNHW
H[SHQVHV´DQGWUHDWPHQWOLPLWDWLRQVLQFOXGHG³OLPLWVRQWKHIUHTXHQF\RIWUHDWPHQWQXPEHURI
YLVLWVGD\VRIFRYHUDJHRURWKHUVLPLODUOLPLWVRQWKHVFRSHRUGXUDWLRQRIWUHDWPHQW´Id.
&)5†FLL$
Id.†FLLLsee ([DPSOH([HPSWLRQV
3DWLHQW3URWHFWLRQDQG$IIRUGDEOH&DUH$FW3XE/1R6WDW
amended by+HDOWK&DUHDQG(GXFDWLRQ5HFRQFLOLDWLRQ$FWRI3XE/1R
6WDW>KHUHLQDIWHU$&$@
7+(/$:$1'32/,&<2)23,2,'6
68'DVDQHVVHQWLDOKHDOWKEHQHILW³(+%´±WKHILUVWVXFKUHTXLUHPHQWLQIHGHUDOODZ,WDOVR
H[WHQGHG WKH 0+3$($¶V UHTXLUHPHQWV WR DOO LQVXUDQFH SODQV RIIHUHG WKURXJK DQ $&$
0DUNHWSODFHDOOEHQFKPDUNDQGEHQFKPDUNHTXLYDOHQW0HGLFDLGSODQVDQG0HGLFDLGSODQV
RSHUDWHGE\PDQDJHGFDUHRUJDQL]DWLRQV0RUHRYHUWKH$&$SURKLELWVLQVXUHUVIURPUHIXVLQJ
WRFRYHUSHRSOHFXUUHQWO\H[SHULHQFLQJ68'RUZLWKDKLVWRU\RI68'DVZHOODVSURKLELWV
LQVXUHUV IURP FKDUJLQJ LQGLYLGXDOV ZLWK 68' KLJKHU SUHPLXPV RU FRVW VKDULQJ EDVHG RQ WKHLU
FRQGLWLRQ
$OWKRXJK WKHVH FKDQJHV DUH ZHOFRPH DQG ZLOO OLNHO\ FRQWLQXH WR LQFUHDVH DFFHVV WR 68'
WUHDWPHQWLQFOXGLQJ0$7IRU28'WKH\DUHQRWDSDQDFHD2QHVWXG\H[DPLQLQJWKH0+3$($
IRXQGWKDWWKHODZGLGQRWLQFUHDVHWKHQXPEHURILQGLYLGXDOVUHFHLYLQJ68'WUHDWPHQWDQGIRXQG
³QRVLJQLILFDQWFKDQJHLQLGHQWLILFDWLRQWUHDWPHQWLQLWLDWLRQRUWUHDWPHQWHQJDJHPHQW´$QRWKHU
UHFHQWVWXG\UHYHDOHGWKDWDSSUR[LPDWHO\KDOIRILQGLYLGXDOVZLWKXQPHWPHQWDOKHDOWKWUHDWPHQW
QHHGV LQFOXGLQJ VXEVWDQFH XVH GLVRUGHU UHSRUWHG FRVW DQG LQVXUDQFH FRYHUDJH DV D EDUULHU WR
DFFHVV 1RQFRPSOLDQFH ZLWK IHGHUDO UHTXLUHPHQWV OLNHO\ FRQWULEXWHV WR WKHVH UHVXOWV $ -XQH
UHSRUWIURPWKH1DWLRQDO&HQWHURQ$GGLFWLRQDQG6XEVWDQFH$EXVHUHYHDOHGWKDWWKHYDVW
PDMRULW\RI$&$EHQFKPDUNSODQVGRQRWVDWLVI\WKH$&$DQG0+3$($¶VUHTXLUHPHQWV0RUH
86&††D%&)5†D
86& † M DSSO\LQJ WKH 0+3$($¶V SDULW\ UHTXLUHPHQWV WR TXDOLILHG
KHDOWKSODQV
Id. †XE$DSSO\LQJWKH0+3$($¶VSDULW\UHTXLUHPHQWVWREHQFKPDUNDQG
EHQFKPDUNHTXLYDOHQW0HGLFDLGSODQV
Id. † XE DSSO\LQJ WKH 0+3$($¶V SDULW\ UHTXLUHPHQWV WR 0HGLFDLG
PDQDJHGFDUHRUJDQL]DWLRQV
Id.†JJD
Id.†JJD
Id†JJE
6XVDQ+%XVFKHWDOThe Effects of Federal Parity on Substance Use Disorder Treatment
$0-0$1$*('&$5(
7LPRWK\%&UHHGRQ%HQMDPLQ/Hࡂ&RRNAccess To Mental Health Care Increased But
Not For Substance Use, While Disparities Remain+($/7+$))
1$7
/ &75 21 $'',&7,21 68%67$1&( $%86( 81&29(5,1* &29(5$*( *$36 $
5(9,(: 2) $'',&7,21 %(1(),76 ,1 $&$ 3/$16 -XQH KWWSZZZFHQWHURQDGGLFWLRQRUJ>KWWSVSHUPDFF7064<./@7KHUHSRUWIRXQGWKDW
2YHU WZRWKLUGV RI WKH SODQV GR QRW FRPSO\ ZLWK WKH $&$¶V
UHTXLUHPHQWVIRUFRYHUDJHRI68'EHQHILWV,,(LJKWHHQSHUFHQWRI
WKHSODQVYLRODWHSDULW\UHTXLUHPHQWVSHUFHQWRIWKHSODQVFRQWDLQ
SRVVLEOH SDULW\ YLRODWLRQV ,,, 1RQH RI WKH SODQV SURYLGH
FRPSUHKHQVLYH FRYHUDJH IRU 68'V E\ FRYHULQJ WKH IXOO DUUD\ RI
FULWLFDO EHQHILWV ZLWKRXW KDUPIXO WUHDWPHQW OLPLWDWLRQV WKH PRVW
IUHTXHQWO\H[FOXGHGRUQRWH[SOLFLWO\FRYHUHGEHQHILWVDUHUHVLGHQWLDO
WUHDWPHQWDQGPHWKDGRQHPDLQWHQDQFHWKHUDS\,93ODQGRFXPHQWV
IRU SHUFHQW RI WKH (+%EHQFKPDUN SODQV ODFN VXIILFLHQW
GHWDLO WR IXOO\ HYDOXDWH FRPSOLDQFH ZLWK WKH $&$ DQGRU WKH
DGHTXDF\RI68'EHQHILWV
,1',$1$+($/7+/$:5(9,(:
9RO
DJJUHVVLYH HQIRUFHPHQW PD\ EH QHFHVVDU\ WR HQVXUH WKH $&$ IXOILOOV LWV SURPLVH RI H[SDQGLQJ
DFFHVVWR68'
,91$/2;21($&&(66
A. Access to Emergency Overdose Treatment
$V GHVFULEHG LQ 6HFWLRQ , RSLRLGV FDQ EH XVHIXO LQ WKH WUHDWPHQW RI VRPH W\SHV RI SDLQ
SURYLGLQJ UHOLHI DQG LPSURYLQJ SURGXFWLYLW\ IRU PDQ\ SHRSOH +RZHYHU EHFDXVH WKH VDPH
UHFHSWRUVWKDWPHGLDWHSDLQDOVRDIIHFWDQXPEHURIRWKHUV\VWHPVDQGIXQFWLRQVRSLRLGWKHUDS\
FDQUHVXOWQXPHURXVSV\FKRORJLFDODQGSK\VLRORJLFDOVLGHHIIHFWV)RUH[DPSOHDSSUR[LPDWHO\
RISDWLHQWVSUHVFULEHGRSLRLGVVXIIHUIURP QDXVHDZKLOHEHWZHHQDQGRIRSLRLG
SDWLHQWVUHSRUWFKURQLFRSLRLGLQGXFHGFRQVWLSDWLRQ³2,&´
0RUHZRUU\LQJIURPDSXEOLFKHDOWKVWDQGSRLQWDUHWKHVHGDWLQJDQGGHSUHVVDQWTXDOLWLHVRI
RSLRLGV235VHLWKHUDORQHRULQFRPELQDWLRQZLWKRWKHUPHGLFDWLRQVFDQUHGXFHWKHERG\¶V
VHQVLWLYLW\WRR[\JHQDQGFDUERQGLR[LGHOHYHOV7KLVFDXVHVWKHUHVSLUDWRU\V\VWHPWRZRUNOHVV
HIILFLHQWO\ UHVXOWLQJ LQ D UHGXFWLRQ LQ WKH DPRXQW RI R[\JHQ DYDLODEOH WR WKH EUDLQ DQG RWKHU
RUJDQV(DUO\UHYHUVDORIWKLVRSLRLGLQGXFHGUHVSLUDWRU\GHSUHVVLRQ³2,5'´LVFULWLFDODVWKH
ULVNRILUUHYHUVLEOHFHOOGHDWKLQFUHDVHVWKHORQJHUWKLVFRQGLWLRQWHUPHGK\SR[LDSHUVLVWV2YHU
$PHULFDQV GLHG LQ RI RSLRLGUHODWHG RYHUGRVH DQG DQ XQNQRZQ EXW PXFK ODUJHU
QXPEHUOLNHO\VXIIHUHGPLQRUWRPDMRUK\SR[LDUHODWHGGLVDELOLW\
%HQ\DPLQHWDOsupra QRWHDW6OLVWLQJPXOWLSOHHIIHFWVRIRSLRLGWKHUDS\LQ
DGGLWLRQWRDQDOJHVLD
-RKQ06ZHJOH&UDLJ/RJHPDQQManagement of Common Opioid-Induced Adverse
Effects$0)$03+<6,&,$1GHVFULELQJWKDWEHFDXVHRIWKHSUHYDOHQFH
RIRSLRLGSUHVFULELQJDQGUHODWHG2,&VHYHUDOGUXJPDNHUVQRZPDUNHWPHGLFDWLRQVVSHFLILFDOO\WR
WUHDWWKHFRQGLWLRQ$WHOOLQJH[DPSOHRIWKHZLGHVSUHDGQDWXUHRIWKHSUREOHPZDVPDQLIVWHGLQ
WKH6XSHU%RZOZKLFKVDZDSSUR[LPDWHO\PLOOLRQVSHQWRQDGVWRUDLVHDZDUHQHVVRI
2,& (G 6LOYHUPDQ Drug makers stand firm on TV ad for opioid-induced constipation 67$7
)HE, KWWSVZZZVWDWQHZVFRP>KWWSVSHUPDFF8=7/(@
1DWKDQ &KHUQ\ HW DO Strategies to Manage the Adverse Effects of Oral Morphine: An
Evidence-Based Report-&/,1,&$/21&2/2*<UHSRUWLQJWKDWWR
RISDWLHQWVUHFHLYLQJRUDOPRUSKLQHIRUFKURQLFFDQFHUSDLQH[SHULHQFHVHGDWLRQRUGURZVLQHVV
-DVRQ0:KLWH5RGQH\-,UYLQHMechanisms of Fatal Opioid Overdose$'',&7,21
SURYLGLQJDQH[KDXVWLYHH[SODQDWLRQRIWKHPDQQHULQZKLFKRSLRLGVFDXVH2,5'DQG
UHVXOWLQJIDWDORYHUGRVH
See . 7 6 3DWWLQVRQ Opioids and the Control of Respiration %5,7,6+ - 2)
$1$(67+(6,$
&DULQH 0LFKLHOV Physiological and Pathological Responses to Hypoxia $0 -
3$7+2/2*<
7KHH[DFWQXPEHULVUHSRUWHGWREHEXWVLQFHDSSUR[LPDWHO\RIRYHUGRVHGHDWKV
GRQRWOLVWWKHGUXJVLQYROYHGWKLVQXPEHULVDQXQGHUFRXQW5RVH$5XGGHWDOIncreases in
Drug and Opioid Overdose Deaths–United States, 2000-2014025%,',7<$1' 0257$/,/7<
:./<5(3
7+(/$:$1'32/,&<2)23,2,'6
/XFNLO\ D PHGLFDWLRQ H[LVWV WKDW HIIHFWLYHO\ DQG UHOLDEO\ UHYHUVHV 2,5' 7KLV PHGLFDWLRQ
FDOOHGQDOR[RQHLVDSXUHRSLRLGDQWDJRQLVWWKDWELQGVWRRSLRLGUHFHSWRUVEXWGRHVQRWDFWLYDWH
WKHP6LQFHQDOR[RQHKDVDKLJKHUDIILQLW\IRUWKHVHUHFHSWRUVWKDQDOORSLRLGVLQFRPPRQXVH
LWGLVSODFHVWKRVHRSLRLGVUHVWRULQJQRUPDOUHVSLUDWRU\UHVSRQVH)LUVWDSSURYHGE\WKH)'$LQ
QDOR[RQHLVDSUHVFULSWLRQPHGLFDWLRQEXWQRWDFRQWUROOHGVXEVWDQFH,WLVRQWKH:+2¶V
/LVW RI (VVHQWLDO 0HGLFLQHV DQG LV WKH VWDQGDUG WUHDWPHQW IRU RSLRLG RYHUGRVH $OWKRXJK
QDOR[RQHLVFDUULHGE\PRVWSDUDPHGLFVLQWKH8QLWHG6WDWHVLWKDVQRWKLVWRULFDOO\EHHQSUHVFULEHG
IRURXWSDWLHQWXVHOLNHO\GXHLQSDUWWRWKHIDFWWKDWLWZDVRULJLQDOO\DSSURYHGRQO\IRULQMHFWLRQ
:LWKWKHLQFUHDVHLQRSLRLGRYHUGRVHGHDWKVWKHUHKDVEHHQPRYHPHQWWRGHFUHDVHWKHDPRXQW
RI WLPH RYHUGRVH SDWLHQWV DUH LQ 2,5' E\ LQFUHDVLQJ DFFHVV WR QDOR[RQH DPRQJ OD\SHRSOH
LQFOXGLQJSHRSOHZKRXVHGUXJVDQGWKHLUIULHQGVDQGIDPLO\PHPEHUV$VHDUO\DVWKHPLG¶V
QDOR[RQH ZDV EHLQJ GLVSHQVHG WR SHRSOH ZKR XVH GUXJV ³3:8'´ LQ VHYHUDO FRXQWULHV LQ
(XURSH3URJUDPVWRGLVWULEXWHQDOR[RQHWR3:8'LQWKH8QLWHG6WDWHVEHJDQRSHUDWLQJVKRUWO\
WKHUHDIWHU%\QHDUO\FRPPXQLW\QDOR[RQHGLVWULEXWLRQSURJUDPVZHUHRSHUDWLQJLQ
WKH8QLWHG6WDWHVDQGSDUWLFLSDQWVLQWKRVHSURJUDPVKDGUHFHLYHGPRUHWKDQNLWVZKLFK
ZHUH XVHG WR UHYHUVH PRUH WKDQ RYHUGRVHV %\ -XO\ WKH QXPEHU RI QDOR[RQH
See -DPHV0&KDPEHUODLQ%UXFH/.OHLQA Comprehensive Review of Naloxone for
the Emergency Physician$0-(0(5*(1&<0('IRUDQH[KDXVWLYHH[SODQDWLRQ
RIWKHPHFKDQLVPDQGHIIHFWRIQDOR[RQH
Id.
'DQLHO 3 :HUPHOLQJ Review of Naloxone Safety for Opioid Overdose: Practical
Considerations for New Technology and Expanded Public Access7+(5$3(87,&$'9$1&(6,1
'58* 6$)(7< 1DOR[RQH DSSURYHG LQ see also 'UXJ (QIRUFHPHQW
$GPLQLVWUDWLRQ
Controlled
Substances–Alphabetical
Order
KWWSZZZGHDGLYHUVLRQXVGRMJRY >KWWSVSHUPDFF%66<==@ 1DOR[RQH QRW RQ OLVW RI
FRQWUROOHGVXEVWDQFHV
:25/' +($/7+ 25* :+2 02'(/ /,67 2) (66(17,$/ 0(',&,1(6 $SULO KWWSZZZZKRLQW>KWWSVSHUPDFF4%0-75@
0DUN$0HUOLQHWDOAssessment of the Safety and Ease of Use of the Naloxone Autoinjector for the Reversal of Opioid Overdose23(1$&&(66(0(5*(1&<0('
see also &RUH\ 6 'DYLV HW DO Emergency Medical Services Naloxone Access: A National
Systematic Legal Review $&$' (0(5*(1&< 0(' >KHUHLQDIWHU
Emergengy Medical Services Naloxone Access@
%UXQR6LPLQLBologna-Naloxone Supplied to Italian Heroin Addicts/$1&(7
FDVHUHSRUWGHVFULELQJWKHSURYLVLRQRIQDOR[RQHWRSHRSOHZKRXVHKHURLQLQWKH(PLOLD
5RPDJQD UHJLRQ RI ,WDO\ .HUVWLQ 'HWWPHU HW DO Take Home Naloxone and the Prevention of
Deaths from Opiate Overdose: Two Pilot Schemes%0-GHVFULELQJD
QDOR[RQHGLVSHQVLQJSURMHFWLQ-HUVH\EHJLQQLQJLQDQGLQ%HUOLQVWDUWLQJLQ
3KLOOLS 2 &RIILQ HW DO Preliminary Evidence of Health Care Provider Support for
Naloxone Prescription as Overdose Fatality Prevention Strategy in New York City-2)85%$1
+($/7+ QRWLQJWKDWQDOR[RQHSURJUDPVZHUHRSHUDWLQJLQ&KLFDJRLQDQG6DQ
)UDQFLVFRDQG1HZ0H[LFRE\
(OL]D:KHHOHUHWDOCommunity-Based Opioid Overdose Prevention Programs Providing
Naloxone–United States, 2010025%,',7<$1'0257$/,/7<:./<5(3)HE
,1',$1$+($/7+/$:5(9,(:
9RO
GLVWULEXWLRQVLWHVKDGLQFUHDVHGWRDQGPRUHWKDQSHRSOHKDGUHFHLYHGNLWVZLWKPRUH
WKDQSRWHQWLDOO\IDWDORYHUGRVHUHYHUVDOVUHSRUWHG$ERXWRIWKHQDOR[RQHGLVWULEXWHG
WKURXJKWKHVHSURJUDPVZDVLQDIRUPVXLWDEOHIRUXVHLQWUDQDVDOO\WKURXJKDQLPSURYLVHGQDVDO
DSSOLFDWRU7KHUHKDVDOVREHHQLQFUHDVLQJLQWHUHVWLQFRSUHVFULELQJQDOR[RQHWRSDWLHQWVEHLQJ
WUHDWHG ZLWK RSLRLGV DQG WR LQFUHDVH QDOR[RQH DFFHVV WKURXJK SKDUPDFLHV 5HFHQWO\ UHOHDVHG
JXLGHOLQHV IURP WKH &HQWHUV IRU 'LVHDVH &RQWURO DQG 3UHYHQWLRQ ³&'&´ IRU H[DPSOH
UHFRPPHQGWKDWQDOR[RQHEHFRSUHVFULEHGIRUSDWLHQWVZLWKDKLVWRU\RIRYHUGRVHDKLVWRU\RID
VXEVWDQFHXVHGLVRUGHUKLJKHURSLRLGGRVHVRUFRQFXUUHQWEHQ]RGLD]HSLQHXVH
%HFDXVHWLPHLVRIWKHHVVHQFHLQUHVSRQGLQJWRDQRYHUGRVHSURYLGLQJQDOR[RQHWRSHRSOHZKR
DUH SUHVHQWRU YHU\ FORVH WR WKH VFHQH RI DQ RYHUGRVH PD\KHOSUHGXFHRSLRLG RYHUGRVHUHODWHG
PRUELGLW\DQGPRUWDOLW\,QLWLDOHYLGHQFHRIVXFKHIIRUWVLVSRVLWLYH0DVVDFKXVHWWVKDVEHHQRQH
RIWKHPRVWSURDFWLYHVWDWHVLQSURYLGLQJQDOR[RQHWROD\SHRSOHDQGGLVWULEXWLQJWKHPHGLFDWLRQ
WKURXJKYHQXHVVXFKDVV\ULQJHDFFHVVSURJUDPVDGGLFWLRQWUHDWPHQWVSURJUDPVDQGFRPPXQLW\
PHHWLQJV$QH[WHQVLYHHYDOXDWLRQRIWKLVGLVWULEXWLRQVFKHPHIRXQGWKDWRYHUGRVHUDWHVZHUH
VLJQLILFDQWO\ORZHULQFRPPXQLWLHVWKDWKDGUHDG\DFFHVVWRQDOR[RQHGLVWULEXWLRQVLWHVFRPSDUHG
WRWKRVHWKDWGLGQRW$VHSDUDWHVWXG\RIQDOR[RQHSUHVFULSWLRQLQ6DQ)UDQFLVFRIRXQGWKDWORQJ
WHUPRSLRLGSDWLHQWVZKRZHUHSUHVFULEHGQDOR[RQHKDGIHZHURSLRLGUHODWHGHPHUJHQF\URRP
YLVLWV LQ WKH VL[ PRQWKV IROORZLQJ WKH SUHVFULSWLRQ WKDQ VLPLODU SDWLHQWV ZKR KDG QRW UHFHLYHG
QDOR[RQH
UHSRUWLQJ WKDW QDOR[RQH KDG EHHQ GLVWUXEWHG WR D PLQLPXP RI SHRSOH VLQFH ZLWK
UHYHUVDOVUHSRUWHG
(OL]D :KHHOHU HW DO Opioid Overdose Prevention Programs Providing Naloxone to
Laypersons–United States, 2014 025%,',7< $1' 0257$/,/7< :./< 5(3 -XQH OD\SHRSOHUHFHLYHGQDOR[RQHDQGUHYHUVDOVUHSRUWHG
Id. -DPLH./LPHWDOPrescribe to Prevent: Overdose Prevention and Naloxone Rescue
Kits for Prescribers and Pharmacists - 2) $'',&7,21 0(' 7UDFL &
*UHHQHWDOOrienting Patients to Greater Opioid Safety: Models of Community Pharmacy-Based
Naloxone+$50 5('8&7,21 - see also &RUH\'DYLV'HUHN&DUUState Legal
Innovations to Encourage Naloxone Dispensing - $0 3+$50$&,676 $66¶1 IRUWKFRPLQJ
'HERUDK'RZHOOHWDOCDC Guideline for Prescribing Opioids for Chronic Pain--United
States, 2016-$0$
$OH[DQGHU < :DOOH\ HW DO Opioid Overdose Rates and Implementation of Overdose
Education and Nasal Naloxone Distribution in Massachusetts: Interrupted Time Series Analysis
%0-
Id.DW See also 6DU]0D[ZHOOHWDOPrescribing Naloxone to Actively Injecting
Heroin Users: A Program to Reduce Heroin Overdose Deaths-2)$'',&7,9(',6($6(6
ILQGLQJ WKDW D GHFUHDVH ZDV DOVR REVHUYHG DIWHU WKH LQLWLDWLRQ RI D ODUJHVFDOH
QDOR[RQHGLVSHQVLQJSURJUDPLQ&KLFDJRLQEXWLWVUHGXFWLRQLVREVHUYDWLRQDO
3KLOOLS2&RIILQHWDONonrandomized Intervention Study of Naloxone Coprescription for
Primary Care Patients Receiving Long-Term Opioid Therapy for Pain $11$/6 2) ,17(51$/
0('
7+(/$:$1'32/,&<2)23,2,'6
7KHLQFUHDVHGGLVWULEXWLRQRIQDOR[RQHLVDOVROLNHO\WRVDYHPRQH\LQWHUPVRIUHGXFHGKHDOWK
FDUH FRVWV DV ZHOO DV UHGXFWLRQV LQ RYHUGRVHUHODWHG GLVDELOLW\ DQG ORVW SURGXFWLYLW\ 7KH PRVW
UREXVWDQDO\VLVWRGDWHIRXQGWKHGLVWULEXWLRQRIQDOR[RQHWRKHURLQXVHUVWREHFRVWHIIHFWLYHHYHQ
XVLQJ H[WUHPHO\ FRQVHUYDWLYH DVVXPSWLRQV $ VHSDUDWH VWXG\ QRWHG WKDW WKH FRVW RI WUHDWLQJ
SHRSOHZKRKDGRYHUGRVHGLQ5KRGH,VODQGKRVSLWDOVDORQHFRXOGKDYHSDLGIRUPRUHWKDQ
QDOR[RQHNLWVDWWKHWKHQFXUUHQWFRVWRI7KHUHLVQRHYLGHQFHWKDWWKHSURYLVLRQRIQDOR[RQH
LQFUHDVHVULVNWDNLQJEHKDYLRU
B. Addressing Legal and Policy Barriers to Naloxone Access
:KLOHQDOR[RQHGLVWULEXWLRQSURJUDPVKDYHH[SDQGHGGUDPDWLFDOO\LQWKHSDVWGHFDGHPDQ\
RI WKH HDUO\ SURJUDPV RSHUDWHG ZLWKRXW FOHDU OHJDO DXWKRUL]DWLRQ %HFDXVH QDOR[RQH LV D
SUHVFULSWLRQPHGLFDWLRQLWFDQEHGLVSHQVHGRQO\RQWKHRUGHURIDPHGLFDOSURIHVVLRQDODXWKRUL]HG
WRLVVXHSUHVFULSWLRQV8QIRUWXQDWHO\PDQ\VXFKSURIHVVLRQDOVPD\EHXQDZDUHRIWKHSUDFWLFH
RISUHVFULELQJQDOR[RQHWRWKHLUSDWLHQWVRUPD\EHZDU\RISUHVFULELQJQDOR[RQHWRSDWLHQWVZKR
PD\ EH DW ULVN RI RYHUGRVH GXH WR FRQFHUQV WKDW GRLQJ VR PLJKW LQFUHDVH WKHLU OLDELOLW\ ULVN
)XUWKHU UHGXFLQJ DFFHVV VWDWH PHGLFDO SUDFWLFH ODZV W\SLFDOO\ SURKLELW SK\VLFLDQV DQG RWKHU
DXWKRUL]HGSUHVFULEHUVIURPRUGHULQJPHGLFDWLRQVIRUSHUVRQVRWKHUWKDQWKHSHUVRQWRZKRPWKH\
DUHWREHDGPLQLVWHUHGDSURFHVVUHIHUUHGWRDVWKLUGSDUW\SUHVFULSWLRQRUWRDSHUVRQWKHSK\VLFLDQ
KDVQRWSHUVRQDOO\H[DPLQHGDSURFHVVUHIHUUHGWRDVSUHVFULSWLRQYLDVWDQGLQJRUGHU
3KLOLS2&RIILQ6HDQ'6XOOLYDQCost-Effectiveness of Distributing Naloxone to Heroin
Users for Lay Overdose Reversal $11$/6 2) ,17(51$/ 0(' ILQGLQJ WKDW
³>Q@DOR[RQH GLVWULEXWLRQ WR KHURLQ XVHUV ZRXOG EH H[SHFWHG WR UHGXFH PRUWDOLW\ DQG EH FRVW
HIIHFWLYHHYHQXQGHUPDUNHGO\FRQVHUYDWLYHDVVXPSWLRQVRIXVHHIIHFWLYHQHVVDQGFRVW´
0LFKDHO$<RNHOOHWDOOpioid Overdose Prevention and Naloxone Distribution in Rhode
Island0('+($/7+5,
0D\D'RH6LPNLQVHWDOOverdose Rescues by Trained and Untrained Participants and
Change in Opioid Use Among Substance-Using Participants in Overdose Education and Naloxone
Distribution Programs: A Retrospective Cohort Study %,20('&(175$/ 38% +($/7+ ILQGLQJWKDW³WUDLQLQJDFWLYHVXEVWDQFHXVHUVLQRYHUGRVHPDQDJHPHQWDQGGLVWULEXWLQJ
QDO[RRQHUHVFXHNLWVGRHVQRWOHDGRSLRLGVHUVWRLQFUHDVHWKHLURYHUDOORSLRLGXVH´
See 86& E% SURYLGLQJ WKDW XQGHU IHGHUDO ODZ SUHVFULSWLRQ PHGLFDWLRQV
³VKDOO EH GLVSHQVHG RQO\ XSRQ D ZULWWHQ SUHVFULSWLRQ RI D SUDFWLWLRQHU OLFHQVHG E\ ODZ WR
DGPLQLVWHUVXFKGUXJ´,QSUDFWLFHWKLVUHTXLUHPHQWKDVEHHQLQWHUSUHWHGWRPHDQWKDWVXFK
PHGLFDWLRQVFDQEHGLVSHQVHGRQO\RQWKHSUHVFULSWLRQRIDSUDFWLWLRQHUOLFHQVHGWRprescribeWKH
GUXJ
/HR%HOHWVN\HWDOPhysicians' Knowledge of and Willingness to Prescribe Naloxone to
Reverse Accidental Opiate Overdose: Challenges and Opportunities-85%+($/7+
ILQGLQJ WKDW RQO\ DERXW RI SK\VLFLDQV VXUYH\HG VDLG WKDW WKH\ ³KDG KHDUG RI WKH
SUDFWLFHRISUHVFULELQJQDOR[RQH´WRLQMHFWLRQGUXJXVLQJSDWLHQWVDQGDPDMRULW\VDLGWKDWWKH\
ZRXOGQHYHUFRQVLGHUSUHVFULELQJQDOR[RQHWRDQLQMHFWLRQGUXJXVLQJSDWLHQW
&RUH\6'DYLV'HUHN&DUULegal Changes to Increase Access to Naloxone for Opioid
Overdose Reversal in the United States '58* $/&2+2/ '(3(1'(1&( GHVULELQJ OHJDO DQG SROLF\ EDUULHUV WR QDOR[RQH DFFHVV DV ZHOO DV PRGLILFDWLRQV WR VWDWH ODZ
,1',$1$+($/7+/$:5(9,(:
9RO
%\-XQHDOOEXWWKUHHVWDWHV.DQVDV0RQWDQDDQG:\RPLQJKDGSDVVHGVRPHIRUPRI
OHJLVODWLRQ GHVLJQHG WR LPSURYH OD\SHUVRQ QDOR[RQH DFFHVV 7KHVH ODZV KDYH WKUHH PDLQ
FKDUDFWHULVWLFVSURYLGLQJLPPXQLW\WRQDOR[RQHSUHVFULEHUVGLVSHQVHUVDQGDGPLQLVWUDWRUV
SHUPLWWLQJQDOR[RQHWREHSUHVFULEHGWRSHRSOHZKRDUHQRWSDWLHQWVRIWKHSUHVFULEHUDQGGLVSHQVHG
E\SHRSOHQRWRWKHUZLVHDXWKRUL]HGWRGLVSHQVHSUHVFULSWLRQPHGLFDWLRQVDQGSURYLGLQJOLPLWHG
FULPLQDOLPPXQLW\WRLQGLYLGXDOVZKRVXPPRQHPHUJHQF\UHVSRQGHUVLQWKHHYHQWRIDQRYHUGRVH
:HZLOOEULHIO\JRWKURXJKWKHVHPHDVXUHVLQWXUQ
1. Immunity for Naloxone Prescribing, Dispensing, and Administration
,QJHQHUDOWKHULVNDVVRFLDWHGZLWKSUHVFULELQJRUGLVSHQVLQJQDOR[RQHLVQRKLJKHUWKDQRWKHU
FRPPRQO\XQGHUWDNHQPHGLFDODFWLYLWLHVDQGPD\LQIDFWEHORZHUWKDQPDQ\,QIDFWDUHFHQW
UHYLHZ IRXQG QRW D VLQJOH LQVWDQFH LQ ZKLFK SUHVFULSWLRQ GLVSHQVLQJ RU DGPLQLVWUDWLRQ RI
QDOR[RQHLQWKHRXWSDWLHQWVHWWLQJKDGEHHQWKHJURXQGVIRUDODZVXLW1HYHUWKHOHVVSK\VLFLDQV
WHQGWRRYHUHVWLPDWHWKHLUULVNRIEHLQJVXHGIRUPDOSUDFWLFHDQGUHODWHGWRUWVDQGPD\EHZDU\RI
SDUWLFLSDWLQJLQQDOR[RQHSURJUDPVRUFRSUHVFULELQJQDOR[RQHEHFDXVHRIOLDELOLW\IHDUV
7R DGGUHVV WKHVH FRQFHUQV DQG HQFRXUDJH WKH SUHVFULSWLRQ GLVSHQVLQJ DQG DSSURSULDWH
DGPLQLVWUDWLRQRIQDOR[RQHWKHPDMRULW\RIVWDWHVKDYHHQDFWHGODZVWKDWSURYLGHOLPLWHGLPPXQLW\
WR SUHVFULEHUV GLVSHQVHUV DQG DGPLQLVWUDWRUV 6SHFLILFDOO\ DV RI -XQH WKLUW\VHYHQ VWDWHV
SURYLGHFLYLOLPPXQLW\WRPHGLFDOSURIHVVLRQDOVZKRSUHVFULEHDQGGLVSHQVHQDOR[RQHWKLUW\WKUHH
SURYLGHFULPLQDOLPPXQLW\DQGWKLUW\WZRSURYLGHSURWHFWLRQIURPGLVFLSOLQDU\DFWLRQIRUDFWLRQV
LQWHQGHGWRDGGUHVVWKHP&RUH\6'DYLVHWDOChanging Law from Barrier to Facilitator of
Opioid Overdose Prevention-/$:0('(7+,&6GHVFULELQJVWDWHRIODZ
UHJDUGLQJQDOR[RQHDFFHVV
35(6&5,37,21 '58* $%86( 32/,&< 6<67(0 KWWSSGDSVRUJ >KWWSVSHUPDFF14<
.9*@ODVWYLVLWHG-DQFOLFNRQ³([SDQGHG$FFHVVWR1DOR[RQH´
6FRWW %XUULV HW DO Legal Aspects of Providing Naloxone to Heroin Users in the United
States,17¶/ -2) '58* 32/¶<H[DPLQLQJOHJDOULVNVDQGFRQFOXGLQJWKDW
SUHVFULEHUVFDQSUHVFULEHQDOR[RQH³ZLWKRXWH[SRVLQJWKHPVHOYHVWRDVLJQLILFDQWULVNRILQFUHDVHG
OLDELOLW\IRUYLRODWLRQRIIHGHUDORUVWDWHODZRUIRUPDOSUDFWLFH´6FRWW%XUULVHWDOStopping an
Invisible Epidemic: Legal Issues in the Provision of Naloxone to Prevent Opioid Overdose '5(;(//5(9>KHUHLQDIWHUStopping an Invisible Epidemic@GHVFULELQJWKH
UHDVRQVWKDWLWZRXOGEHGLIILFXOWWRZLQDWRUWVXLWDJDLQVWDSUHVFULEHUZKRSUHVFULEHVQDOR[RQHLQ
WKHLUQRUPDOFRXUVHRISUDFWLFH
7KLVUHYLHZZDVOLPLWHGWRFDVHVLQWKH:HVWODZGDWDEDVHSee also &RUH\6'DYLVHWDO
Engaging Law Enforcement in Overdose Reversal Initiatives: Authorization and Liability for
Naloxone Administration$0-38%+($/7+HH
$QQ*/DZWKHUVHWDOPhysicians' Perceptions of the Risk of Being Sued-2)+($/7+
32/32/
</3K\VLFLDQVGRRYHUHVWLPDWHWKHULVNRIEHLQJVXHG(PLO\5
&DUULHUHWDOPhysicians' Fears of Malpractice Lawsuits are Not Assuaged by Tort Reforms
+($/7+ $)) &RQFHUQ DERXW PDOSUDFWLFH OLDELOLW\ LV SHUYDVLYH DPRQJ
SK\VLFLDQV
7+(/$:$1'32/,&<2)23,2,'6
UHODWHG WR QDOR[RQH SUHVFULELQJ DQG GLVSHQVLQJ $GGLWLRQDOO\ IRUW\WZR VWDWHV SURYLGH FLYLO
LPPXQLW\WROD\DGPLQLVWUDWRUVDQGWKLUW\WKUHHSURYLGHFULPLQDOLPPXQLW\WRWKRVHLQGLYLGXDOV
2. Prescribing Outside of the Traditional Prescriber Relationship
:KLOHWKH)'$KDVWKHH[FOXVLYHDXWKRULW\WRDSSURYHSUHVFULSWLRQPHGLFDWLRQVWKHDXWKRULW\
WRGHWHUPLQHZKLFKLQGLYLGXDOVDUHSHUPLWWHGWRSUHVFULEHWKHIRUPDWSUHVFULSWLRQVPXVWWDNHZKR
FDQGLVSHQVHXQGHUDYDOLGSUHVFULSWLRQDQGQHDUO\DOORWKHUHOHPHQWVRISUHVFULELQJDQGGLVSHQVLQJ
OHJHQG PHGLFDWLRQV LV OHIW WR WKH VWDWHV 6WDWHV KDYH VRPH XQLIRUPLW\ LQ WKHVH UHTXLUHPHQWV
3UHVFULSWLRQVPD\JHQHUDOO\RQO\EHLVVXHGE\DSHUVRQDXWKRUL]HGWRSUHVFULEHPHGLFDWLRQVZKR
LVDFWLQJLQJRRGIDLWKLQWKHXVXDOFRXUVHRISURIHVVLRQDOSUDFWLFHDQGIRUDOHJLWLPDWHPHGLFDO
SXUSRVH7KHSUHVFULSWLRQRIQDOR[RQHWRDSDWLHQWDWULVNRIRYHUGRVHRIFRXUVHIXOILOOVDOOWKUHH
FULWHULD+RZHYHULQPDQ\FDVHVWKHSHUVRQDWULVNPD\QRWSUHVHQWWRWKHPHGLFDOSURIHVVLRQDO
DQGDGPLWWREHLQJDWULVNRIRYHUGRVHUDWKHUDSDUHQWVSRXVHRUFRQFHUQHGIULHQGPD\DSSURDFK
WKHSUHVFULEHUDQGDVNIRUDSUHVFULSWLRQIRUQDOR[RQHIRUWKHSHUVRQDWULVN8QGHUWUDGLWLRQDO
UXOHV RI PHGLFDO SUDFWLFH WKH SUHVFULEHU ZRXOG QRW EH SHUPLWWHG WR LVVXH D SUHVFULSWLRQ WR WKDW
SHUVRQ IRU XVH RQ D SHUVRQ ZLWK ZKRP WKH SUHVFULEHU GRHV QRW KDYH D FOLQLFLDQSDWLHQW
UHODWLRQVKLS
7RDGGUHVVWKLVODFNRIDFFHVVVWDWHVKDYHDGRSWHGWZRVHSDUDWHEXWUHODWHGSURYLVLRQVWKRVH
WKDW SHUPLW QDOR[RQH WR EH SUHVFULEHG WR WKLUG SDUWLHV DQG WKRVH WKDW SHUPLW QDOR[RQH WR EH
SUHVFULEHG YLD VWDQGLQJ RU SURWRFRO RUGHUV 7KLUG SDUW\ SUHVFULELQJ ODZV ZDLYH WKH JHQHUDO
UHTXLUHPHQWWKDWWKHSUHVFULEHUDQGWKHSHUVRQIRUZKRPWKHPHGLFDWLRQLVLQWHQGHGWKHSDWLHQWDW
ULVNRIRYHUGRVHHVWDEOLVKWKHWUDGLWLRQDOSURIHVVLRQDO±SDWLHQWUHODWLRQVKLSSHUPLWWLQJQDOR[RQHWR
EH SUHVFULEHG WR D SDWLHQW IRU XVH RQ RWKHU LQGLYLGXDOV VXFK DV WKH SDWLHQW¶V IULHQGV IDPLO\
PHPEHUVDQGDFTXDLQWDQFHV$VRI-XQHIRUW\WZRVWDWHVSHUPLWWKLUGSDUW\SUHVFULSWLRQ
RIQDOR[RQH
6WDQGLQJPHGLFDWLRQRUGHUVLQZKLFKDSK\VLFLDQRURWKHUSUHVFULEHUDXWKRUL]HVWKHSURYLVLRQ
RIPHGLFDWLRQWRDSHUVRQZKRPHHWVSUHGHWHUPLQHGFULWHULDDUHFRPPRQLQPHGLFDOSUDFWLFH
See &25(< '$9,6 (7 $/ /(*$/ ,17(59(17,216 72 5('8&( 29(5'26( 0257$/,7<
1$/2;21( $&&(66$1' 29(5'26( *22' 6$0$5,7$1 /$:6 see 7DEOH7KH1HWZRUNIRU
3XE+HDOWK/>KHUHLQDIWHU/(*$/,17(59(17,216725('8&(29(5'26(0257$/,7<@
Id. Stopping an Invisible Epidemic supra QRWH DW ³6XUSULVLQJO\ IHZ VWDWHV KDYH
H[SOLFLW UXOHV GHILQLQJ D SK\VLFLDQ¶V DXWKRULW\ WR SUHVFULEH RU VHWWLQJ FULWHULD IRU DOORZDEOH
SUHVFULSWLRQV´7KLVLVQRWWUXHIRUFRQWUROOHGVXEVWDQFHVZKLFKUHTXLUHDPRQJRWKHUWKLQJVD
OLFHQVHIURPWKH'($WRSUHVFULEH$VQRWHGDERYHQDOR[RQHLVQRWDFRQWUROOHGVXEVWDQFHDWWKH
IHGHUDOOHYHORULQDQ\VWDWH
Seeid. DW³,QDOOVWDWHVDSK\VLFLDQPD\SUHVFULEHQDOR[RQHWRSDWLHQWVZKRDUHDWULVN
RIRSLDWHRYHUGRVHLQDQ\VHWWLQJDQGFHUWDLQO\DVSDUWRIDQRYHUGRVHSUHYHQWLRQLQWHUYHQWLRQ´
'DYLV&DUUVXSUDQRWHDW
Id.
Id.
35(6&5,37,21 '58* $%86( 32/,&< 6<67(0 KWWSSGDSVRUJ
>KWWSVSHUPDFF14<.9*@ODVWYLVLWHG-DQ
Id.
,1',$1$+($/7+/$:5(9,(:
9RO
3HUKDSVWKHPRVWZLGHVSUHDGXVHRIWKHVHRUGHUVLVLQWKHHPHUJHQF\PHGLFDOV\VWHP³(06´
ZKHUHE\DQDJHQF\PHGLFDOGLUHFWRURUVLPLODUO\VLWXDWHGLQGLYLGXDOFUHDWHVPHGLFDWLRQSURWRFROV
WREHIROORZHGE\(06SHUVRQQHO6WDQGLQJRUGHUVKDYHDOVREHFRPHZLGHVSUHDGLQWKHDUHDRI
YDFFLQDWLRQ ZKHUH WKH\ DUH XVHG WR SHUPLW SKDUPDFLVWV RU RWKHU SURYLGHUV WR DGPLQLVWHU
YDFFLQDWLRQVIRUVRPHFRPPRQGLVHDVHVZLWKRXWWKHUHFLSLHQWUHFHLYLQJDQLQGLYLGXDOSUHVFULSWLRQ
IRU WKH YDFFLQH 7KH PDMRULW\ RI VWDWHV KDYH QRZ H[WHQGHG WKLV FRQFHSW WR WKH GLVSHQVLQJ RI
QDOR[RQHSHUPLWWLQJWKHPHGLFDWLRQWREHGLVSHQVHGWRDQ\SHUVRQZKRPHHWVFULWHULDVSHFLILHGE\
WKHSUHVFULEHU:KLOHWKHVHVWDQGLQJPHGLFDWLRQRUGHUVFDQEHILOOHGDWSKDUPDFLHVOLNHDQ\RWKHU
SUHVFULSWLRQ DV RI -XQH IRXUWHHQ VWDWHV DOVR H[SOLFLWO\ SHUPLW OD\SHUVRQV WR GLVSHQVH WKH
PHGLFDWLRQSXUVXDQWWRWKHRUGHUDVZHOO
3. Overdose Good Samaritan Laws
$PRQJ &KULVWLDQV SHUKDSV RQH RI WKH PRVW HQGXULQJ %LEOLFDO VWRULHV LV WKDW RI WKH *RRG
6DPDULWDQ7KHSDUDEOHLVSURPSWHGE\DTXHVWLRQIURP³DFHUWDLQODZ\HU´ZKRKDVLQTXLUHGRI
-HVXVKRZRQHPLJKWREWDLQHWHUQDOOLIH-HVXVUHVSRQGHGZLWKWKHVWRU\RIWKH³*RRG6DPDULWDQ´
$WUDYHOHUSUHVXPDEO\D-HZLVUREEHGEHDWHQDQGOHIW³KDOIGHDG´RQWKHVLGHRIWKHURDG
)LUVWDSULHVWDQGWKHQD/HYLWHGHVSLWHVHHLQJWKHPDQ¶VGLVWUHVVSDVVE\RQWKHRWKHUVLGHRIWKH
URDGIDLOLQJWRSURYLGHDLG+RZHYHUDWKLUGPDQD6DPDULWDQWHQGHGWRWKHPDQ¶VZRXQGV
FDUULHGKLPWRDQLQQDQGSDLGWKHLQQNHHSHUWRFDUHIRUWKHPDQ7KHDQVZHUWRWKHODZ\HU¶V
TXHVWLRQLVWKHQUHYHDOHG³*RDQGGRWKRXOLNHZLVH´
3UHVXPDEO\LQWKHVSLULWRIWKDWDGPRQLWLRQWKHPDMRULW\RIVWDWHVKDYHSDVVHGODZVWKDW
KDYHFRPHWREHNQRZQDV³RYHUGRVH*RRG6DPDULWDQ´ODZV7KHVHODZVDUHLQWHQGHGWRDWOHDVW
See Emergengy Medical Services Naloxone Accesssupra QRWHDW &K\RQJFKLRX -HQJ /LQ HW DO Cost-Effectiveness of Pneumococcal and Influenza
Vaccination Standing Order Programs$0 - 0$1$*,1* &$5( HHsee also
%DUEDUD + %DUGHQKHLHU HW DO Are Standing Order Programs Associated With Influenza
Vaccination?–NNHS, 2004- $0 0(' ',5(&7256 $66¶1ILQGLQJWKDW
VWDQGLQJRUGHUSURJUDPVDUHDVVRFLDWLRQZLWKLQIOXHQ]DYDFFLQDWLRQ
35(6&5,37,21 '58* $%86( 32/,&< 6<67(0 KWWSSGDSVRUJ >KWWSVSHUPDFF14<
.9*@ODVWYLVLWHG-DQ
Id.
2U DW OHDVW WKH WHUP ³*RRG 6DPDULWDQ´ KDV HQWHUHG WKH JHQHUDO SDUODQFH VLQFH PDQ\
LQGLYLGXDOV ZKR XVH WKH WHUP VHHP XQDZDUH RI LWV RULJLQ WKH DXWKRUV WKRXJKW LW LPSRUWDQW WR
VXPPDUL]HWKHSDUDEOHKHUH
Luke7KH*RVSHO$FFRUGLQJWR/XNHLQZKLFKWKHSDUDEOHDSSHDUVZDVDFFRUGLQJ
WRFKXUFKWUDGLWLRQSHQQHGE\/XNHWKH(YDQJHOLVWZKRLVLGHQWLILHGHOVHZKHUHLQWKH%LEOHDVD
SK\VLFLDQColossians³/XNHWKHEHORYHGSK\VLFLDQDQG'HPDVJUHHW\RX´
Luke
Id. DW
Id. DW
Id DW.
7KHVHODZVDUHGLVWLQFWIURPFLYLO*RRG6DPDULWDQODZVZKLFKSURYLGHFLYLOLPPXQLW\WR
UHVSRQGHUVZKRJUDWXLWRXVO\RIIHUPHGLFDOFDUHLQHPHUJHQFLHV)RUDJRRGRYHUYLHZRIWKRVHODZV
see 9LFWRULD6XWWRQIs There a Doctor (and a Lawyer) in the House? Why our Good Samaritan
7+(/$:$1'32/,&<2)23,2,'6
SDUWLDOO\DGGUHVVWKHXQFRPIRUWDEOHIDFWWKDWGHVSLWHUHFHQWVWDWHPHQWVWRWKHHIIHFWWKDWZH³FDQ¶W
DUUHVWRXUZD\RXWRI´WKHSUREOHPRIRSLRLGLQGXFHGRYHUGRVHDUUHVWLVLQIDFWWKHSULPDU\IHGHUDO
DQGVWDWHUHVSRQVHWRGUXJSRVVHVVLRQVDOHDQGUHODWHGDFWLYLWLHV
7RHQFRXUDJHSHRSOHZKRZLWQHVVDQRYHUGRVH PDQ\RIZKRP PD\EHHQJDJLQJLQLOOHJDO
DFWLYLWLHVWRVXPPRQILUVWUHVSRQGHUVWKHPDMRULW\RIVWDWHVKDYHQRZPRGLILHGVWDWHFULPLQDOODZ
WRSURYLGHOLPLWHGLQVRPHFDVHVYHU\OLPLWHGLPPXQLW\WRLQGLYLGXDOVZKRVXPPRQHPHUJHQF\
DLGLQWKHHYHQWRIDQRYHUGRVH7KHILUVWVXFKODZZDVSDVVHGE\1HZ0H[LFRLQ$VRI
-XQH WKLUW\ILYH RWKHU VWDWHV DQG WKH 'LVWULFW RI &ROXPELD KDYH IROORZHG VXLW $V ZLWK
QDOR[RQH DFFHVV ODZV WKHVH PHDVXUHV YDU\ VLJQLILFDQWO\ EHWZHHQ VWDWHV 0RVW VWDWHV SURYLGH D
SHUVRQZKRVXPPRQVHPHUJHQF\UHVSRQGHUVLQJRRGIDLWKSURWHFWLRQIURPSURVHFXWLRQIRUPLQRU
GUXJ SRVVHVVLRQ DQG HLJKWHHQ DOVR SURWHFW WKH FDOOHU IURP EHLQJ DUUHVWHG IRU WKRVH FULPHV
7ZHQW\WKUHH VWDWHV SURYLGH SURWHFWLRQ IURP SURVHFXWLRQ IRU SDUDSKHUQDOLD SRVVHVVLRQ ZLWK
WKLUWHHQSURYLGLQJSURWHFWLRQIURPDUUHVWIRUWKDWFULPH
7KHJHQHUDOWUHQGKDVEHHQWRZDUGSURYLGLQJPRUHUREXVWSURWHFWLRQ)RUH[DPSOHDVRI-XQH
VHYHQWHHQVWDWHODZVSURYLGHWKDWLQIRUPDWLRQREWDLQHGEHFDXVHDSHUVRQFDOOHGIRUDVVLVWDQFH
LQDQRYHUGRVHFDQQRWEHXVHGWRYLRODWHWKDWSHUVRQ¶VSUREDWLRQRUSDUROH8QLTXHO\9HUPRQW¶V
RYHUGRVH*RRG6DPDULWDQODZSURYLGHVSURWHFWLRQIURPFLWDWLRQDUUHVWDQGSURVHFXWLRQIURPDOO
FRQWUROOHGVXEVWDQFHYLRODWLRQV
4. Over the Counter Access to Naloxone
Laws are Doing More Harm Than Good for a National Public Health Security Strategy: A FiftyState Survey-2)+($/7+%,20(',&$//
See, e.g. 0DUN7HQLD‘We can’t arrest our way out of it’: Chesterfield Police Explore New
Ways to Combat Heroin Epidemic :5,&&20 0DU 30 VWDWHPHQW RI 0DMRU
&KULV +HQVOH\ &KHVWHUILHOG &RXQW\ 9$ 3ROLFH ³>:@H FDQ¶W DUUHVW RXU ZD\ RXW ´ RI WKH
RYHUGRVH SUREOHP KWWSZULFFRP >KWWSVSHUPDFF5**5&4+@ see also )UHG 8SWRQ
Upton: We Can’t Arrest Our Way Out of Opioid Epidemic7+('(752,71(:6'HF
30VWDWHPHQWRI865HS)UHG8SWRQ50,³:HFDQQRWDUUHVWRXUZD\RXWRIWKLV
HSLGHPLF´KWWSZZZGHWURLWQHZVFRP>KWWSVSHUPDFF.';/:@
7+( 32/,&< 6859(,//$1&( 352*5$0 $ /$:$7/$6 352-(&7 KWWSODZDWODVRUJ
>KWWSVSHUPDFF38+-8@ODVWYLVLWHG-DQ
Id.
Id.
Id.
Id.
Id.
9767$7$11WLW†F³$SHUVRQZKRLVH[SHULHQFLQJDGUXJRYHUGRVH
DQGLQJRRGIDLWKVHHNVPHGLFDODWWHQWLRQIRUKLPVHOIRUKHUVHOIRULVWKHVXEMHFWRIDJRRGIDLWK
UHTXHVW IRU PHGLFDO DVVLVWDQFH VKDOO QRW EH FLWHG DUUHVWHG RU SURVHFXWHG IRU D YLRODWLRQ RI WKLV
FKDSWHU´³7KLVFKDSWHU´LV&KDSWHURI7LWOHDQGFRQWDLQVPRVWRIWKHVWDWH¶VODZVUHODWHG
WROLFLWDQGLOOLFLWGUXJV
,1',$1$+($/7+/$:5(9,(:
9RO
6WDWHODZFKDQJHVWRSHUPLWWKLUGSDUW\SUHVFULELQJVWDQGLQJRUGHUVDQGOD\GLVSHQVLQJDWWHPSW
WRDGGUHVVWKH PDLQEDUULHUWRQDOR[RQHDFFHVVLWVVWDWXVDVDSUHVFULSWLRQ PHGLFDWLRQ,IWKH
PHGLFDWLRQ ZDV LQVWHDG DYDLODEOH RYHUWKHFRXQWHU ³27&´ PRVW RI WKHVH FKDQJHV ZRXOG EH
XQQHFHVVDU\5HJXODWRU\DXWKRULWLHVLQVHYHUDORWKHUFRXQWULHVKDYHUHFHQWO\WDNHQWKLVRUUHODWHG
VWHSV ,Q )HEUXDU\ $XVWUDOLD UHVFKHGXOHG QDOR[RQH PDNLQJ LW DYDLODEOH ZLWKRXW D
SUHVFULSWLRQ DOWKRXJK LW FDQ VWLOO EH SXUFKDVHG RQO\ IURP D SKDUPDFLVW &DQDGD UHPRYHG
QDOR[RQH IURP WKH QDWLRQDO 3UHVFULSWLRQ 'UXJ /LVW LQ 0DUFK SHUPLWWLQJ SURYLQFHV DQG
WHUULWRULHVWRPDNHLWDYDLODEOH27&7KH8QLWHG.LQJGRPKDVDOVRPRYHGWRLQFUHDVHDFFHVVWR
QDOR[RQH :KLOH LW UHPDLQV D SUHVFULSWLRQ PHGLFDWLRQ WKH SUHVFULSWLRQ UHTXLUHPHQW KDV EHHQ
ZDLYHGLQFHUWDLQFLUFXPVWDQFHVVXFKWKDWLWFDQEHVXSSOLHGE\GUXJWUHDWPHQWVHUYLFHSURYLGHUV
WRDQ\SHUVRQZKRPLJKWEHLQDSRVLWLRQWRXVHLWLQDQHPHUJHQF\8QIRUWXQDWHO\WKH8QLWHG
6WDWHVKDVQRWMRLQHGWKHVHFRXQWULHVGXHLQSDUWWRDPXFKPRUHRQHURXVSURFHVVIRUPRYLQJD
SUHVFULSWLRQGUXJWR27&VWDWXVDQGWKHODFNRIDQLQWHUPHGLDWHFODVVLILFDWLRQ
7KH)HGHUDO)RRG'UXJDQG&RVPHWLF$FWRI>³)'&$´@ODLGRXWWKHIRXQGDWLRQIRUWKH
FRQWURO RI WKHUDSHXWLF GUXJV LQ WKH 8QLWHG 6WDWHV $OWKRXJK WKDW $FW FRGLILHG D GLVWLQFWLRQ
EHWZHHQSUHVFULSWLRQDQGQRQSUHVFULSWLRQGUXJVE\H[HPSWLQJGUXJVGLVSHQVHGE\DSUHVFULSWLRQ
IURPVRPHODEHOLQJUHTXLUHPHQWVLWGLGQRWRWKHUZLVHFOHDUO\GHOLQHDWHGLIIHUHQFHVEHWZHHQWKH
WZRFODVVHV$OWKRXJKWKH)'$ODWHULVVXHGUHJXODWLRQVILUPLQJWKHOLQHVEHWZHHQSUHVFULSWLRQ
,QIDFWWKHVHLQLWLDWLYHVDUHRIWHQUHIHUUHGWRDVSHUPLWWLQJQDOR[RQHWREHGLVSHQVHG³ZLWKRXW
D SUHVFULSWLRQ´ 7KDW VWDWHPHQW LV QRW FRUUHFW See &RUH\ 'DYLV "Over the Counter" Naloxone
Access, Explained 1(7:25. )25 38% +($/7+ / 0DU $0
KWWSVZZZQHWZRUNIRUSKORUJ>KWWSVSHUPDFF%:')@
See 6LPRQ 5 /HQWRQ HW DO Australia Reschedules Naloxone for Opioid Overdose 0(' -2) $867/8QOLNHPDQ\RWKHUFRXQWULHVWKH8QLWHG6WDWHVGRHVQRW
KDYHDIRUPDOFODVVRI³EHKLQGWKHFRXQWHU´%7&PHGLFDWLRQVWKDWFDQEHREWDLQHGRQO\IURP
DSKDUPDFLVWEXWWKDWDOVRGRQRWUHTXLUHDSUHVFULSWLRQSee 86*29¶7$&&2817$%,/,7<2))
12135(6&5,37,21 '58*6 &216,'(5$7,216 5(*$5',1*$ %(+,1'7+(&2817(5 '58* &/$66
8QLWHG 6WDWHV *RYHUQPHQW $FFRXQWDELOLW\ 2IILFH KWWSZZZJDRJRY
>KWWSVSHUPDFF3;*&(.@ +RZHYHU D KDQGIXO RI PHGLFDWLRQV DUH HIIHFWLYHO\ %7& )RU
H[DPSOHWKH&RPEDW0HWKDPSKHWDPLQH$FWRIZKLFKZDVHQDFWHGDV7LWOH9,,RIWKH86$
3$75,27 ,PSURYHPHQW DQG 5HDXWKRUL]DWLRQ $FW RI EDQQHG WKH 27& VDOH RI
SVHXGRHSKHGULQH SKHQ\OSURSDQRODPLQH DQG HSKHGULQH EXW GLG QRW FKDQJH WKHLU SUHVFULSWLRQ
VWDWXV0HGLFDWLRQVFRQWDLQLQJWKHVHGUXJVWKHUHIRUHDUHHIIHFWLYHO\%7&
The Availability of Take-Home Naloxone in Canada&&(1'8%8//(7,1 &DQ&WURQ
6XEVWDQFH$EXVH2WWDZD2QW0DUDW
See 3XE +HDOWK (QJ Guidance: Widening the Availability of Naloxone *298. KWWSVZZZJRYXN >KWWSVSHUPDFF4%1:*(@ ODVW XSGDWHG -XQH 3XE +HDOWK
(QJTake-Home Naloxone for Opioid Overdose in People Who Use Drugs*298. )HE
KWWSZZZQWDQKVXN>KWWSVSHUPDFF9=&.-'%@
)HGHUDO)RRG'UXJDQG&RVPHWLF$FW86&†7KH$FWUHJXODWHVDZLGH
YDULHW\RIUHODWHGLVVXHVIURPIRRGDGGLWLYHVWRPHGLFDOGHYLFHVWRERWWOHGZDWHU
7KLVH[HPSWLRQLVQRZFRGLILHGDW86&†EH[HPSWLQJGUXJVGLVSHQVHG
YLDSUHVFULSWLRQIURPFHUWDLQUHTXLUHPHQWV
7+(/$:$1'32/,&<2)23,2,'6
DQG QRQSUHVFULSWLRQ GUXJV LW ZDV QRW XQWLO WKDW OHJLVODWLRQ FRPPRQO\ UHIHUUHG WR DV WKH
'XUKDP+XPSKUH\$PHQGPHQWVHWRXWWKHUHTXLUHPHQWVWKDWPXVWEHPHWIRUPHGLFDWLRQVWREH
DSSURYHGIRUGLVSHQVLQJZLWKRXWDSUHVFULSWLRQRUGHU7KHRWKHUPDMRUSLHFHRIOHJLVODWLRQLQWKLV
DUHDWKH.HIDXYHU+DUULV$PHQGPHQWDGGHGWRWKHH[LVWLQJERG\RIODZE\UHTXLULQJWKDW
GUXJVEHERWKVDIHDQGHIIHFWLYHDQGVHWRXWWKHEDVLVIRUWKH1HZ'UXJ$SSOLFDWLRQ³1'$´
V\VWHPVWLOOLQXVHWRGD\
3ULRU WR WKH 'XUKDP+XPSKUH\ $PHQGPHQW GUXJ PDNHUV UDWKHU WKDQ D UHJXODWRU\ ERG\
JHQHUDOO\ GHWHUPLQHG ZKHWKHU PHGLFDWLRQV ZRXOG EH PDUNHWHG DV SUHVFULSWLRQRQO\ RU 27&
6XEVHTXHQW WR WKH $PHQGPHQW DOO QHZ PHGLFDWLRQV GHVLJQHG WR EH XVHG E\ KXPDQV DQG DOO
UHTXHVWVWRFKDQJHWKHSUHVFULSWLRQVWDWXVRIDQH[LVWLQJPHGLFDWLRQDUHUHTXLUHGWREHVXEPLWWHGWR
WKH)'$IRUDSSURYDO,IWKH)'$GHWHUPLQHVWKDWWKHPHGLFDWLRQLVQRWVDIHWRXVHH[FHSW
³XQGHUWKHVXSHUYLVLRQRIDSUDFWLWLRQHUOLFHQVHGE\ODZWRDGPLQLVWHU´WKHGUXJRULVOLPLWHG
EHFDXVHRILWVDSSURYHGDSSOLFDWLRQVWREHXVHGRQO\XQGHUWKHSURIHVVLRQDOVXSHUYLVLRQRIVXFKD
SUDFWLWLRQHU LW PXVW EH PDGH DYDLODEOH RQO\ XQGHU D SUHVFULSWLRQ 'UXJV WKDW ZHUH RULJLQDOO\
DSSURYHGIRUSUHVFULSWLRQXVHFDQEHPRYHG27&LIWKH)'$&RPPLVVLRQHUGHWHUPLQHVWKDWWKH
SUHVFULSWLRQUHTXLUHPHQWLV
QRWQHFHVVDU\IRUWKHSURWHFWLRQRIWKHSXEOLFKHDOWKE\UHDVRQRIWKH
GUXJ
VWR[LFLW\RURWKHUSRWHQWLDOLW\IRUKDUPIXOHIIHFWRUWKHPHWKRG
RILWVXVHRUWKHFROODWHUDOPHDVXUHVQHFHVVDU\WRLWVXVHDQGKHILQGV
WKDW WKH GUXJ LV VDIH DQG HIIHFWLYH IRU XVH LQ VHOIPHGLFDWLRQ DV
GLUHFWHGLQSURSRVHGODEHOLQJ
LIWKHGUXJEHDUVDODEHOFRQWDLQLQJWKHQDPHDQGDGGUHVVRIWKHGLVSHQVHU
WKHVHULDOQXPEHUDQGGDWHRIWKHSUHVFULSWLRQRURILWVILOOLQJWKHQDPHRI
WKHSUHVFULEHUDQGLIVWDWHGLQWKHSUHVFULSWLRQWKHQDPHRIWKHSDWLHQWDQG
WKHGLUHFWLRQVIRUXVHDQGFDXWLRQDU\VWDWHPHQWVLIDQ\FRQWDLQHGLQVXFK
SUHVFULSWLRQ
+XPSKUH\'XUKDP$PHQGPHQWVRI3XE/1R6WDWFRGLILHGDV
DPHQGHGDW)HGHUDO)RRG'UXJDQG&RVPHWLFV$FW$PHQGPHQWVKWWSVZZZJSRJRY
>KWWSVSHUPDFF'$'*=@ +XEHUW +XPSKUH\ -U 6HQDWRU IURP 6RXWK 'DNRWD DQG &DUO
'XUKDP5HSUHVHQWDWLYHIURP1RUWK&DUROLQDZHUHERWKFXUUHQWRUIRUPHUSKDUPDFLVWV2ULJLQDOO\
FRGLILHGDW86&†WKH$FWDVDPHQGHGLVQRZIRXQGDW86&†E7KHKLVWRU\
RI WKH 27&SUHVFULSWLRQ FODVVLILFDWLRQ LV RI FRXUVH PXFK ULFKHU WKDQ WKH YHU\ EULHI VXPPDU\
SURYLGHGKHUH)RUDQH[FHOOHQWUHYLHZRIWKH'XUKDP+XPSKUH\$PHQGPHQWDQGUHODWHGLVVXHV
see *UHJRU\ : 5HLOO\ THE FDA AND PLAN B: The Legislative History of the DurhamHumphrey Amendments and the Consideration of Social Harms in the Rx-OTC Switch+$59/
6&+0D\KWWSVGDVKKDUYDUGHGX>KWWSVSHUPDFF=/868$@
'UXJ$PHQGPHQWVRI3XE/1R6WDWFRGLILHGDVDPHQGHGDW
86&†HWVHT
5,&+$5'5$%22'3+$50$&<35$&7,&($1'7+(/$:WKHG
86&†
86&†E$%
&)5†E
,1',$1$+($/7+/$:5(9,(:
9RO
7KHUHDUHWKUHHUHJXODWRU\SDWKZD\VDYDLODEOHIRUVZLWFKLQJDSUHVFULSWLRQPHGLFDWLRQWR27&
D PDQXIDFWXUHU PD\ ILOH D 1'$ D PDQXIDFWXUHU RU RWKHU SDUW\ FDQ SHWLWLRQ WKH )'$ IRU
UHVFKHGXOLQJRUWKH)'$FDQUHFODVVLI\DQDFWLYHLQJUHGLHQWWKURXJKSXEOLVKLQJZKDWLVUHIHUUHG
WRDV27&PRQRJUDSK7KH1'$DQGSHWLWLRQSURFHVVHVDUHXVHGWRUHFODVVLI\DVSHFLILFSURGXFW
ZKLOH WKH PRQRJUDSK FRYHUV WKH DFWLYH LQJUHGLHQW LWVHOI 0RQRJUDSKV KDYH EHHQ HQWHUHG LQ
WZHQW\VL[EURDGWKHUDSHXWLFFDWHJRULHVVXFKDVDQWDFLGVVOHHSDLGVDQGDQWLSHUVSLUDQWV:KLOH
DPRQRJUDSKVZLWFKZRXOGPDNHDOOQDOR[RQHIRUPXODWLRQV27&DQ1'$FDQEHXVHGWRPRYH
RQO\VRPHQDOR[RQHIRUPXODWLRQV27&ZKLOHNHHSLQJRWKHUVSUHVFULSWLRQRQO\6XFKDVLWXDWLRQ
PD\EHDSSURSULDWHZLWKQDOR[RQHZKHUHWKHIRUPXODWLRQVGHVLJQHGIRUOD\SHUVRQDGPLQLVWUDWLRQ
PD\EHDSSURSULDWHIRU27&PDUNHWLQJZKLOHROGHULQMHFWDEOHIRUPXODWLRQVPD\QRWEH
,QJHQHUDODPHGLFDWLRQPXVWPHHWIRXUPDLQFULWHULDWREHDSSURYHGIRU27&GLVSHQVLQJ
WKH GUXJ PXVW WUHDW D FRQGLWLRQ WKDW WKH SDWLHQW FDQ LGHQWLI\ ZLWKRXW WKH EHQHILW RI D PHGLFDO
SURIHVVLRQDOWKHSDWLHQWPXVWEHDEOHWRXQGHUVWDQGKRZWRXVHWKHPHGLFDWLRQE\UHDGLQJWKH
7KHSDUWLFXODU1'$XVHGLVUHIHUUHGWRLQGLIIHUHQWVRXUFHVDVD6XSSOHPHQWDO1HZ'UXJ
$SSOLFDWLRQRUDQ$EEUHYLDWHG1HZ'UXJ$SSOLFDWLRQ$%22' supraQRWH DW see also
Regulatory Mechanisms for Marketing OTC Drug Products )'$ KWWSZZZIGDJRY
>KWWSVSHUPDFF;/%8(5@ODVWXSGDWHG)HEsee also Small Business Assistance:
Frequently Asked Questions on the Regulatory Process of Over-the-Counter (OTC) Drugs)'$
KWWSZZZIGDJRY >KWWSVSHUPDFF'=+49@ ODVW XSGDWHG -DQ 7KH VSHFLILF
SURFHVVIRUWKH³3UHVFULSWLRQWR27&VZLWFK´LVORQJFRPSOLFDWHGDQGEH\RQGWKHVFRSHRIWKLV
DUWLFOH
/HDK &KULVWO Introduction to Nonprescription Products )'$ KWWSZZZIGDJRY
>KWWSVSHUPDFF48(9'&@ ODVW YLVLWHG 2FW . 0RQRJUDSKV HVWDEOLVK FRQGLWLRQV
XQGHUZKLFKDQ27&LQJUHGLHQWLV*HQHUDOO\5HFRJQL]HGDV6DIHDQG(IIHFWLYH³*5$6(´Id.DW
.DUHQ 0XUU\ 0DKRQH\ Overview of the Over-The-Counter Drug Monograph Process
)'$-XQHKWWSZZZIGDJRY>KWWSSHUPDFF9+76;-0@
See 'UXJ $SSURYDOV &LUFXPVWDQFHV 8QGHU :KLFK DQ $FWLYH ,QJUHGLHQW 0D\ %H
6LPXOWDQHRXVO\ 0DUNHWHG LQ %RWK D 3UHVFULSWLRQ 'UXJ 3URGXFW DQG DQ 2YHUWKH&RXQWHU 'UXJ
3URGXFW)HG5HJ6HSW³)'$KDVLQWHUSUHWHGWKHODQJXDJHLQ
ERIWKHDFWWRDOORZPDUNHWLQJRIWKHVDPHDFWLYHLQJUHGLHQWLQSURGXFWVWKDWDUH ERWK
SUHVFULSWLRQDQG27&DVVXPLQJVRPHPHDQLQJIXOGLIIHUHQFHH[LVWVEHWZHHQWKHWZRWKDWPDNHV
WKHSUHVFULSWLRQSURGXFWVDIHRQO\XQGHUWKHVXSHUYLVLRQRIDOLFHQVHGSUDFWLWLRQHU´([DPSOHVRI
WKLVPRYHLQFOXGHLEXSURIHQWKDWEHFRPHV5[DERYHPJ&ORUWLPD]RO5[IRUFDQGLGLDVLVDQG
27&IRUDWKOHWH¶VIRRWULQJZRUPDQGMRFNLWFKRU0HFOL]LQH5[IRUYHUWLJRDQG27&IRUQDXVHD
ZLWKPRWLRQVLFNQHVVId. See .DWKU\Q )R[KDOO OTC naloxone? It's Possible '58*723,&6&20 0D\ KWWSGUXJWRSLFVPRGHUQPHGLFLQHFRP>KWWSVSHUPDFF)988=5@³&ODVVLI\LQJ>QDOR[RQH@
27&ZRXOGSUREDEO\EHDFFRPSOLVKHGWKURXJKWKHQHZGUXJDSSOLFDWLRQ1'$SURFHVV>$QGUHD
/HRQDUG6HJDO 0' GLUHFWRU )'$ 'LYLVLRQ RI 1RQSUHVFULSWLRQ &OLQLFDO (YDOXDWLRQ 2IILFH RI
1RQSUHVFULSWLRQ3URGXFWV@VDLG´,QJHQHUDOLQMHFWDEOHPHGLFDWLRQVDUHQRWDSSURSULDWHIRU27&
ODEHOLQJDOWKRXJKVRPHW\SHVRILQVXOLQDUHDYDLODEOHRYHUWKHFRXQWHUSee 6DUDK-DQH7ULEEOH
You Can Buy Insulin Without a Prescription, But Should You?.$,6(5+($/7+1(:6.+1 'HF
KWWSNKQRUJ>KWWSSHUPDFF+*09(@
7+(/$:$1'32/,&<2)23,2,'6
SDFNDJHODEHOWKHGUXJPXVWEHHIIHFWLYHZKHQXVHGDVUHFRPPHQGHGDQGWKHGUXJPXVWEH
VDIHZKHQXVHGDVLQGLFDWHGDQGKDYHDORZSRWHQWLDOIRUPLVXVHDQGDEXVH
,QSUDFWLFHDVZLWFKIRUHLWKHURIWKHQDOR[RQHIRUPXODWLRQVFXUUHQWO\DSSURYHGIRUOD\SHUVRQ
XVHZRXOGKLQJHODUJHO\RQDVKRZLQJWKDWWKHSDWLHQWFDQVHOIGLDJQRVHVHOIWUHDWDQGVHOIPDQDJH
XVLQJ WKH PHGLFDWLRQ 5HFODVVLILFDWLRQ RI WKRVH GHYLFHV ZRXOG OLNHO\ UHVW KHDYLO\ RQ GDWD
VKRZLQJWKDWWKHFRQVXPHUFDQVDIHO\DQGHIIHFWLYHO\XVHWKHGHYLFHZLWKRXWLQWHUDFWLRQZLWKD
PHGLFDOSURIHVVLRQDODVZHOODVUHDGDQGXQGHUVWDQGWKHODEHO$FFRUGLQJWRWKH)'$RWKHU
TXHVWLRQVWKDWZRXOGQHHGWREHDGGUHVVHGLQFOXGH³ZKDWWKHLPSDFWZRXOGEHLIWKHLQMHFWDEOHZHUH
QR ORQJHU DSUHVFULSWLRQ GUXJ KRZ WR GHDO ZLWK PDQDJHPHQW RI ZLWKGUDZDO UHDFWLRQV ZKHWKHU
QDOR[RQH
VDYDLODELOLW\ZRXOGHQFRXUDJHGUXJDEXVHRUGLVFRXUDJHSHRSOHIURPFDOOLQJDIWHU
DQLQFLGHQWDQGZKDWHGXFDWLRQDQGDGYHUWLVLQJPLJKWORRNOLNH´,QDEORJSRVWWKH)'$¶V
&RPPLVVLRQHURI)RRGDQG'UXJVVDLGWKDWWKHDJHQF\³LVUHYLHZLQJRSWLRQVLQFOXGLQJRYHUWKH
FRXQWHU DYDLODELOLW\ WR PDNH QDOR[RQH PRUH DFFHVVLEOH 7KDW ZRUN EXLOGV RQ )'$¶V UHFHQW
DSSURYDORILQWUDQDVDOQDOR[RQH´+RZHYHULWLVQRWFOHDUZKDWIRUPDOVWHSVLIDQ\KDYHEHHQ
WDNHQWRPRYHVRPHRUDOOQDOR[RQHIRUPXODWLRQV27&
9 &21&/86,21
,QWKH2IILFHRI1DWLRQDO'UXJ&RQWURO3ROLF\VHWWKHJRDORIGHFUHDVLQJXQLQWHQWLRQDO
RSLRLGRYHUGRVHGHDWKVE\ZLWKLQILYH\HDUV,WZDVQRWWREH)DWDORYHUGRVHVRIKHURLQDQG
See generally (ULF3%UDVVChanging the Status of Drugs from Prescription to Over-theCounter Availability1(:(1*-2)0('see &KULVWOsupra QRWH
DW see also Regulation of Nonprescription Products, )'$ KWWSZZZIGDJRY
>KWWSVSHUPDFF-;<30@ ODVW XSGDWHG )HE 27& GUXJV JHQHUDOO\ KDYH WKHVH
FKDUDFWHULVWLFV WKHLU EHQHILWV RXWZHLJK WKHLU ULVNV WKH SRWHQWLDO IRU PLVXVH DQG DEXVH LV ORZ
FRQVXPHU FDQ XVH WKHP IRU VHOIGLDJQRVHG FRQGLWLRQV WKH\ FDQ EH DGHTXDWHO\ ODEHOHG KHDOWK
SUDFWLWLRQHUVDUHQRWQHHGHGIRUWKHVDIHDQGHIIHFWLYHXVHRIWKHSURGXFW
See )R[KDOO supra QRWH VWDWHPHQW RI $QGUHD /HRQDUG6HJDO 0' GLUHFWRU )'$
'LYLVLRQ RI 1RQSUHVFULSWLRQ &OLQLFDO (YDOXDWLRQ 2IILFH RI 1RQSUHVFULSWLRQ 3URGXFWV )RU
QDOR[RQH GDWD ZLOO EH QHHGHG WR DVVHVV ZKHWKHU WKH LQGLYLGXDO DGPLQLVWHULQJ WKH GUXJ FRXOG
SURSHUO\GLDJQRVHWKHRSLRLGRYHUGRVHDQGGHWHUPLQHWKDWLWLVDSSURSULDWHWRJLYHQDOR[RQHEDVHG
XSRQWKHLQIRUPDWLRQLQWKHGUXJIDFWVODEHO
2YHU WKH &RXQWHU +XPDQ 'UXJV /DEHOLQJ 5HTXLUHPHQWV )HG 5HJ 0DU7KHLQIRUPDWLRQWKDWPXVWEHFRQWDLQHGRQWKH27&SURGXFWODEHOLVVHWRXWLQ
IHGHUDO UHJXODWLRQV DQG LQFOXGHV HOHPHQWV VXFK DV WKH DFWLYH LQJUHGLHQW RI WKH PHGLFDWLRQ WKH
SXUSRVHRIWKHPHGLFDWLRQWKHLQGLFDWLRQVDQGDQ\ZDUQLQJVSee &)5†id. DW
†id. DW†Fid.DW†WDPSHUHYLGHQWSDFNDJLQJUHTXLUHPHQWV
)R[KDOOsupra QRWH
5&DOLIIChanging course: A new approach to opioid pain medication at FDA KWWSEORJVIGDJRY>KWWSVSHUPDFF49;040&@
([HFXWLYH2IILFHRIWKH3UHVLGHQWEpidemic: Responding to America's Prescription Drug
Abuse Crisis 2IILFH RI 1DWLRQDO 'UXJ &RQWURO 3ROLF\ KWWSVZZZZKLWHKRXVHJRY
>KWWSVSHUPDFF1<31&@
,1',$1$+($/7+/$:5(9,(:
9RO
235VLQFUHDVHGE\DSSUR[LPDWHO\SHU\HDUIURPWRZKLFKVDZWKHKLJKHVW
QXPEHURIIDWDORYHUGRVHVRQUHFRUG:KLOHDQXPEHURISROLF\DSSURDFKHVKDYHEHHQDWWHPSWHG
WRDGGUHVVWKLVXQSUHFHGHQWHGLQFUHDVHLQSRWHQWLDOO\SUHYHQWDEOHRYHUGRVHGHDWKVLWLVQRWFOHDU
WKDW DQ\ DORQH RU LQ FRPELQDWLRQ KDYH KDG RU ZLOO KDYH D VLJQLILFDQW HIIHFW :KDW EHJDQ
SULPDULO\DVDSUHVFULSWLRQGUXJHSLGHPLFKDVEHHQVKLIWLQJWRZDUGVKHURLQZLWKFRUUHVSRQGLQJ
LQFUHDVHVLQIDWDOLWLHV$UHFHQWZDYHRIGHDWKVDVVRFLDWHGZLWKLOOLFLWIHQWDQ\ODQDORJVPD\VLJQDO
WKHODWHVW±DQGPRVWGHDGO\±ZDYHRIWKHHSLGHPLF
0RVWHSLGHPLFVIROORZDVLPLODUFXUYH±ZLWKGHDWKVULVLQJEHIRUHHYHQWXDOO\IDOOLQJDJDLQ±DQG
LWLVOLNHO\WKDWWKLVRQHZLOODVZHOO7KHTXHVWLRQIURPDVWDQGSRLQWRIPRUDOLW\DQGSXEOLF
KHDOWKLVKRZWRVKLIWWKDWFXUYHVRWKDWWKHIDOOLVTXLFNHUDQGVWHHSHUWKDQLWZRXOGEHLIOHIWWR
IROORZLWVQDWXUDOFRXUVH:KLOHWKHGHYLOLVRIWHQLQWKHGHWDLOVZHWKLQNWKHUHDUHVHYHUDOEURDG
W\SHVRILQWHUYHQWLRQVWKDWZRXOGOLNHO\VKLIWWKDWFXUYHLIEURXJKWWRVFDOH
)LUVWLWLVQHFHVVDU\WREULQJWKHQXPEHURILQDSSURSULDWHRSLRLGSUHVFULSWLRQVDVFORVHWR]HUR
DVSRVVLEOH6RPHLQWHUYHQWLRQVVXFKDVWKRVHWKDWWDUJHW³SLOOPLOOV´DUHVWHSVLQWKLVGLUHFWLRQ
+RZHYHUPRVWSUREOHPDWLFSUHVFULSWLRQVGRQRWFRPHIURPSUHVFULEHUVDFWLQJLOOHJDOO\EXWUDWKHU
IURPPHGLFDOSURIHVVLRQDOVZKRDUHXQDZDUHWKDWWKH\DUHSUHVFULELQJLQDSSURSULDWHO\7KHW\SH
DQGDPRXQWRISDLQDQGDGGLFWLRQWUDLQLQJLQPHGLFDOHGXFDWLRQVKRXOGEHGUDPDWLFDOO\LQFUHDVHG
1DWLRQDO ,QVWLWXWH RQ 'UXJ $EXVH Overdose
Death
Rates
KWWSVZZZGUXJDEXVHJRY>KWWSVSHUPDFF1493@LQWRLQ
5$5XGGHWDOIncreases in Drug and Opioid Overdose Deaths–United States, 20002014 025%,',7<$1'0257$/,7<:./<5(3 ³0RUHSHUVRQVGLHGIURP
GUXJRYHUGRVHVLQWKH8QLWHG6WDWHVLQWKDQGXULQJDQ\SUHYLRXV\HDURQUHFRUG´
,W¶VDFWXDOO\TXLWHGHSUHVVLQJ70+DHJHULFKHWDOWhat we know, and don't know, about
the impact of state policy and systems-level interventions on prescription drug overdose&
'58*$/&2+2/'(3(1'(YLGHQFHRILPSURYHGKHDOWKRXWFRPHV>IURPVWDWHOHJDODQG
SSROLF\HIIRUWV@LVZHDN(0HDUDHWDOState Legal Restrictions and Prescription-Opioid Use
among Disabled Adults1 (1*/ - 0('DPRQJGLVDEOHG0HGLFDUHEHQHILFLDULHV
DXWKRUVIRXQGQRVLJQLILFDQWDVVRFLDWLRQVEHWZHHQRSLRLGRXWFRPHVDQGVSHFLILFW\SHVRIODZVRU
WKHQXPEHURIW\SHVHQDFWHG
:KLOHWKHDEVROXWHQXPEHURISHRSOHXVLQJKHURLQLQWKH8QLWHG6WDWHVLVUHODWLYHO\ORZ
KHURLQDEXVHLVPXFKPRUHGDQJHURXVWKDQSUHVFULSWLRQGUXJDEXVH++HGHJDDUGHWDODrugpoisoning Deaths Involving Heroin: United States, 2000-20131&+6'$7$%5,()KHURLQ
GHDWKVQHDUO\TXDGUXSOHGIURPWR
See generally5RVH$5XGGHWDOIncreases in Drug and Opioid Overdose Deaths–United
States, 2000-2014025%,',7<$1'0257$/,7<:./<5(3
6DOLPD 'DUDNM\ HW DO Applying Farr's Law to Project the Drug Overdose Mortality
Epidemic in the United States ,1- (3,' KWWSVZZZQFELQOPQLKJRY
>KWWSVSHUPDFF4<<13@
7DW\DQD /\DSXVWLQD (7 $/ Effect of a "Pill Mill" Law on Opioid Prescribing and
Utilization: The Case of Texas '58* $/&2+2/ '(3(1' FOLQLFDOO\
VLJQLILFDQWUHGXFWLRQVLQRSLRLGGRVHYROXPHSUHVFULSWLRQVDQGSLOOVGLVSHQVHGDVVRFLDWHGZLWK
LQWURGXFWLRQRISLOOPLOOODZ
7+(/$:$1'32/,&<2)23,2,'6
DQGXSGDWHGWRUHIOHFWEHVWHYLGHQFH:HIXUWKHUVXJJHVWWKDWLQVXUHUPHFKDQLVPVEHPRGLILHG
WRLQFHQWLYL]HHYLGHQFHEDVHGFDUHDQGQRQRSLRLGWKHUDS\VXFKDVWKHUHPRYDORIPHWKDGRQHIRU
SDLQIURPVWDWH0HGLFDLGSUHIHUUHGGUXJOLVWVDQGWKDWVWDWHUHJXODWRU\ERDUGVEHPXFKPRUH
DJJUHVVLYHLQLQYHVWLJDWLQJDQGZKHUHZDUUDQWHGVXVSHQGLQJRUWHUPLQDWLQJSUHVFULEHUVZKRDUH
SUDFWLFLQJEHORZPHGLFDOVWDQGDUGV
6HFRQGDVQRWHGLQWKLVSDSHU0$7LVWKHPRVWHIIHFWLYHFXUUHQWWUHDWPHQWIRUSHRSOHZLWK
VXEVWDQFHXVHGLVRUGHU$FFHVVWR0$7VKRXOGEHGUDPDWLFDOO\LQFUHDVHGDQGJRYHUQPHQWVDQG
SD\RUV VKRXOG UHH[DPLQH SROLFLHV DQG WUHDWPHQW PRGDOLWLHV WKDW GR QRW LQFOXGH 0$7 IRU
LQGLYLGXDOVZLWKRSLRLGXVHGLVRUGHU$FFHVVWRQDOR[RQHVKRXOGDOVREHDSULRULW\LQFOXGLQJ
DGGUHVVLQJEDUULHUVUDLVHGE\WKHFRVWRIWKHPHGLFDWLRQ7KHVORZVKLIWIURPYLHZLQJRSLRLGXVH
GLVRUGHUDVDFULPHLQVWHDGRIWKHPHGLFDOFRQGLWLRQLWLVVKRXOGEHDFFHOHUDWHG
)LQDOO\DQGSHUKDSVPRVWLPSRUWDQWO\ZHPXVWILQGEHWWHUZD\VRIWUHDWLQJSDLQ5HVHDUFKLQWR
DGGLWLRQDO QRQRSLRLG PHDVXUHV WR UHOLHYH SDLQ LV GHVSHUDWHO\ QHHGHG DQG IXQGLQJ LQ WKLV DUHD
VKRXOGEHGUDPDWLFDOO\DQGLPPHGLDWHO\LQFUHDVHG+XPDQVKDYHXVHGRSLRLGVIRUWKHLUHXSKRULF
HIIHFWVIRUWKRXVDQGVRI\HDUVDQGDUHOLNHO\WRFRQWLQXHWRGRVR(YHU\WKLQJSRVVLEOHRIFRXUVH
VKRXOGEHGRQHWRHQVXUHWKDWKXPDQHHYLGHQFHEDVHGWUHDWPHQWLVDYDLODEOHIRUWKRVHZKRZDQW
DQGQHHGLW%XWWKHFXUUHQWHSLGHPLFLVODUJHO\GULYHQE\ZHOOLQWHQWLRQHGDWWHPSWVWRWUHDWSDLQ
ZLWKRSLRLGV:KLOHWKH\VRPHWLPHVIXOILOOWKDWJRDOWKHVLGHHIIHFWVRIWHQRXWZHLJKWKHEHQHILWV
7KHPLOOLRQVRI$PHULFDQV±DQGWKHWHQVRIPLOOLRQVRISHRSOHZRUOGZLGH±ZKRVXIIHUIURPSDLQ
ZLWKQRJRRGZD\WRWUHDWLWGHVHUYHEHWWHU
See generally &RUH\6'DYLV'HUHN&DUUPhysician Continuing Education to Reduce
Opioid Misuse, Abuse, and Overdose: Many Opportunities, few Requirements '58*
$/&2+2/'(3(1'RXWOLQLQJVWDWHRIRSLRLGUHODWHGHGXFDWLRQUHTXLUHPHQWV
&KULVWRSKHU 0 -RQHV (7 $/ Trends in Methadone Distribution for Pain Treatment,
Methadone Diversion, and Overdose Deaths–United States, 2002-2014 025%,',7<$1'
0257$/,7<:./<5(3 GHFUHDVHLQPHWKDGRQHRYHUGRVHGHDWKVDVVRFLDWHGZLWK
DWOHDVWVWDWHVUHPRYLQJPHWKDGRQHIURPWKHLUSUHIHUUHGGUXJOLVWV
See generally/HR%HOHWVN\HWDO)DWDO5H(QWU\/HJDODQG3URJUDPPDWLF2SSRUWXQLWLHV
WR&XUE2SLRLG2YHUGRVH$PRQJ,QGLYLGXDOV1HZO\5HOHDVHGIURP,QFDUFHUDWLRQ1( 8/-
+DUULVRQ -DFREV 7KH 3ULFH RI WKH µ$QWLGRWH¶ WR WKH 2YHUGRVH &ULVLV LV 6N\URFNHWLQJ
%86,1(66 ,16,'(5 $XJ 30 KWWSZZZEXVLQHVVLQVLGHUFRP
>KWWSVSHUPDFF0&66@